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Calcium phosphate (CaP) ceramics having an interconnecting porosity network with pores in the 
appropriate size range for bone ingrowth and re-vascularisation, offer the possibility o f a 
structural-biological matrix for diseased or damaged bone. In order to be integrated by the host 
bone, the bioceramic must have adequate mechanical strength to avoid failure whilst offering a 
bioactive surface for possible bone ingrowth. The aim o f the current research was to address this 
need and to develop novel fabrication procedures, in order to manufacture CaP bioceramics 
consisting of hydroxyapatite (HA), a-tricalcium phosphate (a-TCP) and p-tricalcium phosphate 
(P-TCP), with pores in the correct size range for bone formation and ingrowth, combined with 
sufficient mechanical properties to potentially be used for load-bearing applications.
CaP Open Porous Scaffolds (OPS) and CaP Spinal Fusion (SF) bioceramics have been 
successfully developed with open interconnected porosity ranging from 72-95% by volume. CaP 
bioceramic phases have been prepared with pore sizes from 50- 1000pm, thereby offering a 
structural template for bone ingrowth. Surface defects were found to be the cause for the low 
strengths reported within the OPS bioceramics. Sol-gel solutions that can be applied as low 
viscosity coatings, and which then on sintering form chemical bonds to the CaP surface, were 
used to address the issue o f surface defects, without compromising the structure of the 
interconnected porosity network. The subsequent densification o f the sol-gel ceramic was found 
to increase the strength of the materials. This process resulted in strength increases of up to 
163%, with strengths over 6MPa. The novel fabrication procedures developed can be used to 
produce a range o f diverse CaP bioceramics for specific clinical applications in a range of sizes, 
shapes and chemical compositions. These include novel CaP bioceramics for aiding bone 
ingrowth and re-vascularisation in such applications as spinal fusion, chondylar repair, 
maxillofacial surgery (jaw reconstruction) and impaction grafting. HA/TCP granular materials 
have been developed with improved mechanical resistance and structural characteristics 
compared to a commercially available product, for use as a bone graft substitute material.
This study confirms the potential of the fabricated CaP bioceramics for use as bone substitute 
materials. The research was driven by both the need to improve the materials’ structure-property 
relationship and also to meet clinical needs.
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Glossary o f Terms
Glossary of Terms
Allograft - harvested bone graft in bone banks, taken from donor
patients
Autograft - bone graft taken from patient at time of surgery
Hydroxyapatite (HA) - calcium phosphate based mineral component found in
natural bone -  Caio(PC>4)6(OH)2
physical model simulating a biological environment 
appropriate for biomaterial evaluation 
biological evaluation study o f a biomaterial in a living 
organism, animal or human 
bone forming cell 
bone resorbing cell
bone growth along surface o f implant material, due to 
formation o f hydroxycarbonate apatite mineral 
bone cells found in newly formed osteoid growth 
bone remodelling i.e. continued bone growth 
bone ingrowth into graft material and throughout 
interconnected structure of graft 
a-Tricalcium Phosphate (a-TCP) - calcium phosphate based mineral -  a-C a3(P04)2 










Chapter 1 An Introduction to Calcium Phosphate Bioceramics
The concept of surgical replacement of diseased or damaged bone with a synthetic substance, 
into which bone can grow and regenerate, in order to affect a permanent repair, is extremely 
attractive in orthopaedics.
Currently, bone can be replaced by using autograft and allograft material. However, these 
methods have significant consequences for the patient. Autograft is bone supplied by the patient 
at the time of surgery. A second incision site is created introducing an increased possibility of 
persistent pain or even more serious problems such as infection. Allograft procedures use 
donated bone graft material in order to alleviate diseased or damaged bone. The recipients of 
allogenic bone grafts have a greater possibility of succumbing to infections. In addition, the 
amount of allogenic graft material is severely limited and o f poor quality. Another reason for the 
development o f bone substitute materials is the ever demanding operating procedures that are 
stretching allograft bone stocks to their limits. It is not uncommon for revision joint replacement 
procedures to use allograft material as a structural and biological matrix for graft incorporation. 
Hence, there is a need for a synthetic material that can provide a scaffold for the restoration and 
repair o f natural bone in the body without risking infection. The main requirement for such a 
material would be to maintain structural integrity whilst acting as a support structure for re­
vascularisation.
Over the past thirty years different groups of bone replacement material have been developed 
and their effectiveness as synthetic graft materials assessed. These materials are termed 
bioceramics and include ceramics, glasses and glass-ceramics. Generally, synthetic materials 
become encapsulated by fibrous tissue and become isolated from the surrounding bone when 
placed in an in-vivo environment. Since the early 1970’s, this issue has been overcome by the 
finding that synthetically derived hydroxyapatite (HA) is bioactive in the body. HA is a member 
o f the calcium phosphate (CaP) family and is the main mineral component o f bone. It interacts 
with the host bone by exchanging calcium (Ca2+) and phosphate (PO43') ions to form apatite 
precipitations on the ceramic substrate. This stimulates bone growth and enhances the 
biointegration o f the implant material with the host bone.
The macroporosity is an important criterion in bone ingrowth and plays a key role in a process 
known as osteoconduction, which facilitates possible bone growth. A large interconnected
1
1: Introduction
macroporosity network with pore sizes ranging from 150 - 300pm, aids the infiltration of bone 
and re-vascularisation, allowing bone remodelling. Osteoconductive bioceramics provide a 
scaffold for the ingrowth of bone and are affected by the total porous volume of the material. 
Porous materials have the advantage o f allowing the circulation of bodily fluids and of 
increasing the possibility o f firm attachment o f regenerative bone cells such as osteoblasts (bone 
forming cells) to their surface, hence promoting bone growth at the defect site. However, it is 
inherent that an increase in the total porous volume of an implant decreases its mechanical 
strength. Therefore, there is a trade off between the incorporation o f bony tissue and the 
structural integrity of the ceramic.
The brittle nature of bioactive ceramics such as the calcium phosphates, has limited their scope 
for clinical applications and hence research needs to be conducted in order to improve their 
properties. It is necessary to develop bioactive ceramic CaP materials, which more closely 
approximate the mechanical properties o f bone, in addition to having a porous, interconnected 
structure that can be used to facilitate bone growth.
The goal of the research was to improve on the structure-property relationship of existing 
bioceramics to enable use in load-bearing applications. The bone substitute material should also 
have an interconnected porosity network in the correct size range for bone ingrowth.
1.1 Aims of Research
• To develop and fabricate calcium phosphate (CaP) bioceramics, consisting 
hydroxyapatite (HA), a-tricalcium phosphate (a-TCP) and p-tricalcium phosphate (p- 
TCP), with pores in the correct size range for bone formation and bone ingrowth. This 
necessitates the fabrication of materials with an interconnected hierarchial macroporosity 
network, having pores in the 150 - 300pm size range, for continued bone ingrowth within 
the synthetic bone graft material.
• To improve the structural integrity and mechanical properties o f the materials, whilst 
retaining the interconnected macroporosity network required for bone remodelling.
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• To produce materials that can be tailored in size and shape, and also in chemical 
composition.
• To develop novel fabrication techniques to show the diversity o f applications possible 
with the materials developed, and the versatility in the range of samples that is possible to 
produce.
• To develop bioceramics for specific clinical applications that includes spinal fusion 
interbody applications, chondylar repairs (knee defects), block material for potential use 
in maxillofacial surgery (mandible/jaw reconstruction) and a granular material for use in 
impaction grafting in revision hip procedures.
1.2 Thesis Layout
The research presented here is organised into four main chapters, these being; Literature Review , 
Materials and Experimental Methods, Results and Discussion and General Discussion and 
Conclusions. The Literature Review chapter gives a detailed review of current bone substitute 
materials and their applications, the need for synthetic alternatives and details o f some general 
fabrication techniques for the production o f synthetic bone substitute materials. The Materials 
and Experimental Methods chapter outlines the novel fabrication techniques developed, and the 
methods and apparatus used to characterise the materials that were produced. The results 
obtained, along with an analysis of these findings, are presented in the Results and Discussion 
chapter. In the General Discussion and Conclusions chapter, the major findings of the research 
are brought together and analysed in terms o f the broader context of the subject. The overall 
conclusions from the research are highlighted along with the opportunities for further 
investigation in the future work section of the chapter.
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Chapter 2 Literature Review -  
2.1 Bone
In order to understand the requirements of a bone replacement material, one must understand 
bone histology, structure and biology, in addition to the factors that govern and affect the 
remodelling and development of bone. This section reviews these properties from the point of 
view of a materials scientist. Factors that are relevant to the incorporation o f bone into a 
bioceramic graft material are of primary importance from this perspective and therefore this is 
where the focus lies.
2.1.1 Structure o f Bone
2.1.1.1 Cortical Bone
The total adult skeletal mass o f bone comprises 80% cortical bone. It forms the outer layer of 
bone walls and offers support and protection; it can be classed as a biomechanical material [1]. 
The turnover (i.e. remodelling rate) of cortical bone is slow in comparison to the rapid turnover 
in cancellous bone (spongy or trabecular bone). However, cortical bone has an important role in 
bone remodelling (section 2.1.4). It supplies the only source for new bone forming cells that 
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Figure 2.1: Structure o f  cortical bone [3]
Figure 2.1 above, indicates how cortical bone consists o f long, cylindrical concentric layers of 
bone surrounding a capillary. It is these osteons (or Haversian systems) that are the fundamental 
functional unit o f cortical bone [4]. The importance of these osteons as far as producing a 





Cancellous bone comprises 20% of adult skeletal bone mass. It is metabolically active and 
consists of a lattice o f large plates and rods known as the trabeculae. Figure 2.2 shows the 
structure of cancellous bone.
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Figure 2.2: Structure o f  cancellous (trabecular) bone [3]
Bone marrow occupies the intertrabecular spaces in living bone [5]. The main differences in the 
function of the two varieties of bone are that cancellous bone is far more metabolically active 
and thus controls mineral homeostasis [6]. To a lesser extent it offers structural support, but not 
the biomechanical properties offered by cortical bone [7].
Cancellous bone surfaces contribute to more than 61% of the total bone surface. This is due to 
the fact that the trabecular surface to volume ratio is eight times greater than in cortical bone. 
This explains the large porosity in cancellous bone and why it is the main site for bone 
remodelling activity and bone turnover regulation [1].
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Figure 2.3 illustrates the structural differences between cortical and cancellous bone.
Compact
bone
j G a n c e l l o u ^
Cancellous 
bone (plate)
Figure 2.3: Structural differences between cortical (compact) and cancellous (trabecular) bone
[8]
2.1.2 Composition and Hierarchial Structure of Bone
The skeleton is an adaptable and well architectured frame but also is a dynamic mineral reserve 
bank in which the body stores its calcium and phosphate ions [3]. Bone cells account for only a 
small portion (~ 2%) o f the entire organic component of bone, most o f which is osteoid 
(mineralised bone tissue) produced by bone forming cells [8, 9]. The composition of dried bone 
by weight is 70% mineral and 30% organic. The mineral component consists o f 95% 
hydroxyapatite -  Caio (P O ^  (OH)2, the remaining 5% includes bone apatite impurities such as 
carbonate ions and small amounts of magnesium, sodium, potassium and fluoride and chloride 
ions [10, 11]. The main mineral component o f bone is hydroxyapatite, which is a member of the 
calcium phosphate family [12], The organic component o f bone consists o f 98% matrix and 2% 
bone cells. The matrix mainly consists of 95% collagen and 5% noncollagenous proteins [5]. 
Typical bone cells (section 2.1.3) include bone forming cells (osteoblasts), bone resorbing cells 
(osteoclasts) and cells that originate from osteoblastic formation when surrounded by newly 
formed matrix (osteocytes) [13].
It is important to understand the structural relationships present in bone in order to understand 
the mechanical properties o f bone material. There is a hierarchial structural organisation to bone, 
making the material heterogeneous and anisotropic as well as endowing viscoelasticity [14]. 
Figure 2.4 illustrates this hierarchy.
7
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B o n e




Figure 2.4: The hierarchial structure o f  bone [15]
It can be seen that the structural organisation of bone is as follows:
(1) Cancellous and Cortical Bone.
(2) The Macrostructure: 10 -  500pm, including Haversian systems, osteoid growth and
single trabeculae.
(3) The Micro structure: 1 -  10pm, including lamellae and collagen fibrils.
(4) The Nanostructure: this includes collagen molecules and bone crystals, mainly
hydroxyapatite.
2.1.2.1 Cancellous and Cortical Bone
Both types of bone (cancellous and cortical) can be distinguished by their porosity or density 
[16]. Due to the broader range of densities present in cancellous bone than in cortical bone, there 
is also a wider range of mechanical properties for cancellous bone depending on density, location 
and microstress analysis [15]. The preferred direction of growth for the trabecular struts is down 
the main stress trajectories of the bone -  this is known as W olffs  law [16, 17]. Cortical bone is 
inherently denser and therefore mechanically a more robust material, but it is also affected by 




The osteons present in the hierarchial structure consist of lamellar sheets (mineralised collagen 
fibrils) wrapped in concentric layers around a central canal to form what is known as an osteon 
or Haversian system. Single osteons are usually 150 -  250pm in diameter running roughly 
parallel to the long axis of the bone. For bone ingrowth to occur, a minimum porosity size for 
osteoid growth is required [15], this relates to the diameter of the single osteon. The concentric 
lamellar layers of an osteon surround a supply route for bone cells known as the Haversian canal. 
It is an important structural parameter when considering porosity requirements for replacement 
bone graft material [18].
2.1.2.3 Microstructure
The lamellae found in the osteons are 3 -  7pm in thickness. The most common model proposed 
is that the lamellae lie parallel to each other down the long axis of the osteon [15]. Bone is 
anisotropic in both its structure and properties. The lamellae, which consist o f bundles of 
collagen fibres, are orientated at different degrees within the osteon. Nanoindentation methods 
can now resolve that the orientation and properties o f the lamellae are anisotropic [19].
2.1.2.4 Nanostructure
The nanostructure and sub-nanostructure of bone is made up o f collagen fibres, surrounded and 
infiltrated by mainly hydroxyapatite bone crystals. The dimensions o f bone mineral crystals are 
50 x 25 x 3 nm [16]. Collagen fibres constitute the shape-forming structural framework o f bone 
in which the hydroxyapatite crystals are situated. The hydroxyapatite confers rigidity to the 
collagen framework [1].
It is at this level that bone can be described best as a complex engineering composite material. 
Mineral crystals reinforce the collagen fibres and typical fracture and viscoelastic properties 
cannot be explained by typical molecular mechanisms. Figure 2.5 illustrates a typical stress- 
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Figure 2.5: Stress-strain compression curves fo r  cancellous bone. As relative density increases,
Young’s modulus also increases [16]
It can be seen that bone is a unique material with several distinct levels o f structural organisation. 
Knowledge o f this hierarchial organisation is needed in order to have complete understanding of 
its mechanical properties [11].
2.1.3 Bone Cells
Bone is a specialised connective tissue composed o f intercellular calcified material, the bone 
matrix and three cell types. Osteoclasts are multinucleated giant cells involved in the resorption 
and remodelling o f bone tissue. Osteoblasts are bone forming cells, these synthesize the organic 
components o f the matrix. Osteocytes are bone cells that are found in cavities within the matrix 
[8],
2.1.3.1 Osteoclasts {osteon, bone + klastos, broken)
Osteoclasts resorb mineralised bone matrix. An osteoclast is a multinucleated giant cell that 
ranges in diameter from 20 -  100pm (containing as many as 100 nuclei per cell) [3]. Actively 
resorbing osteoclasts are usually found in cavities on bone surfaces, known as Howship’s 
lacunae. Osteoclasts are derived from the fusion of bone marrow-derived cells. Bone growth 
occurs on the trabeculae of cancellous bone as its mean surface to volume ratio is eight times 
greater than that for cortical bone [1]. Osteoclasts adhere to the bone surface, which acts as a
10
2: Literature Review
permeable seal to maintain the microenvironment for bone resorption to occur [13]. This is made 
possible due to the formation o f a ruffled border which is bone surface facing to ensure the 
integrity of the microenvironment. Figure 2.6 shows the formation of this microenvironment and 
how osteoclasts help to resorb mineralised bone matrix.
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Figure 2.6: The process o f  bone resorption. Bone matrix is removed and the products o f  bone 
resorption are taken up by the osteoclasts' cytoplasm and eventually transferred to blood
capillaries [8]
The osteoclast secretes collagen and other enzymes and pumps protons into sub cellular pockets 
(the microenvironment mentioned above), promoting the localised digestion o f collagen and 
dissolving calcium salt crystals [8]. As a consequence o f this, osteoclasts are polarised when 
active [15]. The life span of an osteoclast in vivo appears to be up to 7 weeks with a half-life o f 6 
-  10 days. To summarise, the osteoclasts solubilise both the mineral and organic component of 
the matrix ready for remineralisation [10],
2.1.3.2 Osteoblasts {osteon, bone + blastos, formation)
Osteoblasts are bone-forming cells. These synthesize and secrete unmineralised bone matrix (the 
osteoid) [3]. The osteoid (~ 10pm in width) is key to the development o f new bone matrix and 
remodelling, be it from growth, healing or disease. Osteoblasts also participate in the 
calcification of bone and help regulate the flux o f calcium and phosphate ions in and out o f bone.
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Osteoblast cells are essential to bone remodelling. The schematic in figure 2.7 illustrates the 
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Figure 2 .7: Intramembranous ossification [8]
The bone remodelling that is shown in figure 2.7 above is described in greater detail in section
2.1.4.1 -  Formation of Bone Growth - Osteogenesis. Osteoblasts synthesise collagen and form a 
matrix that traps cells. Meanwhile, the osteoblasts differentiate to become osteocytes. The lower 
part of the illustration (figure 2.7) shows osteoblasts being trapped in newly formed bone matrix, 
which is the beginning o f osteocyte growth [8]. Osteoid is the secretion o f unmineralised bone 
matrix (from the osteoblastic cells) that leads to the synthesis o f the organic bone matrix. 
Osteoblasts require a scaffold (e.g. trabecular or Haversian system) on which to synthesise the 
osteoid [20].
2.1.3.3 Osteocytes (osteon, bone + kytos, cell)
Osteocytes, which derive from osteoblasts, lie in the Howship’s lacunae situated between 
lamellae of the matrix [19]. These cells are formed after the bone forming osteoid stage and are 
20 -  60pm in size. This allows fluid flow to transfer information to surface cells. Osteocytes may
(1) stabilise bone mineral by maintaining the ionic concentration that controls the efflux o f 
calcium ions, (2) detect microdamage and (3) respond to strain in order to influence and adapt 
modelling behaviour through cell-cell interaction [1]. They play a key role in the restructuring 
process that constitutes the regulation of mineral activity and the sensing o f strains [8].
12
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2.1.4 Bone Remodelling and Osteogenesis
Bone remodelling produces and maintains bone that is both biomechanically robust and 
metabolically active. Mature bone is superior to immature (woven) bone from a structural point 
o f view, however the quality o f mature bone deteriorates with time. Thus bone must renew or 
replace itself continuously [9]. The remodelling process has many different influential effects on 
bone quality at the tissue level. It helps to respond to local stresses by changing its 
microarchitecture and replacing dead or hypermineralised bone [14]. Bone forming surfaces are 
characterised by a covering of osteoblasts. Resorbing bone surfaces have cavities that contain 
osteoclasts [6]. The concept of bone remodelling is that every bone-remodelling unit (BRU) is 
initiated by the activation of osteoclastic cells [17]. An activation-resorption sequence occurs 
called coupling. The process is followed by new bone formation by autoinduction [20]. In which 
both the inductor cells and the induced cells are derived from ingrowing cells of the host bed. 
During remodelling, bone surfaces may be in one of three functional states: forming, resorbing 
or quiescent [21]. The system is more complex than a simple chemical stimulus and direct cell 
response. The remodelling process demands tight regulation and fine-tuning o f osteoclast and 
osteoblast activity [10].
2.1.4.1 Formation of Bone Growth - Osteogenesis
Figure 2.7 illustrates the processes that occur during bone remodelling and these are explained in 
detail here. For the removal and replacement o f pre-existing bone to take place, the bone surface 
must be activated and mineralised in six consecutive steps. Once concluded (be it a new osteon 
or trabecular surface area) the new ossified tissues and bone structure can be said to have 
undergone osteogenesis. These stages are as follows:
(1) Resting: Inactive surfaces are termed in the resting stage. This consists o f about 80% 
cancellous and cortical bone at any one time [7].
(2) Activation: The conversion of quiescent bone surface to a level whereby resorption 
activity takes place is referred to as activation. The recruitment of osteoclasts is required 
in order to resorb mineralised bone tissue [1,6].
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(3) Resorption: Erosion of bone takes place due to the intimate contact o f osteoclasts with 
the exposed surface bone. This creates cavities known as Howship’s lacunae. The mean 
depth of erosion is around 60pm [1].
(4) Reversal: The coupling o f osteoclasts and osteoblasts occurs at this stage due to the lack 
of osteoclasts and the presence o f mononuclear cells within the cavities. Osteoblast 
stimulating factors are released from the bone matrix in order to polarise the osteoblasts 
[12].
(5) Formation: Matrix syntheses followed by extracellular mineralisation are the two stages 
of bone formation. The new osteoblasts begin to deposit a layer o f bone matrix referred 
to as the osteoid seam.
(6) Mineralisation: There is a negative bone balance as a result o f bone remodelling. 
Creating a negative bone balance conserves trabecular bone next to the marrow. 
Remodelling increases as a result o f disease [20]. Mineralisation by osteoblast activity 
occurs automatically as a result o f forming an osteoid seam.
Matrix formation occurs at the interface between osteoblasts and osteoid growth and is the basis 
for bone remodelling. Full regeneration o f bone only occurs once complete mineralisation has 
taken place [3]. This is known as osteogenesis and complete mineralisation can take between 3 -  
6 months [5]. It is this development of osteoid growth and replacement o f immature bone and old 
bone via resorption and remodelling that is known as bone regeneration and osseous growth [1].
Remodelling continues throughout life, secondary bone is continuously resorbed and replaced by 
new generations o f bone e.g. cortical bone has a mean age of twenty years and cancellous bone 
one to four years [12]. The process helps to maintain the strength of bones for load bearing and 
to keep the strains experienced from exceeding the modelling threshold, thus reducing 
microdamage. In addition, calcium homeostasis is maintained in order to help repair any 




Bone grafts have been employed for bone repair for more than a hundred years [17]. The 
following section will assess the demands placed on a bone graft, the different bone grafts 
available, the advantages and disadvantages o f these grafts and ultimately the need to develop a 
synthetic alternative for use when bone grafting.
2.2.1 Osteoconduction and Grafting
Bone graft tissues are osteoconductive [12, 20, 22]. This is the ability o f a material to encourage 
bone growth along its surface when placed in the vicinity o f viable bone or differentiated bone- 
forming cells. Figure 2.8 represents a structural allograft from the iliac crest, which is located in 
the pelvis. Note the highly porous cancellous bone area that is necessary for full osteogenesis 
and marrow formation due to its high surface to volume ratio, thus termed a metabolically active 
material.
Figure 2.8: Bone graft material from  iliac crest in the hip (whole picture ~ 25mm) [23]
Bone grafting is a dynamic procedure. A successful bone graft must interact and exchange 
calcium and phosphate ions with the host in order to provide functions for and allow 
osteogenesis whilst maintaining mechanical support [22, 24]. Therefore, over time the structure 
is completely encased in remodelled bone deposits from the host [25]. Figure 2.9 below 
illustrates the three-dimensional relationship and time sequence for the incorporation o f a bone 
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Figure 2.9: Ideal bone graft material fo r  incorporation o f  osteoid growth [24]
Initial migration of fluid and osteoprogenitor cells into the porous structure allows an excellent 
surface area on which bone cells can operate [12]. The porosity is key in order to allow bone 
cells such as osteoclasts (20-100pm), osteoblasts (15-30pm) and osteocytes (20-60pm) to 
provide fibrovascular tissue growth which is followed by further cemented bone layers on top 
leading to lamellar bone and osteoinduction (osteons ~ 150-250pm) [12].
Bone grafts can be classified as either bulk or particulate (granular) or structural and non- 
structural, depending on their purpose [26]. Particulate grafts are used for non-structural 
functions (e.g. space fillers) where as structural grafts must be able to withstand the forces 
applied to the host area. This occurs in bulk bone grafts such as for large bone segmental defects.
There are two main bone grafts used: autografts and allografts. It is necessary to assess and 
evaluate these bone grafts before understanding why there is a growing demand for a synthetic 
bone graft material.
2.2.1.1 Autografts
Autograft material is bone stock taken from the patient at the time o f surgery. Due to the 
difficulty in finding a suitable donor site coupled with the high rate o f donor site morbidity, it is 
a procedure rarely used [22].
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Autografts are described biologically as “the golden standard”. They facilitate osteogenesis. 
Cancellous autografts with their high surface area, high porosity and pore interconnectivity, 
permit fluid flow and capillary growth, and allow bone cells to dominate bone resorption [27]. 
Remodelling and the incorporation o f bony tissue throughout the graft is usually complete within 
a year [12]. However, early stabilisation due to the bioactivity offered by the graft is the reason 
for good early fixation [22].
2.2.1.2 Allografts
Allograft material is harvested and placed in bone banks that must adhere to the standards of 
such institutes as the American Association of Tissue Banks [22]. It is harvested from joints and 
bones of patients who are severely affected by such diseases as osteoarthritis and osteoporosis. 
There is also a limited supply of allograft. Due to disease and infection, it can take up to three 
hip joints to provide enough cortico-cancellous allograft material for one revision hip 
replacement. Thus, there is always a negative growth rate in the bone banks. The material is 
preserved by freeze-drying methods, however this significantly reduces the immune response 
[22]. There is always some doubt in the patients’ minds about the risk of transmission of 
infections, even though every bone sample accepted as allograft is treated and analysed [28].
The main difference in the two grafts biologically is that necrotic (dead) graft bone remains in 
the allograft significantly longer than autografts [29]. Vascular ingrowth is slower and less 
extensive than with autografts. Depending on the degree of generic disparity between the host 
and graft there may be adverse histological responses such as inflammation [30].
Allograft is used in greater quantities than autograft mainly to avoid a second morbidity site and 
due to the difficulty in harvesting a sufficient amount of bone material from the patient’s own 
skeleton [26]. Allograft material can be cortical, cancellous or a combination o f both. Therefore, 
it can offer an excellent combination of properties from structural support to bioactivity and 
osteogenesis. Bone grafting is a necessity in such procedures as revision Total Hip Replacement 
(THR) and revision Total Knee Replacement (TKR) [31-33].
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2.2.2 Applications o f Bone Grafts
A brief introduction to some of the procedures in which bone grafting is used is now presented. 
It demonstrates the diversity and wide range o f their application. It also indicates how many 
different forms of bone graft are required from bulk material through to particulate and powder 
forms o f bone graft.
2.2.2.1 Total Hip Replacement (THR)
In the UK each year 50,000 hip replacement operations are performed with a 1% failure rate and 
of those 15% are hip revisions [28]. It is quite common for people to outlive their first hip and 
have two, three or more hip revisions.
The goal of THR has remained the same since the procedure began in the 1960’s, that is, to 
achieve a durable, painless and functional hip in those people affected by severely limiting 
arthritic conditions [31-33]. In THR both parts of the joint, the femoral head and the acetabular 
socket, are replaced. During hip replacement surgery, on the femoral side, the head is removed 
and a surgical grade chrome cobalt steel or titanium stem with a metal or ceramic ball is inserted 
into the medullary canal of the femur. The stem is usually fixed using polymethylmethacrylate 
(PMMA) cement. On the pelvic side, an area o f the acetabulum is removed and a 
hemispherically shaped hole is forged out. A polymer or ceramic cup is inserted and fixed 
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Figure 2.10: Hip prosthesis [34]
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The materials selected for their application in THR (figure 2.10) have been chosen due to their 
low weight and high strength (stainless steel or titanium for implant stem and implant ball), and 
their low coefficient of friction (polymer or ceramic insert). The integration of the cup into the 
acetabular bone, by cementing, is done to achieve an intimate contact between fixation and host 
bone.
THR expanded in the 1960’s and 1970’s due to the pioneering work of Sir John Chamley (1910 
-  1983). He devised the first low friction arthroplasty whereby both ball and socket were 
replaced with the acetabular and femoral components usually fixed in place with bone cement. 
The innovative feature was the use of very small femoral heads with a diameter o f 22.5mm. 
These were fixed in place using acrylic cement and articulated on a polyethylene socket - hence 
the term metal on plastic joint. This particular design dramatically improved the quality of life 
for patients. The procedure is quicker with shorter hospital stays and more consistent pain relief 
than previously experienced with existing procedures [34]. Many variations have been developed 
including McKee’s metal on metal joint and ceramic-ceramic ball and socket prostheses [35].
The stability of the implant depends on the mechanical fixation and interlocking of the implant. 
If cyclic movement under loading is less than 75 pm, then living bone forms up to the surface of 
the implant [34]. Hip replacements are subjected to two kinds o f micromovement post-surgery. 
One is cyclic, which is recoverable, the second is migration, which is non-recoverable 
displacement. If this subsidence occurs early on then there is a high probability of failure and 
hence the need for revision operations.
2 2 2 .2  Impaction Grafting
Impaction grafting fundamentally addresses the problem of bone stock loss, instead of the 
compensation of bone. The large femoral cavity in hip revision operations affected by bone loss 
(due to subsidence) is filled with morsellised cancellous bone harvested from donor femoral 
heads [37]. The ideal graft should be mechanically stable, have at least osteoconductive 
properties, be free from infection, readily available and easy to store. The problems with 
allograft material associated with impaction grafting are its availability, quality, antigenicity, risk 
of infection and storage problems. However, if  the allograft does not offer a site for the 
development of vascularisation (i.e. osteoclastic and osteoblastic activity) migration and 
subsidence of the femoral stem can occur [31, 37, 38].
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One procedure for impaction grafting is in hip revision, whereby stem loosening occurs due to 
both cyclic and migration movement o f the stem. The impaction grafting procedure is described 
and shown in figures 2 . 1 1  and 2 .1 2 .
A flexible stainless steel mesh is fixed peripherally to the femoral head and acetabular region in 
order to secure rigidity. Frozen morsellised allograft bone chips are then impacted into the mesh 
and femoral head by metal impactors and the use of a hammer. The allograft is compressed 
tightly with the hammer to ensure good fixation (figure 2.11). Usually a second layer o f allograft 
is then layered on top of the first in order to optimise the packing properties of the allograft (i.e. 
good fixation). Finally a polyethylene cup is cemented in place with bone cement in order for the 
implant ball to articulate against the femoral head (figure 2 . 1 2 ).
Figure 2.11: Allograft is compressed tightly with a hammer [31]
Figure 2.12: A polyethylene cup (L) is cemented in place with bone cement [31]
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Allograft material is not consistent in its properties both biologically and structurally; this is the 
main reason why there is a need for a bone replacement material.
2.2.2.3 Bone Grafting in Total Knee Replacement (TKR)
The use o f bone graft for femoral component revision can be subdivided into two broad 
categories. Particulate graft usually fills small defects less than 1cm3. Structural allograft is often 
used for defects greater than 1cm3 [29, 32, 33, 39]. Structural bone grafting in knee revision 
operations generally has good results at short-to-medium follow-ups compared with THR [32]. 
Impacted morsellised allograft is used in revision TKR [29, 33]. The goal for revision TKR is the 
same as for revision THR. Figure 2.13 shows significant bone loss in the knee joint o f a patient 
(> lcm 3), needing bulk allograft to offer structural support.
Figure 2.13: View o f  the major defect component looking down on the knee jo in t [32]
In a situation where particulate (granular) allograft material is used it is important that the chips 
are not made too small because a slurry will be formed that cannot support the implant [33].
Histological evaluation provides the only absolute evidence for graft viability -  stability and 
bony tissue incorporation. To achieve this goal, integrity o f the implant-interface, graft-host bone 
interface and a securely supported stem are imperative in the tibia and femur [33, 40]. In the best 
case scenario, due to the poor biocompatibility of allograft compared to autograft, the allograft 
may show healing at the graft-host junction. This is followed by vascular invasion and 
osteoclastic resorption o f the existing dead bone followed by osteoblastic deposition o f viable 
bone over a time period of a few days [29].
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Allograft material is in much greater supply than autograft, even though it is biologically inferior 
to autograft. However, as previously discussed, allograft reserves are rapidly becoming depleted 
and there is a demand for a synthetic alternative to combine the biological properties of 
autografts and the structural support o f allograft without the risk o f infection or antigenicity.
2.2.2.4 Interbody Spinal Fusion Applications
Over 200,000 surgical spine procedures are performed in the United States each year. This 
compares with 50,000 in the United Kingdom and Europe. This relatively new procedure is an 
attempt to fuse two interbody vertebrae by creating a bone regenerative bridge. This bridge must 
have osteoconductive and osteoinductive properties combined with a stiff, strong durable 
structure that allows further remodelling and complete osteogenesis (i.e. the implant is 
completely overtaken by the host capillaries, cells and tissue) [41].
Lumbar interbody fusions use cage devices made of titanium (due to its low weight and high 
strength) to improve the overall stiffness o f the graft. The structural allograft sits inside the cage 
and allows osteoconduction through the transfer of lattice ions to and from the graft and host. 
Spinal fusion rate (ingrowth of bone into the graft) increases with mechanical loading [13, 19], 
therefore, it is necessary to provide stress shielding for the main regenerative graft [14, 42]. 
Stress shielding is a phenomenon undertaken by cortical bone in certain parts of the body in 
order to relieve the cancellous bone region of the high stresses that could cause failure. A 
titanium cage is used as an attempt to create an optimal structural environment for fusion due to 
the high compressive forces subjected to the vertebrae in the spine [43]. The graft material is 
either in bulk or particulate form and is fixed inside the titanium cage in contact with the two 
vertebrae.
2.2.2.5 Maxillofacial and Long Bone Segmental Defects
Maxillofacial operations require very little structural support compared with the high mechanical 
loading of the hip, knee and spine. Therefore, usually it is possible to for the surgeon to remodel 
the whole (or part) o f the mandible without having to undertake an autograft procedure.
Long bone segmental defects such as caused by fracture o f the tibia, flbia or femur are extremely 
difficult to graft as there is often a need for a structural cortico-cancellous graft that enables good
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vascularisation properties and offers structural support [44]. The quality o f graft needed is very 
high and these applications can be termed “specialised”.
To summarise, there is a need to produce in large supply a synthetic alternative to natural bone 
graft material in both bulk and particulate form. The material must be able to influence the 
activity of osteoclastic cells which in turn stimulate osteoblastic development and enhance 
bonding of the implants to host bone. This biological requirement must be conjoined with a 
structurally long lasting framework for complete incorporation of bony tissues. The examples of 
procedures required to restore bone stock loss or to increase the quality o f the bone at the defect 
site is ever increasing, as is the need for both bulk and particulate forms of synthetic graft 
materials for more advanced, specialised techniques.
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2.3 Requirements of a Bone Replacement Material - Calcium Phosphate
Due to the immunological restrictions and limited availability associated with both autografts 
and allografts, there is a need to find a synthetic alternative that is able to offer both potential for 
osteogenesis and structural support in both bulk and particulate form.
The following section details the requirements o f a synthetic bone graft as well as the potential 
o f a replacement material to fulfil this obligation i.e. to be a successful biomineralised 
regenerative bone replacement. The synthetic material should offer the same properties as a bone 
graft, which is a full structural and biological matrix for complete revascularisation o f the 
implant area.
The minimum requirement for a graft material is to interact with the host’s mechanical and 
biologic environment in order to induce osteogenesis (complete bone remodelling over time) 
[22]. It is this criterion that finally governs the potential of a graft material for bone replacement 
applications. The main requirements of a bone replacement material are:
1) Bioactivity -  chemical interaction with bone required for bone formation.
2) Mechanical Properties -  need to ensure structural integrity o f implant.
3) Porosity -  to allow remodelling of osseous tissues (osteogenesis).
It has been found since the 1970’s that certain ceramic materials exhibit unique biological 
properties when placed in an osseous environment [45-48]. Table 2.1 shows a list o f synthetic 
calcium phosphate (CaP) bioceramics and other materials developed commercially that exhibit 
this property.
Calcium phosphate’s are a class of ceramics that can be termed bioactive. CaP ceramics exhibit 
osteoconductivity and have been shown to possess a strong CaP-bone interface [49-53]. The 
materials properties required of a bone replacement material (detailed above), along with details 
o f chemical activity are detailed in this section.
The motivation for using CaP ceramics was initially due to the finding that calcium phosphates 
were biocompatible with bone mineral [54, 55], It must be remembered that bone mineral is in 
the form of hydroxyapatite (HA -  Caio (P O ^  (OH)2 ), which is a member of the calcium
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phosphate family. A layer o f biologically active hydroxycarbonate apatite must form for a bond 
with tissue to occur. It is the rate of hydroxycarbonate apatite formation that varies greatly from 
the pure stoichiometric form of hydroxyapatite to the calcium deficient tricalcium phosphate -  
Ca3 (P04)2 (TCP) [55]. Due to the ever-increasing joint replacement and revision procedures that 
now occur, there is a growing demand for a biocompatible synthetic bone replacement material.
CaP ceramics have outstanding properties. These include a similarity in chemical composition to 
bone mineral, bioactivity and the ability to promote cellular function leading to formation of a 
strong bond between bone and the implant interface [49-56]. In addition, they have the unique 
property known as osteoconduction and with the correct pore size distribution even 
osteoinduction [55-57]. Osteoconduction is the ability to invite cell growth to supply bone 
formation, and osteoinduction is the capability to provide osteogenesis i.e. bone remodelling as 
would occur in natural bone.
Name Manufacturer Material
Endobon Merck, CH Biological hydroxyapatite 
(HA)
BoneSource Orthofix Inc., USA Tricalcium phosphate (TCP)
Vitoss Ortho vita, USA Tricalcium phosphate (TCP)
Triosite Zimmer, USA Biphasic HA/TCP
BoneSave Stryker Orthopaedics, USA HA/TCP granules
OP-1 Stryker Biotech, USA Recombinant human BMP-7 
with type I collagen
Bioglass US Biomat. Corp., USA Bioactive glass
Table 2.1: List o f  some well known commercial synthetic calcium phosphates and other
materials developed commercially.
CaP ceramic graft material offers the possibility o f being completely remodelled by the host 
surrounding host bone so that in this respect is like a scaffold material offering initial support 
and integrity to a defect area (e.g. bone loss due to osteoporosis) [50].
Therefore, the possibility o f calcified tissue replacement following the implantation o f a CaP 
based substrate is a concept that deserves extensive study. It is essential that the replacement 
material does not suffer deterioration once implanted. CaP implant materials are composed of the 
same ions that make up the bulk of natural bone mineral [54, 58]. As a consequence, when these
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materials are implanted in bone they are capable of participating in CaP solid solution reactions 
at their surfaces.
The one property that bioceramics must have is survivability (i.e. a life span of > 20 years). The 
unique set of requirements set out at the beginning of this section, have made specially designed 
bioceramics one o f the most remarkable accomplishments o f ceramic research. The development 
of CaP ceramics has in the past concentrated upon enhancing the biological response of apatitic 
implants [59, 60]. The future research trends appear to focus on improving the strength o f CaP 
bioceramics without compromising an interconnected porosity distribution suitable for possible 
osteogenesis [50].
2.3.1 Biocompatibilitv of the Calcium Phosphates and Natural Bone Mineral
The biocompatibility of CaP ceramics correlates with statements such as that made by Hench in 
1975 that “an ideal implant material must have a dynamic surface chemistry that induces 
histological changes at the implant interface which would normally occur if  the implant were not 
present” [51]. The success o f CaP compositions can be attributed to the essential roles o f calcium 
(Ca2+) and phosphate (PO34') ions in the natural process of bone regeneration. CaP based 
compounds are osteoconductive and can establish a physico-chemical bond to bone during the 
bone regenerative process. Their degree of reactivity with living tissues, which relates to the 
healing ability, depends on the chemistry as well as on the physical structural features such as 
mineralogical composition, crystalline state, porosity, pore size, interconnectivity o f pores and 
sintering temperature.
Hydroxyapatite ceramics have proved to be biocompatible and bioactive materials that can 
chemically bond with bone; de Groot [61] reports of trials that have been successfully completed 
for repair of bone defects and augmentation o f osseous tissues. The work of de Groot, Best, 
Bonfield et. al [62, 63] on dense sintered synthetic hydroxyapatite, has shown this ceramic to be 
totally biocompatible and to form a direct bond with the neighbouring bone [64-72].
The biocompatibility of the CaP family is not only suggested by its composition, but also by 
results o f in vivo implantation, which according to published information show no inflammation 
and no foreign body response [73, 74]. New bone formation has been found to develop at both
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the edge of a defect and on the ceramic surface; according to many authors it is conducted along 
the hydroxyapatite, forming a bridge between the host bone and the hydroxyapatite [61, 75-77].
Figures 2.14 and 2.15 demonstrate the osseoconduction properties over time o f a synthetic CaP 
implant, indicating excellent biocompatibility. In this experiment a material known as “Synthos” 
is used to induce regeneration o f bony defects in rabbits. Note the increase in size of blood 
vessels in figure 2.15 that is taken 58 days postoperatively [78].
Figure 2.14: Photomicrograph taken at 8 days postoperative showing increased vascularisation 
through implant material Scale lcm  ~ 100pm. [78]
Figure 2.15: Photomicrograph showing the tremendous increase in size o f  blood vessels in 
implant material, associated with osseoconduction and excellent biocompatibility after 58 days
post-operative. Scale lcm  ~  100pm. [78]
The resorption of CaP ceramics has been the subject of many studies [74, 79-81]. It has been 
suggested that the resorption rate of CaP implants is related to their form, chemical composition 
and structure, including macroporosity and microporosity. Both chemical dissolution and cell- 
mediated resorption are involved in the resorption process, which accounts for the bioactivity of 
these materials and also for the osseoconductive properties [52, 53, 57, 74, 79, 80].
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In order to promote remodelling and osteogenic growth, Urist proposed a novel factor to help 
induce bone growth [20]. The factor, Bone Morphogenetic Protein or BMP, is responsible for a 
variety o f events in cellular embryogenesis [62]. An example of a BMP is recombinant human 
BMP (rhBMP), which induces bone formation in a process that mimics ossification. BMPs are 
used in conjunction with drug delivery systems. These range from collagen composites to 
varying polymeric scaffolds to bioceramics. An ideal delivery system that would allow a slow 
release o f the BMPs should be biologically and immunologically active, quickly absorbed and 
supportive of osteogenesis [62]. Large microporosities are formed in CaP bone replacement 
materials, and it is through this medium that BMPs can be released as a drug release mechanism 
in order to promote remodelling.
CaP ceramics have been shown histologically to be mineralised by active osteoblasts, as figure 
2.16 indicates [8 ].
Host Bone





Figure 2.16: The presence o f  bone cells encourages bone remodelling [8]
It appears from the studies previously referred to, that the resorption of CaP biomaterials is 
beneficial to bone formation and that free Ca2+ ions could be considered as the origin of 
bioactivity. However, too much dissolved Ca2+ and PO43' ions, leads to a sharp change in the 
microenvironment that may disturb the activity of the host cells, and create adverse effects on 
tissues [77, 80, 82].
However, the crucial bioactivity demands o f these implant materials must be combined with 
initial mechanical properties comparable to that o f natural bone so that the materials structural 
integrity is upheld [83-85].
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2.3.2 Dependence of Bone Ingrowth on the Pore Size and Pore Distribution -  Tissue Reaction 
and the Effect on Strength
In the development o f CaP ceramics, attention is particularly placed on the influence o f pore size 
on the bone ingrowth behaviour. Macropores of at least 50 - 100pm are required to host the 
cellular and extracellular components of both bone and blood vessels, and those greater than 
150pm are expected to be effective for osseoconduction to be successful [64, 65, 8 6 , 87, 88]. 
Therefore, the control of porosity within CaP ceramics is an important subject for investigation.
The characteristics of porosity strongly affect the mechanical behaviour o f ceramic foams (with 
interconnecting networks o f pores making osseoconduction possible) with compressive modulus 
and compressive strength being highly sensitive to both density and pore isotropy [89, 90, 91]. 
Therefore, implants with larger pore sizes will inherently be weaker as a result o f an associated 
reduction in density, however they may be more successful in promoting osseoconduction [54, 
72].
Numerous authors [65, 70, 73, 80] suggest a minimum pore size o f 150 -  300pm is required for 
sustained healthy bone ingrowth in ceramic structures. There is a general agreement that an 
increase in the volume of bone ingrowth is directly related to an increase in pore size. However, 
some authors [84, 92] have challenged this, suggesting that it is an increase in the connectivity of 
the pores and the frequency o f the pore interconnections, that results in greater penetration of 
bone ingrowth [76].
Since bone differs structurally depending on its function and location in the body, the same pore 
shape and size may not be ideal for all potential uses [20]. Pore size and topography can be 
carefully modulated to control the interconnectivity of the porous network (by changing the 
porosifier size), which has been found to be an important factor in CaP bioceramics [49, 93, 94]. 
Osseous proliferation is sensitive to surface topography, strain and other mechanical stimuli. 
Cells can discriminate against even subtle changes in topography, and they are most obviously 
sensitive to chemistry, topography and surface energy [95].
Previous studies have shown how porous devices are prepared by impregnation: cellulose 
sponges with controlled pore morphology are treated in a hydroxyapatite slurry to obtain the
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bimodal porous structure [8 6 ]. Figures 2.17 and 2.18 show the morphology o f the porous 
structures, and in particular the macro-and microporosity.
Figure 2.17: Morphology o f  porous hydroxyapatite at low magnification, indicating 
macroporosity distribution (25mm=500pm) [86]
Figure 2.18: Morphology o f  porous hydroxyapatite at high magnification, indicating 
microporosity distribution (27mm ^5pm) [86]
Macrostructural analysis has demonstrated from previous studies the complex inter-relationship 
between the structural features o f an open pore structure, pore size and density [57, 63, 96, 97]. 
Compression testing has also demonstrated the effect o f density and macro/microstructural 
anisotropy on the mechanical properties o f the ceramic devices. Figure 2.19 shows the results o f 
a study carried out by Fling, Best and Bonfield [63] on the variation o f compressive stress with 
apparent density (given as the dry weight o f the body divided by the volume) o f a commercially 
available product Endobon®, which is a biological hydroxyaptite (Ca/P ratio o f 1.67). NB. This 
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Figure 2.19: Effect o f  variation o f  the apparent density on the ultimate compressive strength o f
porous HA samples [63]
The results obtained from previous studies on porous HA [63, 8 6 , 89] in particular by Hing, Best 
and Bonfield, underline the importance o f a full structural and mechanical characterisation of 
porous ceramic implant materials, and the extensive study still required to further develop this 
technology.
The strength-porosity correlation may in form the design o f porous CaP ceramics with optimised 
mechanical strengths. Figure 2.20 shows how porosity affects the compressive strength o f  dense 
CaP bioceramics as a result o f the different types o f pore geometry (created by using different 
shaped particles as a porosifier).
2 0 -
Figure 2.20: The compressive strength-porosity behaviour o f  porous HA ceramics with different 
types o f  pore geometry; circle: spherical, triangle: ellipsoid, rectangular: oblate [80]
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Hing and Bonfield et. al [89] also stated how the bone ingrowth has a strong reinforcing effect 
on porous CaP ceramic implants. An increase in ultimate compressive stress from 2MPa to 
20MPa has been reported for coralline porous HA after 100 days implantation (figure 2.21) [79].
200160100
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Figure 2.21: The variation o f  compressive stress as a function o f  implantation time [79]
Porous, interconnected structures that possess a bioactive element, invite ingrowth of bone into 
the implant leading to a more securely fixed and integrated repair. Ideally, porous implants 
should induce a response similar to that o f fracture healing when placed in an osseous 
environment [42, 52, 89].
The porosity distributions that result from the use o f cellulose sponges as a porosifier, give rise 
to both macro-and microporosity (figures 2.17 and 2.18), and also give rise to an interconnected 
network of porosity. All these parameters are important when considering the development of 
CaP ceramics, as through the interconnecting porosity the nutrients are exchanged between 
pores, enhancing bone ingrowth into the scaffold [8 6 , 98]. Thus, the pore size has to be 
considered in order to optimise the mechanical strength o f CaP ceramic bone substitutes for 
clinical load-bearing applications [27, 99-102].
The structural and mechanical properties o f some current bone replacement materials are 
reviewed in table 2.2. The structural and mechanical properties o f cancellous and cortical bone 
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* The content o f bone varies due to its location in the body. 
** Porosity size range in bone can be greater than this.
Table 2.2: Review o f  structural and mechanical properties o f  some current bone replacement
materials.
It can be seen from table 2.2 that it is difficult to combine both an interconnected, high volume 
porosity network, with sufficient mechanical properties for load-bearing applications. Work done 
by Sepulveda and Binner on HA foams illustrates this point. On the other hand, those materials 
with a low volume porosity and isolated porosity have sufficient mechanical properties for 
possible load-bearing applications.
Therefore, the relevance for extensive study into the nature of the porosity and its distribution 
within CaP ceramics is obvious. Special attention must be given to achieve a full characterisation 
of the micro-macroporosity distribution, its morphology and hence resulting effect on 
mechanical properties, in particular compressive strength. It is therefore a challenge to attempt to 
reproduce those structures as found in cortical and cancellous bone [90].
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2.3.3 Chemistry and Phase Transitions of Calcium Phosphates
The calcium phosphates belong to a family of minerals crystallising with a hexagonal symmetry, 
which are found extensively in nature [67, 103]. The chemistry o f calcium phosphates is 
extremely complex with a series o f related inter-substitions possible, giving rise to various 
“impure” and/or calcium deficient apatites e.g. natural bone can have up to 8% carbonate [104], 
resulting in numerous biphasic calcium phosphates being formed.
The general chemical formula of the apatites is IV ^Y O ^X
where M = divalent cation (such as Ca2+)
X = univalent anion (such as OH")
Y = trivalent species usually phosphorous, which forms an oxyanion.
As the name hydroxyapatite (HA) is used for a wide range of compositions beyond the ideal 
formula -  Caio(P0 4 )6(OH)2 (where the Ca:P ratio is 1.67), great caution must be exercised when 
comparing different results. The exact composition seems to be an important parameter, since the 
biodegradation rate, for example, depends on it [64]. Tricalcium phosphate -  Ca3 (P04)2  (TCP) 
has a Ca:P ratio of 1.5 and is termed a calcium deficient apatite.
Commercially produced powder forms of calcium deficient HA sintered at 800 - 900°C begin to 
form p - tricalciumphosphate (p-TCP) as densification occurs. At, or near, 1180°C, p-TCP 
transforms (via an allotropic transformation) into a  - tricalciumphosphate (a-TCP). At this point 
the density decreases slightly due to a volume increase [64]. NB. These transitions only occur in 
low crystallinity grades o f hydroxyapatite.




Figure 2.22: SEM  micrograph o f  J3-TCP sintered at 1100X7 (x700) [67]
Figure 2.23: SEM  micrograph o f  a-TCP sintered at 1200 *C (x2100) [67]
When the atomic ratio o f Ca:P o f an initial slurry mix is different from the ideal Ca:P ratio i.e. 
1.67, the ceramic body sintered at temperatures in excess of 1000°C is generally composed of 
several phases such as HA + calcia (CaO) when the Ca:P ratio is greater than 1.67, or HA + TCP 
when the Ca:P ratio is less than 1.67 [64]. According to Royer et. al [64], TCP appears to play an 
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Figure 2.24: Flexural strength as a function o f  temperature fo r  pure HA, indicating strength 




On transformation from P-TCP to a-TCP, there is a volume increase that introduces compressive 
stresses at the surface. Compressive forces can reduce the critical flaw size and increase the 
corresponding failure strength [104].
At around 1350°C the final theoretical density (-98% ) is obtained. For temperatures above 
1350°C, the flexural strength breaks down because the samples are degraded following the 
decomposition o f a-TCP into tetracalciumphosphate (Ca4P2 0 c>) [64].
The most widely studied CaP ceramics are tricalciumphosphate (TCP), hydroxyapatite (HA) and 
the newest tetracalciumphosphate (which has lower strengths) [62]. The appeal o f the calcium 
phosphates rests largely with their biocompatibility since they are protein free, offer minimal 
immunological reactions, foreign body reactions or systemic toxicity have also been reported 
with their use [89, 104, 105]. The chemical and mineralogical similarity of calcium phosphates 
with the calcified tissue that they are replacing may provide a template for osseous growth 
(regeneration of local environment) and/or subsequent remineralisation [106].
There is evidence that biphasic ceramics (consisting o f a-TCP or P-TCP in conjunction with 
HA) are biologically more active than pure HA ceramics alone [104]. Also the biological 
behaviour of these biphasic CaP ceramics containing P-TCP is superior in terms of new bone 
formation.
Figure 2.25 shows how the sintering temperature affects both the porosity and the compressive 




Pores of 1 -  10pm in diameter allow cell ingress in an implant. In conjunction with this a high 
microporosity volume enhances the wetting of bodily fluids on the implants, which increases the 
surface area for cell interaction. Porosity ranging from 10 -  100pm in diameter helps develop the 
propagation of bone growth. For continued vascular growth and osteoid formation, an 
interconnected pore structure with pore diameters greater than 1 0 0 pm is required whereby 
osteoblasts may form the beginnings o f bone growth. Some authors claim that larger incidents of 
interconnecting pore diameters are required i.e. > 300pm for bony ingrowth, and that it is the 
amount o f interconnectivity and the interconnected pore size that determines the success o f CaP 
implants [81, 82, 84]. The design o f synthetic bone graft material with a porosity network 
mimicking that of the bimodal structure o f bone (i.e. with a cortical-cancellous porosity 
distribution), combined with sufficient mechanical strength to withstand the local forces applied 
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Figure 2.25: The dependency o f  compressive strength and porosity on
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2.4 Fabrication Techniques for Calcium Phosphate Bioceramics
Fabrication processes for CaP bioceramics vary from mechanical slip cast processes to 
hydrothermal and chemical processes such as foaming and sol-gel reactions [108-114].
The main challenge when fabricating CaP bioceramics (as far as bone remodelling and continued 
vascularisation are concerned) is to allow enough interconnected porosity without compromising 
the structural integrity. There is much more scope for fabrication o f cortical bone replicate 
specimens, as the biological requirements in terms of porosity, are not as demanding as for 
porous CaP bioceramics [108]. The final step in the fabrication of CaP bioceramics is nearly 
always sintering by a thermal process. The fabrication processes outlined below are used to 
produce a green body, which is ready for sintering.
2.4.1 Powder Preparation
There are numerous methods for producing synthetic hydroxyapatite and other forms of CaP 
powders. However, the favoured production route is termed the wet chemical method.
It derives from the basis that Ca and PO4 ' ions react in aqueous solution to form the initial 
hydroxyapatite [115]. Reaction 1 below shows a classic example o f synthesising theoretically 
pure hydroxyapatite powder with a Ca:P ratio of 1.67 [109].
10Ca(NO3)2 + 6(NH4)3 P 0 4 + 2NH3.H20  pCsLl0 (P 0 4)6 (OH)2 +20N H 4NO3 (1)
where Ca(N03)2 - calcium nitrate
(NH4)3 P 0 4 - ammonium phosphate 
NH3.H20  - ammonia solution 
NH4N 0 3 - ammonium nitrate
Cajo (P04)6 (OH)2 - theoretically pure hydroxyapatite (Ca/P ratio of 1.67)
Calcium nitrate solution is mixed (in drop steps) in stoichiometric proportions into ammonium 
phosphate solution. This mixture is stirred at a temperature o f 90°C. While stirring, ammonia 
solution is added to keep the pH value at no less than 9 (to avoid formation o f CaO). The 
suspended sediment is then filtered and washed several times until the pH value is equal to 
approximately 7. This final sediment is dried at 110°C for 3hrs and calcified at 700°C for 3hrs.
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The calcified sediment is then dispersed in ethanol solvent and ground for 24hrs. The final 
hydroxyapatite (HA) powder is dried in air (relative humidity -  50%, temperature -  25°C) [109, 
115, 116].
Figure 2.26 shows a TEM micrograph indicating the dimension and sizes of powders produced 
by the wet chemical method.
Figure 2.26: TEM o f  HA powder after calcining at 800°C fo r  3hrs [116]
The ease and convenience of this process is that it allows Ca/P regulation of the final product. 
Crystalline or amorphous HA powders can be produced by varying the Ca:P ratio; (e.g. HA -  
Ca:P ratio 1.67, TCP -  Ca:P ratio 1.5), this may also be achieved by including such phases as 
calcium phosphate hydrate, therefore it is possible to fabricate HA, tricalciumphosphate (TCP) 
or a biphasic CaP material from the base powders.
Utilisation of these powders allows thermo-chemical procedures for producing CaP bioceramics 
in both bulk and granular form. Mechanical processes have also been developed (e.g. slip casting 
and pressing) in order to produce dense CaP bioceramics [114]. Other chemical processes such 
as foaming by polymerisation reactions to produce porous bioceramics have also been explored.
2.4.2 Foaming and Gelcasting
Foaming is a process whereby gas bubbles are introduced to the slurry in order to encourage 
interconnectivity o f the pores on drying and sintering [110, 117-119]. Ultrasonification o f 
powders by the incorporation of methyl cellulose followed by immediate drying at 90 -  100°C
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for 24hrs allows the foaming to occur. Figure 2.27 shows an example of the final HA bioceramic 
after sintering up to 1350°C [117].
Figure 2.2 7: SEM  micrographs o f  HA bioceramic produced by foam ing [118]
High drying temperatures are required to immobilise the slurry particles therefore less drainage 
occurs [110]. Figure 2.28 shows a flow chart o f the foaming process.
The process offers good structural integrity however the interconnectivity between pores is 
limited as the polymerisation process is difficult to control.
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Figure 2.28: Flow chart describing stages offoam ing o f  CaP bioceramics [119]
Gelcasting is very similar to foaming, only that in gelcasting the foam structure produced is more 
ordered and controlled giving circular pores of varying sizes [120]. After foam formation, 
polymerisation o f the monomers on heating promotes setting. The pore size depends on the time
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o f polymerisation and can be varied by expansion o f the foam prior to polymerisation [113]. 
Figure 2.29 shows an example of the gelcast structure.
Figure 2.29: CaP bioceramic produced by gelcasting [120]
Ceramic gelcasts can produce porosities ranging between 40-90%, with pore sizes ranging from 
30-2000pm [121]. Two different amide monomers, combined with a suitable dispersing agent, 
allow for optimum polymerisation [1 1 1 ].
2.4.3 Thermochemical Processes
Fabrication procedures that fall into this category utilise chemical interactions, novel pore 
generators and the use o f high temperatures [76, 112, 114, 116].
2.4.3.1 Burnt-out Polymeric Spheres (BurPS)
The aim of this process is to produce porous CaP ceramics with controlled porosity by using 
various polymeric materials as pore generators [76]. Figure 2.30 shows an example o f a HA/a- 
TCP with PMMA powder as a porosifier.
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Figure 2.30: HA/a-TCP ceramic with 33.8vol% PMMA powder as porosifier [122]
It is possible to induce pore sizes in the correct size range for osteoconduction (150 - 300pm) by 
this process. However, the particles will not make contact and therefore the porosity is isolated. 
Larger number o f particles are required to obtain any degree o f interconnectivity, however the 
structural integrity then becomes compromised.
Pore generators used include polyvinyl butyral (PVB), polymethylmethacrylate (PMMA), 
polyethylene oxide (PEO) and polyvinyl chloride (PVC). Particle sizes can range from 50 -  
250pm (±50pm). Usually particles greater than 250pm in diameter can cause cracking between 
pores, generally weakening the material [76, 122, 123]. Pore generator mixtures can range from 
30-60% depending on the amount of porosity required (i.e. density of sample) and strength 
requirements. The mixed powders (HA and polymer) are then subjected to uniaxial die-pressing 
at pressures of over 20MPa.
Polyethylene oxide (PEO) is believed to be the powder material that offers the greatest degree of 
interconnectivity while PMMA is known to create horizontal cracking on pressing, thus 
compromising the structure [122]. Finally, burn out must be completed in order for the CaP 
ceramic to be non-toxic and bioactive with the host human tissue.
It is difficult to obtain the correct pore distribution and interconnectivity for BurPS materials to 
be considered as potential bone replacement materials.
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2.4.3.2 Calcium Phosphate Sol-Gels
This process is extremely similar to the preparation of CaP powders using the wet chemical 
method. CaP sol-gel materials offer a useful method for preparing tailor made coatings and dense 
CaP [112]. Typically CaP gel can be produced from the reaction given in reaction 2 below:
pH 1 0 - 1 2
10Ca(NO3) 2 + 6 H3PO4 + 2NH4O H  > Caio (P 0 4) 6 (OH ) 2 + 20HNO3 + 2NH3 (2)
r.t.
Figure 2.31 indicates the apparatus and experimental procedure commonly used for gelatinous 
production o f CaP.
Gelatinous suspension 
o fC a 5<P04)6(OH)2
__ M agnet
Aged between Oh 





Figure 2.31: The synthesis o f  CaP gel [124]
A stoichiometrically proportioned amount o f phosphoric acid is titrated into a glass beaker 
containing calcium nitrate. The pH is kept between 10 and 12 by adding ammonium hydroxide at 
a drop at a time. By ensuring the pH is 10 -  12, development o f gelatinous suspension of CaP is 
facilitated. This suspension is aged at room temperature for 0-48hrs, and is filtered and washed 
to obtain the correct Ca/P ratio. Pure HA has a Ca/P ratio of 1.67. TCP has a CaP ratio o f 1.5
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[109]. Limited bioceramics have been prepared using this technique due to the difficulty in 
obtaining the correct Ca/P ratio.
2.4.3.3 Freeze-drying
The freeze-drying process has been used to produce both dense and porous freeze-cast CaP 
bioceramics [116] (powder preparation takes place as described in section 2.4.1), by placing the 
pre-synthesisea gel o f CaP in liquid nitrogen and at iow pressures (3-6 bar, 1 bar ~ 105 Pa). An 
infrared lamp at an intensity in the order of 3000Wm'2 accelerates the process. This procedure is 
maintained for 36-72hrs or until freeze-drying is complete. Figure 2.32 shows sample 
preparation o f freeze-drying.
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Figure 2.32: Sample preparation o f  freeze casting [124]
The green compacts thus produced are then heated and sintered for three hours at a temperature 
range of 1100-1350°C depending on choice o f phase composition [116].
In contrast, porous CaP ceramics produced by freeze-drying methods utilise the vaporisation of 
water vapour as a porosifier. After freeze-drying at -60°C, samples are allowed to thaw, they are 
then dried in an airflow oven and sintered up to 1350°C [124]. It is difficult to fabricate
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bioceramics from this method due to the difficulty in eliminating cracking in the material on 
thawing.
2.4.4 Mechanical Processing
Both porous and dense CaP ceramics can be produced by a range o f physical processes which 
include slip casting, pressing, extrusion and tape casting [80, 125, 126]. Both these and many 
other processes utilise the properties of a preformed ceramic slurry. The slurry must be able to 
flow and form a cast in order to produce a green body. The two most popular mechanical 
processes are tape and slip casting.
2.4.4.1 Tape Casting
Tape casting is a well known process for producing mechanically robust electronic materials e.g. 
in capacitators. The process has only been used relatively recently (mid 90’ s) to fabricate CaP 
bioceramics [127]. The advantage of the method is that by understanding both slurry rheology 
and slip properties; it is possible to produce both dense and porous CaP bioceramics. Tailored 
gradients of porosity ranges have also been produced in CaP bioceramics produced by tape 
casting [128].
After slurry formation, the slip is cast onto a glass plate by means of a doctor blade. The 
produced tape, once the solvent has evaporated, contains ceramic powder and the remainder 
being made up of binders, plasticisers, dispersant and other additives that develop into pore 
generators on sintering [128, 129]. The green tapes obtained can be fired to produce dense or 
porous bioceramics depending on the amount of additives present in the slip.
This process is extremely successful in producing dense bioceramics. Porosity may be 
introduced however it is difficult to maintain the structural integrity o f the bioceramic (as with 
BurPS materials).
2.4.4.2 Slip Casting
Through the development o f die-pressing technology to produce CaP bioceramics, difficulties 
have been encountered when using conventional methods to form complex geometric shapes
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[130]. Numerous advantages stem from casting a ceramic slip into a mould. These include 
controlled geometry, structural uniformity and the minimisation of defect size. Traditionally, slip 
casting is used for producing dense materials (and can be used to produce dense bioceramics) 
however understanding slip properties and the thermochemical processes that occur on sintering 
will allow the production o f porous CaP bioceramics to be developed.
As with tape casting, it is difficult to develop interconnected pores without compromising 
strength [130]. The strength-porosity relationship with respect to slipcast CaP ceramics is shown 
in figure 2.33. Two different porosifier sizes are used for comparison purposes.
0 .4 2 0  mm
50
Figure 2.33: Strength-porosity correlation fo r  HA bioceramics with different sized porosifiers
[130]
The slurry rheology is of extreme importance in slip casting as this controls the uniformity o f the 
macropore distribution [130]. It is crucial to obtain a porous structure of various sizes (i.e. to 
facilitate fluid flow, cell development and bony tissue ingress) in order for vascularisation to 
occur. However, due to the difficulty in obtaining an interconnecting pore distribution, literature 
regarding the continued ingress of bone cells and tissue is sparse. Slip casting processes however 
are still successful in producing dense CaP bioceramics (cortical replication) [130].
2.4.5 Open-Pore Ceramics Produced by Foam Replication Method
Since the development and pioneering work o f Scwartzwalder and Somers [131, 132], ceramic 
foam technology and the number of published papers and patents on the subject has increased at
46
2: Literature Review
an exponential rate [133] Figure 2.34 indicates this rise in interest and development in ceramic 
foams.
S cien tific  papers!
Number o f  Publications
Figure 2.34: The rise in publications in ceramic foam  technology since 1977 [133]
According to Gibson and Ashby [5], one can properly speak o f ceramics being foams only when 
the relative density of the material is < 0.3. Such materials consist o f 3-dimensional array of 
polyhedral cells, with diameters ranging from 10-7000pm [5]. The fabrication process however 
ultimately controls the actual cell size and cell shape. Foams are often classed by the nature and 
structure of the cells: closed or open. Structurally closed-cell ceramics do not have 
interconnected pores. Open-celled ceramics guarantee interconnectivity. Figures 2.35 and 2.36 
show examples o f a closed cell ceramic and an open celled ceramic respectively.
Figure 2.35: Microstructure o f  closed cell Ca-Mg-Zr phosphate (CMZP) ceramic [108]
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Figure 2.36: Microstructure o f  open cell Ca -  Mg-Zr phosphate (CMZP) ceramic [108]
Ceramic foams can be used in diverse applications such as filters for molten metal, to extract 
noxious particulates in diesel exhaust gases, as catalyst supports, thermal protection systems, 
components in solid oxide fuel cells, lightweight sandwich structures and they offer potential as 
bioceramic graft material [133]. The unique properties o f ceramic foams include low density, 
high surface area to volume ratio (as does cancellous bone), high porosity and high degree of 
interconnectivity of cells [133]. Common ceramics that are fabricated into ceramic foams include 
Silicon Carbide, Silicon Nitride, Zirconia and Alumina.
The three main properties o f a synthetic bone graft - bioactivity, porosity and strength - are of 
extreme importance when fabricating bioceramic foams from calcium phosphate (HA, TCP or 
biphasic HA/TCP). The bioceramic must be able to participate in ionic exchanges in order to 
promote bone cell activity. Pores greater than 300pm are required for continued bone 
remodelling and osteogenesis to occur. The bioceramic must be porous enough to allow cell and 
tissue ingress, but it must also be strong enough to withstand the stresses of the defect area.
A description of the most common method for producing open-pore ceramic foams is now 
presented.
2.4.5.1 Polymer Foam Replication
This technique involves coating a reticulated polymeric foam by immersing it into a ceramic 
slurry. The impregnated foam is then compressed to ensure filling o f the void space with slurry,
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it then passes through a set of rollers to remove any excess slurry. After drying, the polymeric 
material is burnt off to leave a ceramic foam that structurally resembles that of the polymer 
template [30, 108, 109, 133, 134].
Figure 2.37 shows a typical flow diagram of the procedure.
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Figure 2.37: Typical flow  chart fo r  polymer foam  replication procedure [109]
Two aspects are critical to selection o f the foam template material. O f the polymeric materials 
available, polyurethane (PU) is the most attractive. This is due to its low softening temperature 
and ease o f bum out which minimises thermal stresses that may fracture unsintered ceramics 
[108] and its ability to recover its original shape after impregnation o f the slurry.
Figure 2.38 represents the structure of a typical PU foam template.
Figure 2.38: Porous structure o f  PU foam  [109]
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Two other routes may also be used to process ceramics made by the polymer foam replication 
method:
1) coating o f the foam with a sol-gel or colloidal solution
2) pyrolysing the polymer foam then coating the carbonaceous skeleton with ceramic using 
chemical vapour infiltration techniques. This process is also known as obtaining ceramic 
materials from pre-ceramic polymers [108, 133].
The pyrolysis temperature of the PU foam determines the maximum temperature at which the 
ceramic foams can operate without undergoing further micro structural or dimensional changes 
(with the exception of densification on sintering) [133]. A slow pyrolysis rate is required 
(<5°C/min) to allow for gas evolution to occur. On complete bum out o f the polymeric foam, a 
hollow cavity is formed. Three-dimensional reticulates permit the formation o f regularly 
arranged three-dimensional porosity within the struts o f the ceramic. Figure 2.39 shows this 
characteristic.
Figure 2.39: Detail o f  a strut showing the nature o f  the internal porosity on polymer burn out
[133]
The development o f the cavities shown in figure 2.39 can significantly reduce the strength o f the 
ceramic according to Griffith’s law [135, 136].
2.4.5.2 Strength-Porosity Relationship
By varying the pore size and total porosity o f the PU foam template, it is possible to produce 
ceramics with a wide range o f mechanical properties. Figure 2.40 shows an example of such a 
strength-porosity relationship in porous HA created by centrifuging the impregnated foam 
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Figure 2.40: Strength-porosity relationship o f  HA bioceramic [109]
The failure o f these materials usually occurs by collapse of a narrow band of cells perpendicular 
to the loading direction [136]. Experimentally, it has been found that the strength of porous 
ceramics is decreased in an exponential relationship with porosity. Equation 3 below represents 
an analytical relationship for the effect o f porosity [137].
a  = a 0.e'bP (3)
where a  = applied stress (MPa)
Go = theoretical stress (MPa) 
b = constant (~ 4-7)
P = volume fraction of porosity
The sensitivity o f the material behaviour to the microstructure o f brittle cellular solids, and the 
need for understanding this relationship is o f extreme importance for bone replacement 
applications [5, 81]. It must be remembered that bone is viscoelastic and the proposed substitute 
material is ceramic therefore the failure mechanisms for both are completely different.
2.4.5.3 Ceramic Slip Properties of PU Foam Replication Method
During the slip impregnation stage o f fabrication, the slip must be fluid enough to enter, fill and 
uniformly coat the internal three-dimensional structure o f the foam. However, if  the slip is too 
viscous then the production o f a uniform ceramic green body is difficult. If the viscosity is too 
low, then the slip flows out o f the foam and does not impregnate and satisfactorily coat the struts 
o f the foam [127, 134].
£  1 5
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It is suggested that a combination o f thixotropic and high viscosity slips are necessary for 
optimum impregnation o f the polymer foam template. The pseudo-plastic nature of a thixotropic 
slip allows it to flow relatively easily whilst still able to retain sufficient viscosity under static 
conditions to coat the struts of the PU foam successfully [134].
2.4.5.4 Novel Fabrications using Foam Replication Technique
It is possible to develop the foam replication technique further in order to alter the structural and 
mechanical properties o f the ceramic. Porosity gradients can be incorporated into the PU 
templates by compression moulding prescribed shapes that geometrically have position 
dependent porosity [138].
To reduce the occurence of bum out cracks from the PU foam, methods have been developed 
whereby the ceramic slip is sprayed onto and into the PU substrate. The slip droplets penetrate 
the PU struts and on sintering the presence o f microstructural cracking is reduced [139]. In 
addition to this, recoating the sintered ceramic using a lower viscosity slip (compared to that 
used for the first coating on the foam), in order to alleviate the presence of microcracks, has also 
been employed in an attempt to improve mechanical properties [140]. Work done by Kim, Kim 
and Knowles [141] also presents research detailing the coating o f bioactive porous scaffolds with 
varying calcium phosphate phases.
Ceramic slip rheology has a profound effect on the properties o f the final ceramic foam [135, 
140]. It is imperative to produce a thixotropic slip to allow high solid loading contents, which in 
turn increases the density of the stmts and hence increases strength [140].
The foam replication method of producing open cell bioceramics has one major structural 
advantage over other fabrication procedures such , as foaming or gelcasting. The process 
guarantees interconnected porosity and a structure that closely resembles that of cancellous bone. 
The PU template can be chosen (or fabricated) so that the pore size is in the correct range for 
osteoconduction and further bone induction processes such as osteogenesis (i.e. pores 150 - 
300pm).
Inherently linked to large pore sizes and a large porosity are poor mechanical strengths. 
Structural integrity is crucial to bioceramic technology. Continued bone remodelling and
52
2: Literature Review
revascularisation of the defect site depends on the presence o f the correct pore distribution as 
described in section 2.3. However, this potential for osseous growth within the implant is useless 
without the ability of the material to keep its structural form intact and hence its pore distribution 
intact. Complete burnout of all slip additives and PU foam template is essential for 
biocompatibility. The biological properties of the CaP powder ultimately affect the bioactivity 
nature of the ceramic.
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2.5 Variability in Strength of Ceramics
The fabrication process that has been chosen, governs the properties o f the ceramic materials 
produced. Ceramics are sensitive to parameters such as binder content, powder content, sintering 
temperature, sintering time and heating and cooling rates [142]. It is possible that any of these 
parameters may alter the microstructure of the ceramic and hence its properties.
The failure of ceramic structures under load can be dominated by non-yielding mechanisms. In 
brittle fracture, there is usually localised and limiting plasticity, and defects are generally 
macroscopic. The mechanism of brittle fracture usually begins with the initiation of a crack, 
which normally originates at small flaws on the surface that cause a concentration of stress and 
the ultimate brittle failure o f the material as the crack exceeds the critical crack size for failure. It 
is therefore imperative in ceramic fabrication to produce defect free products in order to 
maximise strength.
2.5.1 Strength and Brittle Fracture
In theory, ceramic structures should have outstanding mechanical properties, as the separation of 
two planes of atoms would determine their strengths. However, in practice, surface flaws (and 
internal flaws) in the structure, have the most profound effect on lowering the strength of 
ceramic structures.
2.5.1.1 Theoretical Strength
The theoretical strength o f ceramics may be calculated from the stress required to separate two 
rows of atoms simultaneously across its cross-section. The theoretical strength can be calculated 
by equation (4):
c th = (Ey/a0)1/2 (4)
where a th = theoretical strength (MPa)
E = Young’s modulus (e.g. HA = 80-1 lOGPa (GNm‘2), PSZ = 200GPa) 
y = surface energy (Jm ")




However, the observed strengths of brittle materials are often much less (-250 times less) than 
the predicted strengths (equation 4) [143]. When fracture dominates, the fracture stress is 
exceeded before the yield stress and plastic deformation are limited to the localised high stress 
areas associated with defects. An applied stress causes elastic strain energy within the material. 
When a crack propagates, strain energy is released, reducing the overall energy. The energy lost 
has gone into forming two new surfaces that have been created due to the extension o f the crack. 
The flaws associated with this failure are known as Griffith flaws.
2.5.1.2 Griffith Theory
Griffith used the proposition that an existing crack will propagate under an applied stress if  the
total energy of the system is lowered. The critical condition is reached when a decrease in the
stored elastic energy (Ua) o f a stress body, is equivalent to the energy required to create two new
surfaces (UY) due to fracture. The total energy of the body (U) represents the combined stored
elastic energy and the energy required to form two new surfaces. From this analysis, the 
following results are obtained:
Ua = (- n a 2a2)/2E (5)
Uy = 2 x (2ay) = 4ay (6 )
U = Ua+ U y (7)
where a = Crack size (m)
a  = Critical stress for failure (MPa)
E = Young’s Modulus (MPa) 
y = Surface energy (J m ')
Therefore, the total energy (U) o f the body follows equation (8):
0 = - (7ra2a2)/2E + 4ay (8)
When the energy system is at equilibrium, the change in energy (dU o) equals zero and is a 
function of crack length a.
d U o /d a  =  0 ( 9 )
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Thus,
d (-7tCT2a2/E) + (4ay) = 0 (10)
da
a crit = (2Ey/7ia),/2 (11)
1 /9Since E and y are constant, crack propagation will take place when the product a(a) exceeds a
critical value [143].
2.5.2 Surface Flaws
Experience has shown the most damaging flaws in most ceramic structures occur in association 
with the surface [143-145]. Surface flaws in ceramics can be produced in the forming process, 
they can be created during subsequent finishing processes, or simply by poor handling [146]. At 
sufficiently high loads, existing submicroscopic flaws are propagated under high stress and 
extend and cause failure [146]. The larger the flaw (or rather its effective zone of influence) the 
lower will be the strength. Thus, in generating a microstructure, strength can only be optimised 
by removing as many surface flaws as possible [145].
An important consequence of the Griffith theory is that brittle fracture is initiated at the most 
serious flaw [143]. The size of flaw that can be tolerated in a ceramic, depends on the ‘in 
service’ requirements of the product and the strength required [145]. In the case o f a bioceramic, 
the implant must integrate with the host bone before stress to failure occurs in order to provide 
full osteoconductive support.
Due to the formation of surface flaws that magnify the stress on loading, and lower the strength 
of the materials, invariably there is a large scatter in the strengths. Therefore, it is imperative to 
test large numbers of samples in order to evaluate the scatter found in the results [144]. Hence, it 
is a necessity to be aware of these structural weaknesses that lower the strengths of ceramics, in 
order to optimise the material’s properties. The first microstructural target for strength should be 
the reduction in size of surface flaws [144].
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2.5.3 Structural Toughening Mechanisms
There have been substantial increases in strength made by achieving control o f microstructure. 
Strengthened ceramics show a dramatic lack o f resistance to crack propagation once failure 
stress is exceeded [143]. A wide range of processes, including the following, can act as 
strengthening mechanisms used to obtain higher strengths in ceramics:
Annealing
Compressive surface stresses 
Minimizing grain size 
Minimizing porosity 
Solid solution hardening [142]
One approach to increasing both strength and reliability in brittle materials is to decrease the 
characteristic flaw size. As a result reliability increases as smaller flaws can often grow to a 
limiting size before failure. Much effort has concentrated on improving the surface flaw size 
population, and the resistance to crack growth, this has been known as ‘flaw tolerance’ [143].
2.5.3.1 Coatings and Compressive Stresses
Processes for strengthening ceramics by using low expansion coatings or by placing the surface 
into deliberate compression, results in increases in the nominal stress at which surface flaws act 
to cause failure [142, 144, 147]. Compressive surface stresses are induced during cooling 
processes, because the interior volume o f the material contracts more than the volume surface; 
thus placing the surface into compression [144]. This process is successful due to volume 
changes that occur. Therefore, the stresses are retained in the structure and the material remains 
stable. The principle criterion for selection o f bodies for strengthening by compressive surface 
stresses is that fracture due to externally applied loads must normally originate at surface flaws 
[142, 144].
The role of surface flaws in the fracture o f ceramics, has led to the development o f a number of 






Quenching o f coatings 
Ion exchange
Forming o f low expansion solid solution surface layers
Forming surface layers by reactions or phase transformations, characterised
by an increase in volume
Partially stabilised zirconia (PSZ) is an example of such a material in which a phase 
transformation produces a volume increase (~ 9%), and hence places the surface into 
compression resisting crack growth. Additions of CaO, MgO or Y2O3 partially stabilise the 
zirconia in the cubic form. On cooling through the transformation range (~1000°C) the unstable 
body transforms from the tetragonal to the monoclinic cubic structure and places the surface into 
compression [144].
To achieve the properties required, the selection o f chemistry, choice o f raw materials and the 
optimisation o f processing towards an ideal target microstructure, must be analysed [145]. The 





Organometallic chemistry relates to compounds in which an organic group is attached through 
carbon to an atom that is less electronegative than carbon (i.e. generally compounds that contain 
a direct metal-carbon bond) [148, 149]. Organometallic precursor materials are designed to 
contain structural units o f the inorganic material that will be produced. The actual transformation 
into an inorganic material takes place by a sequence of condensation reactions during heating. At 
higher temperatures, the material can be crystallised into a thermodynamically stable ceramic 
[150, 151].
The method consists of making a homogeneous solution of the component organometallic, in a 
suitable solvent (usually the parent alcohol), and then using a hydrolysis reaction to produce a 
gel containing the hydrated metal oxide. The gel is dried and sintered to produce a ceramic 
material at temperatures much lower than that required by conventional melting processes [152, 
153].
The advantages of the process include lower sintering temperatures, high purity, uniformity and 
the ease of application. As the precursor material is in solution e.g. magnesium methoxide 
(magnesium in solution in methanol), films or coatings may be applied to complex shapes and to 
a wide range o f substrates to optimise for example optical, electrical and mechanical properties 
[151].
2.6.1 Mechanisms of Ceramic Formation from Organometallic Precursors
Ceramic precursor organometallics based on compositions such as M(OR)n, where M = metal 
e.g. silicon, sodium, zirconia, R = methyl (CH3), ethyl (C2H5), are popular precursors because 
they react readily with water to hydrolyse [154]. When dissolved in pure water, water molecules 
hydrolyse metal cations, Mz+, and a hydroxyl ion (OH') attaches to the metal atom, according to 
the hydrolysis reaction (12):
M(OR)n + H20  ----------► HO -  M(OR)n-i + ROH (12)
Depending on the amount o f water present, hydrolysis may go to completion, so that all o f the 
OR groups are replaced by OH' ions [155]. According to reaction (13) if completion occurs:
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M(OR)n + H20  ----------► M(OH)n + nROH (13)
where ROH = alcohol (e.g. CH3 OH methanol)
M(OR)n = organometallic (e.g. zirconium butoxide Zr(OR)4)
M(OH)n = metal hydroxide (e.g. magnesium hydroxide Mg(OH)2)
This process can also stop when the metal is only partially hydrolysed -  M(OR)n-i(OH)n.
The hydrolysis reaction occurs in organometallics, due to the presence of highly electronegative 
OR groups (i.e. 7i electron donors) that stabilise the metal in its highest oxidation state, which 
leaves the metal very susceptible to nucleophilic attack (i.e. molecules/compounds that like to 
attach to positive ionic groups) [156].
It is also possible for two partially hydrolysed molecules to link together in a condensation 
reaction such as in reaction (14). The inorganic metal oxide is formed as a result o f the process
[156].
M(OR)n -  OH + M(OR)n -  O H ---------------------- ► M (0R)n-0 -n(R0)M  +H20  (14)
By definition, condensation liberates a small molecule, such as water or alcohol. This type of 
reaction can continue to build larger and larger oxide containing molecules by the process of 
polymerisation [150, 153] or as it sometimes termed -  polycondensation. This eventuality results 
in a metal oxide network forming.
When sufficient M-O-M bonds are formed, they act co-operatively as colloidal (submicron) 
particles or a sol. Since the sol is a low viscosity liquid, it can be cast into a mould, or used for 
coatings or as a film former. With time and increasing temperature, the colloidal particles 
condense into metal oxide species to form a three dimensional network. The physical 
characteristics of this gel network depend greatly on the size o f particles and extent of cross- 
linking prior to gelation [150].
Further careful drying of the sol-gel must be carried out to relieve large surface stresses that can 
form as cracks during drying. Final densiflcation of the gel occurs by sintering at high
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temperatures to reduce porosity and surface area. Figure 2.41 shows the structural characteristic 
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Figure 2.41: Structural changes associated with sol-gel process [156]
2.6.2 Applications o f Sol-Gels in Ceramic Technology
Sol-gel and ceramic materials made from organometallic precursors, have been used in the 
application o f glasses, crystalline ceramics and coatings for optimising material properties such 
as optical, electrical, chemical and mechanical characteristics [157].
The sol-gel process described in this section is particularly suited for numerous applications. The 
versatility o f the process and examples of applications are described here.
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2.6.2.1 Sol-Gel Materials Demonstrating Bioactivity
The ability to tailor the chemical properties of the sol-gel by the choice and reaction path of 
organometallics is an advantage for the production o f bioactive sol-gel glasses, as researched by 
Hench [151, 158]. Bioactive implants that form a mechanically strong bond to bone, are 
important due to their potential long survivability [158]. Figure 2.42 shows the importance of 
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The most common sol-gel derived glass composition SiC>2 -  CaO -  P2O5, has been shown by 
Hench and West [151] to form hydroxycarbonate apatite bone bridges between the implant and 
the host bone. Bone activity was found in melt derived ceramics o f the same composition [151].
It has been shown that the process described to produce ceramics, from the use o f organometallic 
compounds, makes the materials attractive for producing controlled interactions between 
inorganic materials and biological molecules [158]. The availability o f such low temperature 
viscous sintering rather than by cooling from a melt, provides the possibility o f forming ceramic 
bodies with unique distributions of phases for specific applications [151, 158].
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2.6.2.2 Coatings and Films
The ability for low viscosity sol-gel solutions fabricated from organometallic precursors, to coat 
large areas and complex geometries, offers possibilities in numerous areas [159]. These include 
protecting underlying the ceramic, metal or polymer surfaces from harsh chemical environments. 
It is also possible to produce net shapes and net surface components by casting the solution into 
precision moulds [160], and by coating large and complex net shapes with precision uniformity
[157]. Perhaps the most common thin film forming process involves spin coating of the sol-gel 
solution required onto a substrate. The presence of atmospheric water immediately causes 
hydrolysis. On heating to temperatures from 400° - 850°C, an amorphous film crystallises to 
produce a polycrystalline ceramic. This is the case for the ceramic Barium Titanate. 
Disadvantages of the processes described using organometallic precursors, include the raw 
material cost for fabricating large quantities of material and also that gelation, drying and 
densification are all relatively lengthy processes [161].
The sol-gel process is particularly suited for the preparation o f coatings and films. Not only does 
the use of liquid solutions at room temperature have great advantages, but also the techniques for 
preparation of multi component homogeneous liquid solutions for a wide range o f crystalline and 
non-crystalline coatings, can be applied to numerous substrates [148].
The ability to modify the surfaces of ceramics so as to alter their response to mechanical forces 
and to promote strength is attractive in certain applications. With suitable coatings it is possible 
to increase, for example, the scratch resistance of materials, and similar techniques to provide 
engineering gradations in chemistry for improved bonding [159]. It may be possible to reduce 
surface flaws by the flow and viscous sintering of sol-gel derived solution into surface defects, 
this would strengthen the material.
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2.7 Summary of Literature Review Findings
Bone has outstanding properties; it is a dynamic, living material that provides mechanical 
support, homeostasis, bone remodelling and also regulates ionic reserves in the body. Bone 
grafts, such as autograft and allograft, are used to treat bone loss, infection and diseased or 
damaged bone. However, these materials pose problems associated with their use, namely the 
availability and volume o f graft is limited. Allograft procedures risk infection and disease, and 
autograft procedures increase the pain for the patient, as a second incision site is required. 
Therefore, there is a need to develop a material that is capable of osteogenesis (bone 
remodelling), while also offering structural support to the affected area.
Calcium phosphates have been shown to be suitable candidates for the production of bone 
substitute materials. Their chemical composition resembles that of natural bone and allows ionic 
exchanges between the implant and host bone demonstrating the ability to form 
hydroxycarbonate apatite bone “bridges”, resulting in secure fixation of the implant. This 
bioactivity is essential to encourage osteoblastic (bone forming cell) activity. In order for bone 
remodelling to occur, calcium phosphates must also demonstrate an adequate strength-porosity 
relationship, to ensure that osteogenesis is possible while also providing a structural matrix for 
biomechanical support. For continued bone growth to occur, a hierarchial pore structure is 
required, with pores ranging in size from 150 -  300pm. To sustain osteogenesis, the synthetic 
material must provide sufficient strength to ensure good fixation between the implant and the 
host bone structure.
Various different fabrication techniques have been developed to manufacture calcium phosphate 
ceramics that resemble both cortical bone (dense material) and cancellous bone (porous 
material). These include numerous thermochemical techniques, such as foaming and gelcasting 
in addition to mechanical techniques, such as slip casting and tape casting. It has proved to be 
difficult to provide a bioceramic material capable o f providing both a high volume porosity 
network (with large pores) combined with sufficient strength to support the material during bone 
remodelling.
However, ceramic fabrication also has limitations due to the presence of surface flaws in the 
finished articles that lower the strength of the products on loading. These structural weaknesses 
must be overcome in order to develop successful bone substitute materials. One method to
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relieve these surface flaws is to develop coatings or films that place the surface flaws under 
compression and therefore provide resistance to crack growth and thus increase the strength of 
the material.
To date, however, there has been limited research conducted to assess the materials properties 
and design of bone substitute materials to encompass a structural-biological matrix as found in 
bone grafts. If the complications associated with bone grafting are to be overcome, their root 
causes must be identified, and, in order to achieve this, consideration must be given to the 
contributory effects o f bone substitute materials and their design.
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2.8 Objectives and Aims of Research
The initial objective of the research was to address the need to develop and fabricate calcium 
phosphate (CaP) bioceramics comprising hydroxyapatite (HA), a-tricalcium phosphate (a-TCP) 
and P-tricalcium phosphate ([3-TCP) with pores in the correct size range for bone formation and 
bone ingrowth. This necessitated the fabrication of materials with an interconnected 
macroporosity network (i.e. pores > 10pm), having pores in the size range 150 - 300pm, for 
continued bone ingrowth within the synthetic bone graft material.
From the literature search, it was found that there are difficulties in combining both the structural 
and porosity requirements needed for a successful CaP synthetic bone graft material. Thus a 
further objective o f the research was to improve the structural integrity and mechanical 
properties o f the bioceramics produced, without compromising the interconnected macroporosity 
network needed for bone ingrowth. The use o f organometallic precursors as treatments for the 
CaP bioceramics was used in order to reduce, or even eliminate, surface microcracks that result 
in structural weaknesses in the materials on loading.
There was a need to develop fabrication processes that could be used to produce bone substitute 
materials in a variety of sizes, shapes and perhaps, most importantly, chemical composition. The 
research presented highlights the diversity and range of samples that can be produced by the 
methods developed.
CaP bioceramics were also fabricated for the production of novel bioceramics for specific 
clinical applications that include spinal fusion interbody applications, chondylar repairs (in knee 
defects), granular bioceramic material for use in impaction grafting in revision hip procedures 
and materials with potential for use in maxillofacial surgery (mandible/jaw reconstruction). This 
highlights the need to not only develop CaP bioceramics for research purposes in the laboratory 
but also to develop bioceramics for specific clinical applications that are currently employed by 
orthopaedic surgeons.
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Chapter 3 Materials and Experimental Methods
3.1 Calcium Phosphate Base Powders and their Phases
The base powders used in the research were Grade 118 and Grade 130 forms of hydroxyapatite 
(HA), supplied by Stryker Orthopaedics. Grade 118 is less crystalline than 130, and contains 
calcium deficient HA, which permits phase transitions to occur. This allows the final sintered 
products to consist o f P - tricalcium phosphate (p-TCP) and a-tricalcium phosphate (a-TCP). 
Grade 130 is a stable, crystalline phase o f HA and does not thermally transform to TCP. 
Therefore, using a combination o f the two powders one can produce any combination o f 
HA/TCP bioceramic composition. In addition, samples comprising purely HA, a-TCP or p-TCP 
can be made.
The base phase is HA, chemical formula Caio (PC>4)6 (OH)2. This can be thermally transformed 
in its amorphous form (grade 118) to produce p - and a  - TCP (Ca3 (P O ^ ), at 900 -  1000°C, p- 
TCP forms, up to 1180°C this phase is stable. Above 1180°C, it transforms to a-TCP and above 
1350°C tetracalcium phosphate is formed. The schematics below indicate the phase transitions 
that occur on heating o f the powders:
heat
Grade 118 H A --------- ►P-TCP + a-TCP
Ca deficient, low crystallinity
heat
Grade 130 H A --------- ► HA
Crystalline HA phase
It is generally accepted that there is a trade off in properties between the high biological response 
of P-TCP and the high loading properties of HA. This is summarised in figure 3.1.
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^  Mechanical properties
HA < a-TCP « <  P-TCP 
Biological resorption ^
Figure 3.1: Duality between mechanical properties and bioactivity o f  calcium phosphates
3.2 Polyurethane (PU) Foam
PU reticulated foams obtained from Sydney Heath and Sons Ltd, were used to produce varying 
densities o f bioceramic scaffold material by mimicking the positive or negative image o f the 
foam. A ceramic slip was used to either impregnate or coat the struts o f the foams. The foam 
structures can be described as open and reticulated, and were used in two different pore sizes - 
30 and 45 ppi (pores per inch). The PU foams were used as structural templates for the 
production o f open porous bioceramic materials.
3.3 Thermogravimetric Analysis (TGA)
TGA was performed on both 30ppi and 45ppi PU foam in addition to PU foam coated with the 
bioceramic slip. Samples with a mass of lm g were placed inside an alumina crucible that was 
suspended inside a heating chamber. The crucible mass was then measured with increasing 
temperature, PU foam samples were heated from 1 °C to 600°C at a heating rate of 1 °C/min. The 
PU foam coated with bioceramic slip was heated at the same rate but up to a maximum 
temperature o f 1300°C. Step increases in temperature were made every 0.1 °C. Plots were 
subsequently made of mass loss against increasing temperature, in order to evaluate the 
characteristics of the PU foam and slip coated foam during the sintering cycle.
3.4 Optical and SEM Characterisation
Off cuts from each set of fabricated samples were chosen for further analysis by optical 
microscopy and scanning electron microscopy (SEM) analysis. The SEM images were later used 
to analyse the porosity distribution of the samples by image analysis software via computer 
manipulation (section 3.5).
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The off cuts of the fabricated samples described in section 3.8, were either mounted in epoxy 
resin, cured and then subsequently ground and polished, or cut to size to fit on a plate ready for 
SEM analysis. These samples were then gold sputtered and immediately analysed by a JEOL 
6310 model SEM with an accelerating potential o f 15kV.
Both macroporosity and microporosity examination followed. However, concentration focused 
more on macroporosity analysis, as the macroporosity distribution appears to have a greater 
influence on the mechanical properties of the samples. However, an extensive examination of 
both types of distributions, how different sintering temperatures affect them, the drying 
mechanisms and the type of porosifiers used then followed.
3.5 Image Analysis and Porosity Evaluation
Micrographs produced from SEM analysis, showing both macroporosity and microporosity 
distribution in the specimens were analysed by the computer software -  Optimas 6.1 -  to 
calculate not only the total porosity present in the samples, but also the macro-and microporosity 
distributions. Other useful data such as the average area equivalent diameter o f the pores 
present, and the size and shape of the porosity have also been analysed.
The images were first scanned into the software and subsequently “cleaned” to produce a sharper 
image, which in turn results in more efficient and accurate results. This is because the software 
used identifies colour threshold differences in the micrographs used. By “cleaning” the 
micrographs via computer manipulation the clarity of each phase (grain and porosity phases) is 
improved.
The data set of the samples analysed was then exported to an Excel file for further numerical and 
graphical analysis (e.g. to calculate porosity distributions and to show how the experimental 
parameters affect the macroporosity and microporosity).
3.6 X-Ray Diffraction (XRD) Analysis
In order to assess the accuracy of the amounts of different phases present in the bioceramics 
made, a Phillips X-Ray Diffractometer was used by using C ua radiation with a wavelength of 
1.54A. The data range was set at 20° < 20 < 60°, with a scan step size of 0.01°. This produced a
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file containing the counts recorded at each step. These counts were then plotted against the 20 
angles. The strong reflections in the traces were then matched against standard diffraction 
patterns for all calcium phosphate materials via computer software PDFC 2.00.
3.7 Slip Preparation
In total, six slips have been prepared each with different properties, although more than six slips 
have been fabricated during the research to optimise the slip properties; it is these specific slips 
that have been used in the current research. Table 3.1 summarises the slip formulations for the 
research undertaken. The 45 ppi foams were impregnated with slips that were slightly less 
viscous than those used for impregnation o f 30 ppi foams. This was because 30 ppi foams have 
larger interconnected pore channels than their 45 ppi counterparts.
For all the slips, the liquid components were added first and stirred vigorously under motorised 
stirring at 20 rpm. Each form of HA powder (118 and 130) was then added and again vigorously 
stirred until all powder was incorporated into the slip. Remaining individual dry components 
were then added and stirred vigorously once again until all the dry materials were incorporated 
into the slip. Fabrication o f the slip was complete once a handful (~ 50g) of zirconia milling 
media was inserted into the slip ready for ball milling for 24hrs at 20 rpm. The approximate ratio 
of HA:TCP for the Impact-Impregnated (I.I.), granular and Open Porous Scaffolds (OPS) was 
75:25 %. The Spinal Fusion samples fabricated from 118 powder comprised pre-dominantly p- 
TCP when sintered at 1150°C, and a-TCP at temperatures above 1180°C. The samples 
fabricated from 130 powder comprised HA.
In order to achieve a thixotropic nature to the slips produced, various binders, plasticisers and 
surfactants have been employed. Dispex A40 is a non-ionic surfactant that acts as a deflocculant 
to avoid agglomeration o f the slip. Methyl cellulose, polyvinyl alcohol (PVA) and 
polyvinylpyrrolidone (PVP) are high molecular weight binders that provide stability and aid 
thixotropy. Polyethylene glycol (PEG) is a plasticiser that gives the slip some fluidilty and helps 
the movement of the slip. Octyl alcohol is an anti-foaming agent used to avoid the presence of 
air bubbles and nonyl phenol is used as an aid to adhesion i.e. for slip to adhere to PU foam.
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Spinal Fusion -  45 ppi
Ingredients Physical
Form
45 ppi 30 ppi 45 ppi 30 ppi HA Slip TCP Slip
HA118(g) Powder 187.5 225 250 250 0 600




Liquid 750 750 500 500 500 500
Dispex 
A40 (ml)
Liquid 1-2 2-3 12 10 7.5 7.5




Powder 7.5 7.5 10 10
PVA (g) Powder - - - - 6 6







Liquid - - - -
5
5
Table 3.1: Summary o f  slip formulations fo r  different fabrication methods
3.8 Range of Fabricated Samples
There were five fabrication methods used in the research detailed here, each resulting in different 
CaP structures. The first fabrication method details a process called Impact-Impregnation (I.I.). 
The main aim of producing samples using this method was to fabricate HA/TCP bioceramics 
with a guaranteed interconnected porosity network. This process is described in section 3.8.1. 
The second method is termed the Open Porous Scaffold (OPS) method. The objective was to 
produce HA/TCP bioceramics with larger pore sizes and greater volume porosity while retaining 
the interconnectivity o f the pores. This process is detailed in section 3.8.2. The third method 
follows on from the OPS method and details a process that produces HA, a-TCP and P-TCP 
bioceramics for a practical application termed Spinal Fusion (SF) Interbody Operations. The 
fabrication method for SF bioceramics is detailed in section 3.8.3 and shows the diversity and the 
range o f samples that can be produced from the technique developed. Once again the 
interconnected porosity, as fabricated in the OPS structures, must be retained on fabrication
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while improving the mechanical properties. The fourth method again illustrates the diversity of 
the techniques developed, and the range of materials that can be made. A granular form of the 
block material fabricated by the I.I. method was produced for the specific purpose of acting as a 
synthetic alternative for impaction grafting in revision hip operations. This work is detailed in 
section 3.8.4. The fifth method follows on from the SF method (section 3.8.3), whereby SF 
sintered samples were treated with a sol-gel solution, with the intention of improving the 
mechanical properties. The method must not compromise the interconnected porosity network 
needed for possible bone regeneration that was produced with the earlier methods. The process is 
detailed in section 3.8.5.
3.8.1 Impact-Impregnation (I.I.) Bioceramics
Twenty samples were prepared for each batch of slip (for 30 and 45 ppi foam samples) thus 
totalling forty samples (twenty for the 45 ppi samples: ten fired at 1280°C and ten at 1150°C, 
and twenty for the 30 ppi samples: again, ten fired at 1280°C and ten at 1150°C).
The foams (30 and 45 ppi) were measured and cut to approximate dimensions of 40 x 40 x 15 
mm in preparation for impregnation by the milled slurry, and placed overnight in distilled water 
in order to clean any inclusions off the foam to assist slip adhesion. The foams were then taken 
out and allowed to dry fully on tissue paper ready for slip impregnation. The washing and drying 
procedure for the PU foams, described here, was a common part for all the fabrication processes.
A small polyethylene container (~ 200ml in size) was filled half to two thirds full o f the slurry 
from the slip. A cut foam specimen was then introduced to the slurry. The foam was squeezed 
and dipped into the slurry. During the expansion back to its original shape and size, the slurry 
impregnated the foam. During this expansion, the foam was placed under the slurry line as to 
both introduce the slurry to the foam and to remove any air present in the foam.
Tissue paper was then placed as a cover over the container (NB. The lid o f the container was not 
tightened, as this would prevent the airflow necessary through the foam). The container was then 
systematically impacted against a solid surface to drive out the air from the foam and to improve 
impregnation. A combination of both firm and light impact were undertaken in an attempt to 
drive out the air from the foam. The specimen was then removed from the container and placed 
to dry either on a metal mesh (grill) or on tissue paper. The small container was then topped up
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with the slurry from the corresponding slip and the process repeated. This process was repeated 
for each batch with the corresponding foams.
3.8.2 Open Porous Scaffolds (OPS) Bioceramics
A mechanical plunging machine that was designed and developed specifically for impregnation 
of the PU foams was used to impregnate the OPS slips, described in table 3.1, for the 30 and 45 
ppi foams respectively.
Samples were cut into dimensions of 40mm in length by 25mm in width by 10mm in depth, and 
washed and dried as for previous methods.
Foam samples were inserted into the mechanical plunging machine, which consisted o f a channel 
where the slip was poured and a plunger controlled by a screw thread action that compressed the 
foam. The plunger was then drawn down (via the screw thread) and pushed all the slip out o f the 
foam. On subsequent retraction of the plunger, the slip was drawn up into the foam 
(impregnation) to coat the struts; this process was repeated to ensure the coating o f the struts of 
the foam. This process was known as the dipping process.
The second stage of fabrication was the dripping process. The foam sample was held above the 
slip bath to allow the excess liquid to seep out of the foam, and to fully coat the stmts of the 
foam. This was possible as the slips used in the production of OPS were not as viscous as the 
slips used for I.I. fabrication. The foam was drip cast on all sides (one to two minutes on each 
side) so that stmts were coated evenly.
The foam samples were then immediately sprayed with high velocity compressed air 
(approximately two minutes on each side). This was done to  avoid the formation o f any closed 
cells, ensure coating of the foam stmts and to aid drying. Interconnectivity between the pores 
was guaranteed. This was known as the drying stage. Longitudinal and transverse pore shaped 
samples as well as spherical (or as-received) pore foams, were then fabricated by the same 
process, as described in the following section.
Finally, the sample was allowed to dry for one minute on each side on tissue paper, at room 
temperature, to extract all excess moisture.
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3.8.2.1 Directionallv Elongating Cells of PU Reticulated Foam
In order to mimic the orientated trabecular structure found in cancellous bone, a technique was 
developed to stretch and elongate the cells of the PU foam. Figure 3.2 shows the apparatus used 
to directionally elongate the polyurethane foam to produce elongated cells in the polymer 
template prior to fabrication.
Steel bar clamped in place to ensure stands
are upright and stretching PU foam
T = 150°C PU foam in 
stretched state
G-clamps Stand
PU foam in non­
stretched state
Metal grill
Figure 3.2: Set-up fo r  directional elongation o f  PU foam
Samples o f 30 and 45 ppi PU foams were cut to dimensions of 24cm x 8cm x 2.5cm. The end 
2cm were clamped by steel lap joints to enable four G-clamps to slide over two stands all fixed 
on a metal grill. The stands were stretched in place so that elongation was 30% of the original 
length, and clamped in place by a steel bar. The whole set-up was then placed in an air flowing 
oven at 150°C for 15 minutes. The temperature o f 150°C was chosen as it is close to the glass 
transition temperature (200°C) and therefore allows slight chain flow and hence on subsequent 
cooling the polymer chains were “frozen” in place in their elongated state. The set-up was taken 
out o f the oven and left for 15 minutes in an air-flowing chamber at room temperature. The foam 
was then taken out of the grips and cut longitudinally to sample dimensions o f 40mm x 25mm x 
10mm (the same dimensions as for as-received foams). The same sample dimensions were cut at 
a perpendicular plane to produce transverse samples. The elongation procedure results in 
changes in the pore geometry of the foam, from mainly spherical to ellipsoidal in shape; this is 
illustrated below in figure 3.3.
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Figure 3.3: The treated foam s produce elliptical shaped pores as opposed to the spherical pores
present in the as-received (or pre-treated) foam s
In total, 120 samples were fabricated by the OPS method producing an open interconnected 
porous structure resembling a scaffold. Typical mass of samples after the fabrication process and 
drying on tissue overnight (~15hrs) varied from 3 -  5g. The samples were dried in an oven at 
120°C for six hours to ensure all excess moisture was extracted. Typical mass of samples after 
drying at 120°C varied from 2 -  4g. Final densification masses range from 1.5 -  3.5g.
3.8.3 Spinal Fusion (SF) Bioceramics
The SF method is a further development of the OPS procedure. Cylindrical sections o f the 45 ppi 
PU foam were hot cut using a die of diameter 13mm and length 20mm. These sections o f foam 
were placed in distilled water overnight to ensure that any inclusions were removed from their 
surface. The foam samples were then treated in the same manner as for the OPS samples and 
dried on tissue paper in air for one hour under a hot lamp at 75°C ± 5°C.
The second stage of fabrication consists of rolling the cylindrical sample in the same thixotropic 
slip used for the initial fabrication. This was done to achieve a dense, outer shell protecting the 
internal interconnected porosity network and to offer mechanical support. Immediately upon 
completion of rolling and production o f a wet coating, samples were placed in tissue paper and 
rolled gently in order to ensure that the slip did not penetrate the pores, and that cracking due to 
poor drying could be eliminated. Samples were then left rolled in tissue to dry in air at room 
temperature for 24 hrs.
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3.8.4 Calcium Phosphate (CaP) Granular Material
Angular foam pieces (30 and 45 ppi) were randomly cut (can also be done with die) into shapes 
ranging in size from 2-4mm, 3-5mm and 4-8mm. These were impregnated and fabricated 
identically to the I.I. procedure (section 3.8.1). Granules were removed from the slip by sieving 
and placed on tissue paper in order to remove any excess moisture (one minute on each side). 
The granules were then placed in an airflow oven at 120°C in order to guarantee that the granules 
were moisture free so that thermal cracking could be avoided on sintering. All the granules were 
sintered at 1280°C in order to achieve consistency in the results. Once sintered, the granules 
were placed in a polyethylene container together with zirconia milling media and ball milled for 
six hours to round off the edges o f the granules. This process optimised the packing potential 
when die-plunger compression testing was performed.
3.8.5 Sol-Gel Treated SF Bioceramics
SF samples were made and sintered as described in section 3.8.3. A soda sol-gel solution was 
prepared according to reaction 15:
M (0R)x + xH20  ----------- ► M(OH)x + xROH (15)
where M = metal atom 
O = oxygen
R = alkyl group e.g. CH3, C2H5 
H = hydrogen
Therefore, by using sodium methoxide as an organometallic compound capable o f participating 
in hydrolysis and condensation reactions to form a sol-gel solution, reaction 16:
NaOCH3 + H20  ----------- ► NaOH +CH3OH (16)
where NaOCH3 = sodium methoxide 
NaOH = sodium hydroxide 
CH3OH = methanol (as by product)
Thus, by the stoichiometric equation used, it is possible to calculate the volume o f sodium 
methoxide and water required to form the sol-gel reaction. Therefore, 30g o f sodium methoxide
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<3
corresponds to lOg of water. The density o f sodium methoxide was 0.945g/cm (from Aldrich 
suppliers), thus:
Volume of sodium methoxide required = mass/density = 30/0.945 = 31,75ml.
Therefore, the volume ratio of sodium methoxide to water used for the sol-gel reaction was 
31.75ml: 10ml. These quantities were mixed together in a glass beaker and 0.5g o f crushed 
oxalic acid, which acts as a drying control (i.e. stops film cracking on drying) was added. 
Raising the temperature speeds up the sol-gel process, and therefore the solution was placed in 
an airflow oven at 70°C for one hour. Pre-sintered SF samples (HA, a-TCP and P-TCP) were 
then immersed in the solution mixture and positioned in a vacuum at 70°C for 30 mins to ensure 
that all air had been expelled from the samples, and the solution could penetrate the entire SF 
samples. The samples were then removed and quickly spun dried by hand in order to eradicate 
excess solution and dried in air at room temperature.
3.9 Drying of Samples
The drying o f the samples fabricated was carried out in two stages. Drying took place slowly to 
ensure that surface stresses that cause cracking were relieved, and hence surface cracks were 
eliminated. The first stage of drying was usually at room temperature (25°C ± 5°C) and the 
second at a higher temperature (70 -  120°C) to ensure moisture extraction. Slightly different 
drying procedures were used for different fabrication techniques; these are detailed in the 
following sections.
3.9.1 I.I. Bioceramics
For comparative purposes two different drying mechanisms were used during the Impact- 
Impregnation (I.I.) fabrication procedure (section 3.8.1). Half of the samples from each 
batch/slip were dried on a metal mesh or grill, consisting o f circular holes to drain any excess 
moisture from the foams. The second drying procedure was to dry the specimens on the same 
metal mesh but this time overlayed with tissue paper in an attempt to extract any excess moisture 
from the foams and improve the porosity characteristics. The samples were left to dry in air at 
room temperature for 24 hours and then dried in air at 40°C for a further 24 hours.
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3.9.2 OPS Bioceramics
OPS samples were allowed to dry on tissue paper, which was also placed on top of the scaffolds, 
for 24 hours at room temperature. Following this, OPS samples were then placed in an airflow 
oven at 120°C for a further 24 hours for moisture extraction.
3.9.3 SF Bioceramics
Cylindrical OPS structures, diameter 13mm ± 1mm, length 20mm ± 1.5mm, prior to fabrication 
o f the dense, outer shell, were dried under a hot lamp at 75°C ± 5°C for one hour. After 
fabrication of the dense exterior section of the structure, samples were dried in tissue paper and 
rolled to ensure the entire exterior surface was in contact with the tissue, and left for 24 hours at 
room temperature. On removal from the tissue paper, the SF samples were then dried in an 
airflow oven at 120°C for 24 hours.
3.9.4 CaP Granular Material
The granular material, fabricated using the same I.I. procedure, was solely dried on tissue paper 
in air at room temperature for 24 hrs, and then dried in air at 40°C for a further 24 hrs.
3.9.5 Sol-Gel Treated SF Bioceramics
Sol-gel treated SF bioceramics were dried for 24 hrs under a hot lamp at 75°C ± 5°C. Samples 
were then freeze-dried, in order to remove any water and methanol (by-product from sol-gel 
reaction) absorbed within them by a process o f sublimation. This involved immersing the 
samples in liquid nitrogen, with a freezing rate fast enough to avoid the formation of large 
crystals. They were then placed in the chamber of an Edwards-Pearse Tissue Dryer EPD3, 
together with phosphorous pentoxide, used to absorb vapour during the freeze-drying process. 
The chamber was evacuated to 10’1 torr, and the temperature lowered to -60°C. This was left 
overnight, after which the temperature was increased to 25°C and the samples removed. The hot 
lamp drying and freeze-drying were performed to ensure complete extraction of excess moisture 
and methanol that was a by-product of the sol-gel process. This ensures that on sintering, surface 
cracks in the sol-gel surface layer would be eliminated. Samples were then sintered at 500°C and 
1100°C - section 3.8.4.
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3.10 Sintering of Samples
The sintering regimes that were common to all the fabrication techniques are described in 
sections 3.10.1 to 3.10.4. First, the PU foam was burnt off and pyrolised at 500°C, followed by 
densification o f the ceramic slip, and finally the samples were cooled at an appropriate rate to 
produce a structurally strong bioceramic free of defects.
Although the three stages described were constant in the production o f the HA/TCP bioceramics, 
the sintering regimes used, offer some subtle variations.
3.10.1 I.I. Bioceramics and HA/TCP Granular Material
The sintering procedure used for the I.I. bioceramics is shown in figure 3.4. The sintering 
chamber was heated (from room temperature) at a rate o f 60°C/hr for 10 hours. It was then held 
at 600°C for one hour to ensure that the PU porosifier foam was completely burnt out. The 
chamber was then set to heat up at a rate of 120°C/hr until the sintering temperature o f either 
1280°C or 1150°C was reached. This temperature was then held for four hours. The chamber 
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Figure 3.4: Sintering procedure fo r  I.I.bioceramics at 1150°C and 1280°C
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3.10.2 OPS Bioceramics
The sintering regime for the OPS bioceramics is shown in figure 3.5. From room temperature, 
the sintering chamber was heated at a rate of 30°C/hr until 300°C was reached. This temperature 
was then held for two hours. The chamber was further heated up to 450°C at a ramp rate of 
30°C/hr and held for two hours. Further heating occurred up to 600°C at 30°C/hr and this 
temperature was once again held for two hours. The sintering procedure from this point on was 
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Figure 3.5: Sintering procedure fo r  OPS bioceramics at 1150°C and 1280°C
3.10.3 SF Bioceramics
The sintering regime for the SF bioceramics is shown in figure 3.6. From room temperature, the 
sintering chamber was heated at 100°C/hr up to a temperature o f 120°C. This temperature was 
held for one hour. The chamber was then set to heat up at a rate o f 30°C/hr until 550°C, and this 
temperature was held for one hour. The chamber then heated up at a rate o f 120°C/hr up to the 
maximum sintering temperature (1150 -  1350°C) and held for two hours. The sintering chamber 
was then programmed to cool down at a rate of 240°C/hr and shut itself off at 20°C.
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Figure 3.6: Sintering procedure fo r  SF  bioceramics at 1150°C  - 1350°C
3.10.4 Sol-Gel Treated SF Bioceramics
The sintering regime for the SF bioceramics treated with sol-gel solution is shown in figure 3.7. 
From room temperature, the sintering chamber was heated at 60°C/hr up to a temperature of 
500°C. This temperature was held for 1.5 hrs. The chamber was then set to cool down to room 
temperature at a rate o f 240°C/hr until 20°C. The same sintering regime was used for the sol-gel 










Figure 3 .7: Sintering procedure fo r  SF bioceramics treated with sol-gel at 500°C and 1100°C
81
3: Materials and Experimental Methods
3.11 Bulk Density Measurements
Bulk density measurements were used, whereby the mass and volumes of the samples were 
calculated. Apparent density measurements were then made and used only for comparative 
purposes between all the materials tested.
3.11.1 Impact-Impregnated Samples
The samples (40) were allowed to cool to room temperature and left at this point, in air, for 24 
hours to ensure their integrity. They were then machined to form cubes o f dimensions of 15 x 15 
x 15 mm (or as close as possible to these dimensions). The samples then were ground to the 
exact dimensions. Simple density measurements were undertaken, as the results were used only 
as a comparison within the set of samples produced.
Once ground, the dimensions of each sample were measured using a micrometer to ensure the 
accuracy of each sample. A mean volume for each sample was then calculated. The mass o f the
cubes were also measured, thus simple density measurements could be made. The cubes were
prepared in readiness for compression testing. The offcuts of the samples were used for image 
analysis and SEM imaging.
3.11.2 Open Porous Scaffolds
Sintered scaffold samples (120) were measured using a micrometer and their masses recorded 
prior to mechanical testing. The bulk density was then calculated.
3.11.3 SF Bioceramics and Sol-Gel Treated SF Bioceramics
The ends o f the SF structures (100) were ground down flat in the same manner as for I.I. samples 
to ensure that the surfaces were as close to parallel as possible for compression testing. A 
micrometer was used to measure the mean volume of the materials. The mass was taken and bulk 
density measurements calculated.
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3.12 Mechanical Characterisation
3.12.1 Compression Testing
Compression testing was performed using an Instron 1122 bench-top test machine fitted with a 
5kN load cell. Testing was performed under automatic machine control and load was applied 
axially to the specimens with a crosshead speed o f 2mm/min until catastrophic brittle failure 
occurred. Figure 3.8 illustrates the equipment used.
Figure 3.8: Schematic diagram o f  mechanical testing (compression testing) equipment 
The subsequent compressive stress (CS) was then calculated for each specimen:
CS = Maximum force (N)
Area o f specimen (m2)
3.12.2 Three-Point Bend Test
The same Instron machine and machine settings were used as for compression testing, except a 
three-point bending jig  with a distance between rollers o f 20mm was used to establish the 
breaking stress of the OPS. Figure 3.9 illustrates the 3-point bending test set-up.
Sample
Force
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Figure 3.9: Two-dimensional view o f  3-point bending test procedure
The maximum breaking stress (gb ) o f each OPS is calculated by equation 17:
a B = Fmax . (Lc/4I) (17)
where Fmax = maximum force at failure (N)
L = distance between rollers (0.02m)
c = distance from cross-sectional centre of scaffold to rollers (m) 
I = moment of inertia = wh3/12
3.12.3 Die-Plunger Compression Testing of Granular Material
HA/TCP granules ranging in size from 2-4mm, 3-5mm and 4-8mm were tested by a standard 
die-plunger compression test. Using a measuring tube, 10cm3 o f HA/TCP granular material were 
poured into a hollow tube (die) with a diameter o f 20mm, as shown in figure 3.10. It was ensured 
that all granules had settled in the die before beginning testing. The operating procedure is 
described below.
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Figure 3.10: Schematic o f  the die-plunger compression test
To enable accurate conversion o f deformation into strain measurements, the starting position o f 
the plunger was noted on each test. Larger particles do not pack well inside the die and on 
compression granules topple, crush and re-order themselves to give misleading results. The 
crosshead speed was set at 2mm/min. The following loading cycle was applied for each batch o f 
synthetic granules:
1) Loading to 500N.
2) Force held constant for a relaxation period o f 30s.
3) Force released and returned to zero.
4) Steps 1 -3  are repeated.
5) Loading up to 1000N.
6) Force held constant for a relaxation period of 30s.
7) Force released and returned to zero. Retrieval of granular material.
The recorded force and displacement data from the Instron machine (via Marandy software on 
PC) were subsequently converted into stress and strain measurements and used to calculate the 
relative compressive modulus between the batches of granules tested. NB. These results are used 
for comparative purposes only between the granules tested.
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3.13 Wicking Experiments
This experiment was carried out to evaluate the wicking properties o f samples comprising the 
three separate phases -  HA, a-TCP and p-TCP -  in the form of SF samples.
A 2% aqueous solution o f methylene blue polychrome (used as an indicator solution) was 
prepared, and a small amount used to cover the bottom of a petri dish. SF samples were then 
placed upright in the petri dish and their wicking properties assessed.
HA, a-TCP and P-TCP phases were observed at 1, 10, 40 and 60 minute intervals after being 
placed in the indicator solution. The length o f time taken for the SF phases to be saturated was 
the factor being determined.
In a separate experiment, SF samples (HA, a-TCP and p-TCP) were left completely submerged 
in solution for 24 hrs. This was performed to evaluate the mass gain o f the samples, due to the 
uptake of indicator solution.
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Chanter 4 Results and Discussion
In this section, the main structural and material property differences between the fabricated 
samples along with an analysis of the findings is presented. It is useful for the purpose o f this 
research to clarify the meaning o f macroporosity and microporosity. Pores with dimensions in 
the size range 1-1 Opm are classified as micropores, and those with dimensions greater than 
10pm are classed as macropores.
4.1 Image Analysis and Thermogravimetric Analysis (TGA) of PU Foams
This section sets out an analysis of the PU foams used as porosity templates in the fabrication 
methods. SEM analysis o f the porosifier foams and cumulative pore distribution o f the foams, as 
well as TGA analysis were carried out.
4.1.1 Image Analysis of PU Foams
Figures 4.1 and 4.2 shows the structure of the reticulated 45 and 30ppi PU foams by digital 
photography and from SEM analysis respectively.
Figure 4.1: 45 and 30 ppi P U foam
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Figure 4.2: SEM  image o f  45 ppi PU foam
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Figure 4.3: Distribution o f  pores in PU  foam s prior to fabrication
The mean pore size for the 45 ppi foams was 533.1 pm, and the mean pore size for the 30 ppi was 
797.7pm. These were calculated as the average from the equivalent area diameter of the pores 
measured by the Image Analysis software (section 3.5).
4: Results
The foams offer an excellent template for the production o f bone substitute materials. The foams 
possess interconnected porosity in the correct size range for possible bone ingrowth.
4.1.2 TGA of PU Foams
Figure 4.4 (a) and (b) show the TGA curves for the 30 ppi and 45 ppi foams respectively.
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Figure 4.4 (a): TGA curve fo r  30 ppi foam
TGA Curve for45ppi PU Foam
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Figure 4.4 (b): TGA curve fo r  45 ppi foam
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These TGA curves indicate similar traces for both grades of foam. Softening begins at 150°C, 
with sharp decreases in mass from 175°C -  325°C due to molecular side groups such as urethane 
and allophante groups being burnt away. The foams were burnt out completely at 500°C. Figure 
4.5 shows a TGA curve o f a 45 ppi foam that has been impregnated by CaP slip.
TGA Curve for PU 45ppi foam and CaP Slip
| f  26
23
200 400 600 800 
T em perature (°C)
1000 1200 1400
Figure 4.5: TGA curve fo r  45 ppi foam  impregnated with CaP slip
It can be seen from figure 4.5 that the foam follows the same characteristics as shown in figures
4.4 (a) and (b) up until 500°C. Above 500°C, due to dehydroxylation of the CaP slip, the mass 
steadily decreases until 1300°C. Figure 4.6 shows a detailed view o f figure 4.5 in the 
temperature range 400 -  1300°C. It can be seen that there is a drop in mass at 700°C due to 
dehydroxylation in the CaP slip. At temperatures above this, there was a steady decrease in mass 
until ~ 1180°C whereby transformation from p-TCP to a-TCP occurs (section 3.1 and 4.2).
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Figure 4.6: TGA curve fo r  45 ppi foam  impregnated with CaP slip from  400-1300°C  
4.1.3 Summary of TGA and SEM Analysis of PU Foam
SEM and cumulative pore distribution analysis indicate that the PU reticulated foams are a 
successful template material to act as a porosifier for bone substitute materials.
The 30 and 45 ppi foams begin to soften at 150°C, with complete material burnout occurring at 
500°C. The CaP slip decreases in mass steadily from 700 -  1300°C, with substantial decreases in 
mass at ~ 700°C as slip densification begins, and at ~ 1180°C when thermal transformation from 
P-TCP to a-TCP occurred.
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4.2 X-Ray Diffraction (XRD) Analysis
XRD analysis was used to evaluate the differences in chemical composition o f the base powders, 
the different CaP phases produced (HA, a-TCP and p-TCP) and the different phases produced in 
the bioceramics as a result o f the sol-gel treatment. The identification o f mixed phase materials is 
more complicated as the strong reflections from different phases overlap and this superposition 
creates strong reflections and to some degree disguises the distinctive diffraction pattern of the 
phases present. This makes qualitative identification o f the phases present very difficult. This is a 
limitation o f the XRD method that can be resolved by other techniques such as neutron 
diffraction and EDAX analysis.
4.2.1 Base Powders
The base powders used in the research, supplied by Stryker Orthopaedics, offer versatility in 
their application and the range of composition o f materials that can be fabricated. On sintering, 
grade 118 allows transformation to TCP. Grade 130 remains predominantly as HA. Figures 4.7 
(a) and (b) show XRD traces of the base powders 118 and 130 respectively before sintering.
800
C alcium  Phosphate  
Hydrate Peaks (2 6 .4 °  and 
3 0 .4 °)
30 39 90 59 60
Figure 4.7 (a): XRD trace fo r  grade 118 Figure 4.7 (b): XRD trace fo r  grade 130
powder before sintering powder before sintering
As indicated on figure 4.7 (a), there were two major calcium phosphate hydrate peaks at 26.4° 
and 30.4° with the remaining peaks corresponding to HA. The addition of calcium phosphate 
hydrate lowers the Ca:P ratio below that o f the HA stoichiometric ratio o f 1.67, and therefore, on
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subsequent sintering, thermal transformations allow TCP to form. Grade 130 powders indicate a 
correlation with the stoichiometric form of HA. Also of note were the low level counts for the 
background of the 130 powders when compared to 118 powders, this is indicative o f a high 
degree o f crystallinity in the former.
Table 4.1 and figure 4.8 show, by the number o f counts, the thermal transformation o f the base 
powders 118 and 130 at 1150 -  1350°C. The phases were calculated from the intensity counts of 
the characteristic peaks o f the particular phase to be calculated, divided by the total intensity of 
the peaks o f all three phases present.
%
Phase
1150°C 1200°C 1250°C 1300°C 1350°C
118 130 118 130 118 130 118 130 118 130
HA 5.6 80.2 4.7 83.2 3.9 85.6 5.4 90.8 5.2 91.2
a-TCP 22.3 6.5 38.7 9.9 40.2 9.8 45.3 6.2 45.5 5.3
P-TCP 72.1 13.3 56.6 6.9 55.9 4.6 49.3 3.0 49.3 3.5
Tabic 4.1: Thermal transformation o f  base powders 118 and 130 post-sintering
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Fisure 4.8: Thermal transformations o f 50/50 mix o f  powders 118 and 130
Table 4.1 and figure 4.8 illustrates the increase in the amount o f a-TCP with increasing 
temperature. Table 4.1 shows that powder 118 forms p-TCP at 1150°C. On increasing
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temperature, the amount of p-TCP decreases and the amount of a-TCP increases. As discussed 
in section 3.1, a thermally activated reaction occurs at ~ 1180°C transforming p-TCP to a-TCP. 
This transformation was due to the lower Ca:P ratio present in the 118 powder, and therefore on 
sintering the material forms non-stoichiometric calcium phosphate materials i.e. tricalcium 
phosphate.
The 118 powders sintered at 1150°C transform pre-dominantly into TCP with 72.1% being p- 
TCP and 22.3% as a-TCP (table 4.1). On further sintering to 1300°C the presence o f the a-TCP 
phase has increased to 45.3%. The formation of a-TCP produces a hard, glassy microstructure 
that forms from an allotropic transformation due to thermal changes in the p-TCP-to-a-TCP 
structural change, as described above and in section 3.1. The 130 powders pre-dominantly 
remain as HA at all temperatures (table 4.1).
4.2.2 CaP Traces
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Figure 4.9 (c): XRD trace fo r  J3-TCP bioceramic
Figure 4.9 (a) is the XRD trace of the HA phase fabricated from powder 130. There is no 
indication of the presence o f a-TCP or P-TCP peaks. Figure 4.9 (b) is the XRD trace of the a - 
TCP phase fabricated at 1300°C. The main a-TCP peaks, at 31.1° and 34.3°, give an indication 
o f the quantity o f the a-TCP present, as there was no overlap with any o f the strong peaks from 
the smaller amount o f p-TCP present. Figure 4.9 (c) illustrates the XRD trace for the p-TCP 




Figure 4.10 shows the XRD traces of the HA, a-TCP and [3-TCP phases compared with the 
traces from samples treated with soda sol-gel.
 HA
- H A N a
 A lph a TCP
 A lpha TCP Na
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Figure 4.10: Comparison o f  XRD traces fo r  HA, a-TCP and  y3-TCP before and after application
o f  the sol-gel
The greatest mechanical strength increases due to the sol-gel treatment, were found with the TCP 
samples. The XRD traces of these materials indicate a more pronounced change in chemical 
structure, as only slight changes have occurred in HA samples where, relatively, the strength 
increases were not as profound. The apatitic structure o f the materials produced has been altered 
due to the sol-gel treatment, most likely sodium phosphate phases have been developed.
At 37.4° there is a peak that is characteristic of those materials treated with soda sol-gel. This 
peak is present in all three phases treated with the sol-gel solution. This is the only change to the 
HA structure, however there are numerous more peaks in relation to the TCP structures. These 
peaks are identified at 44.1°, 45.1° and 47.3°. In addition to these peaks, the peaks from 31.8° -
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33° have been altered in intensity. This is due to the fact that there are peaks that overlap with 
the TCP peaks, hence altering the XRD trace and chemical structure, due to the sol-gel treatment 
whereby quite possibly sodium phosphate phases have developed.
4.2.4 Summary of XRD Results
Base Powders
Differences in the base powders 118 and 130, were due to the presence o f a calcium phosphate 
hydrate phase in the 118 powder, which ultimately lowered the Ca:P ratio and hence on sintering 
allows transformation to P-TCP and a-TCP. Grade 130 remains as HA on sintering. At 1150°C, 
grade 118 powder was pre-dominantly 75% p-TCP and 25% a-TCP. At 1300°C, 50% of the p- 
TCP thermally transforms to a-TCP. Grade 130 on sintering, remained as HA and only a very 
small amount of p-TCP was present at 1150°C.
Sol-Gel Treatments
The sol-gel treatments have had the greatest affects on the chemistry o f the TCP structures, 
presumably due to the presence of vacancies in the structure (lower Ca:P ratio). It is these 
bioceramics that showed the greatest increase in strength on mechanical testing. The large 
microporosity present in the TCP samples (compared to HA), and thus the ability of the sol-gel 
to bond to the surface of the TCP, has allowed changes in the structure. This indicates 
improvements in the structure-property relationship of the bioceramics and correlates with the 
improved mechanical properties achieved.
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4.3 Impact-Impregnated (I.I.) Bioceramics
For the fabrication of I.I. bioceramics, three variables were used in order to ascertain differences 
in the macroporosity distribution and the resultant effect on mechanical properties. Alterations to 
the macroporosity distribution included changes to the total volume porosity, the mean pore size 
and standard deviation of the pore size. The three experimental variables included the different 
grade of foam porosifiers used during fabrication (30 and 45 ppi), the sintering temperature 
(1150°C and 1280°C) and the drying medium used (metal mesh or tissue paper). Table 4.2 
indicates that there were eight batches of materials produced, and illustrates how the variables 
were used in the experimental procedure (NB. There were five samples per batch thus totalling 
forty samples).
Porosifier Foam Type 
(PPi)
Drying Method Sintering temperature 
(°C)
Batch 1 45 Metal Mesh 1280
Batch 2 45 Tissue Paper 1280
Batch 3 45 Metal Mesh 1150
Batch 4 45 Tissue Paper 1150
Batch 5 30 Metal Mesh 1280
Batch 6 30 Tissue Paper 1280
Batch 7 30 Metal Mesh 1150
Batch 8 30 Tissue Paper 1150
Table 4.2: The batches o f  samples fabricated from  the I.I. procedure
In total, forty samples were fabricated with twenty samples fabricated from 30 ppi foam and 
twenty from 45 ppi porosifier foams. Half o f the samples fabricated from the two different 
porosifier foams were dried on metal mesh, and the other half were dried on tissue paper. From 
the samples dried on metal mesh, half were sintered at 1150°C and half at 1280°C. The same 
sintering procedures were used for the tissue dried samples. Therefore, there were eight different 
batches of material with five samples per batch totalling forty samples.
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Figures 4.11 (a) and (b) show digital camera images o f the sintered bioceramics fabricated with 
the I.I. method. The images show cut sections from the samples illustrating the internal structure 
o f the bioceramics. The large closed porosity that can be seen throughout is the result o f poor 
impregnation in the fabrication stage. The 1150°C samples appeared to be slightly more friable 
in texture than the 1280°C samples. I.I. samples made from the 30 ppi foams also appeared to be 
slightly more friable in appearance and nature than the samples made from 45 ppi porosifier 
foams. This was especially true when dried on the metal mesh instead o f the tissue, due to the 
ease o f flow o f slurry through the larger pores on the mesh, which leaves an impression on the 
surface o f the dried specimen. All I.I. samples were fired in the same sintering oven.
Figure 4.11 (a): I.I. bioceramic sintered at Figure 4.11 (b): I.I. bioceramic sintered at
1280°C. Approximate composition 75% HA, 1150°C. Approximate composition 61% HA,
14% a-TCP, 11% P-TCP 4%> a-TCP, 35% P-TCP
4.3.1 Image Analysis - Macroporositv
The following results show the macroporosity present in the I.I. samples, including examples of 
the micrographs from SEM analysis and the macroporosity distribution from the I.I. fabrication 
method.
Sections of the samples from each batch were used to evaluate the macroporosity distribution for 
that particular batch before sectioned into cubes for compression testing (section 4.3.3). The total 




The Optimas 6.1 computer software was used for image analysis (as described in section 3.5) on 
two micrographs that were taken from SEM analysis. These images were scanned into the 
software and “cleaned up” to improve the clarity of the images and hence the accuracy of the 
results. The macroporosity distribution was evaluated from four images for each sample (entire 
area of sample), and the results of the mean pore size, standard deviation pore size and the total 
volume porosity were correlated to the experimental variables (the sintering temperature, the 
type of porosifier used and the drying medium).
Tables 4.3 (a) and (b) represent comparative macroporosity distribution data between those 
samples dried on metal mesh and those dried on tissue paper respectively. It was found that the 
drying method had the greatest influence on the macroporosity distribution o f the I.I. fabricated 
samples. Drying the I.I. samples on tissue instead o f on metal mesh improves the extraction of 
moisture from the samples, and as a result, the macroporosity o f the tissue dried samples was 
reduced.
The variations found due to the different drying regimes, also affected the standard deviation o f 
the pore size and the maximum pore size found. Those samples dried on metal mesh possessed 
larger incidences of closed porosity, and it is this porosity caused due to poor drying, that 
accounts for the disruption in the structure, and as a consequence increases the deviation in the 
pore size present, table 4.3 (a).
Samples dried on tissue paper have a reduced level o f large closed porosity, thus the deviation in 
the size of the porosity present was reduced, table 4.3 (b). As a consequence, this improved the 
interconnectivity of the porosity and the accuracy of the measurement o f the interconnected bow 
tie shaped porosity (i.e. the mean pore size). Incidents o f larger sized pores were numerous in 
samples dried on metal mesh when compared to those dried on tissue paper. As a result o f this 
closed porosity from poor drying, the maximum size porosity found in samples dried on metal 
mesh was substantially larger than those dried on tissue paper.
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75 14 11 1280 45 30.6 1475.4 93.3 161.5
61 4 35 1150 45 17.3 800.5 84.8 107.1
75 14 11 1280 30 19.1 5967.3 113.0 335.5
61 4 35 1150 30 28.3 2926.1 133.6 266.4
Table 4.3 (a): Macroporosity data fo r  1.1, samples dried on metal mesh




















75 14 11 1280 45 21.4 744.3 102.9 108.9
61 4 35 1150 45 10.8 959.1 92.9 73.9
75 14 11 1280 30 9.5 479.4 104.0 78.7
61 4 35 1150 30 6.9 697.1 109.7 78.1
Table 4.3 (b): Macroporosity data fo r  samples dried on tissue paper
Due to poor moisture extraction in the samples dried on metal mesh (compared to those dried on 
tissue paper), large, circular closed pores were present (from air voidage) that disrupt the 
interconnectivity of the porosity distribution, provided by the porosifier foam burnout. Drying on 
tissue reduces the number o f incidents o f closed porosity and as a consequence offers an 
improved interconnected porosity network following the burnout o f the porosifier foam. Figures
4.12 (a) and (b) show SEM images of sections o f samples dried on metal mesh and tissue paper 
respectively.
The bow tie shaped pores result from porosifier foam burnout (interconnected porosity), and the 
large circular pores were due to poor moisture extraction and therefore created air voidage and
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closed pores on sintering. There was greater clarity in the interconnected porosity network in 
those samples dried on tissue paper, figure 4.12 (b), as the porosity distribution was not disrupted 
by the presence of closed porosity.
Interconnected  
porosity  from  foam  
burnout -  bow  tie 
shaped pores
C losed  
porosity  from  
poor m oisture  
extraction
Figure 4.12 (a): SEM  micrograph o f  a section o f  a 45 ppi sample dried on metal mesh
Im proved clarity  
in interconnected  
pore netw ork o f  
bow  tie  shaped  
pores
C losed  pores  
from poor  
drying w ere  
reduced in 
size  and 
num ber
Figure 4.12 (h): SEM  micrograph o f  a section o f  a 30 ppi sample dried on tissue paper
The mean pore size o f the 30 ppi foams was larger than for the 45 ppi foams. The number o f 
interconnected bow tie shaped pores (from foam burnout) was fewer, however they were greater 
in size. This was a function o f the type o f porosifier foam used and not the drying method. Both
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foam samples possess the same volume o f foam and hence the 30 ppi samples possess larger 
pores created due to foam burnout than for 45 ppi foams, as they were inherently fewer in 
number.
As a consequence of drying on tissue paper, there were fewer counts o f porosity as the number 
of incidences o f closed porosity was reduced. The cumulative pore distribution graphs o f those 
samples dried on metal mesh compared to drying on tissue are shown in figure 4.13. NB. The 
pore size scale bar has been limited to 500pm although there were counts o f porosity above this 
size. However, these counts were small compared with the rest o f the data set, therefore were not 
included in this comparison.
Tissue
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Pore Size (jum)
Fisure 4.13: Cumulative pore distribution graph fo r  samples dried on metal mesh and tissue
paper
The majority o f the porosity from the I.I. method was not ideally sized for possible bone 
substitute material applications. The recognised ideal pore size for bone regeneration to occur is 
150 -  300pm, as discussed in sections 2.3 and 2.4. The mean porosity size from all I.I. samples 
was 104.3pm ± 48.4pm (as a 95% confidence level).
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The type of porosifier used pre-dominantly determines the mean pore size of the porosity. It is 
also worthy to note that drying on metal mesh, which accounts for the presence of closed 
porosity, and using 30 ppi foams, possess a large deviation in their results.
The 30 ppi impregnated samples possess larger pore channels than those samples fabricated from 
45 ppi foams. Therefore, it remained possible that slip would flow out o f the foam during drying 
(“slumping”), thus increasing the mean pore size o f the 30 ppi foam samples and the deviation in 
the result. Moisture extraction due to drying on tissue paper was more sensitive in the 30 ppi 
foam samples. This effect is shown in figure 4.14 below.
The shape of the porosity was also not ideal for potential bone substitute applications, as the bow 
tie shaped interconnected pores were larger at their edges than at their centre, suggesting that 
bone growth would not occur throughout the bioceramic.
Mesh Tissue
Fisure 4.14: Total volume macroporosity o f  I I  samples as a function o f  the drying method used
It can therefore be concluded that the macroporosity distribution fabricated from the I.I. samples 
does not possess guaranteed interconnected porosity in the correct size range for possible bone 
remodelling (i.e. 150 -  300pm). This was mainly due to the formation of closed pores due to 
poor drying on metal mesh. Drying on tissue paper improves the interconnectivity o f the porosity 
and reduces the overall total volume porosity by 51%. The large differences in structure caused 
by the drying method had the greatest influence over the porosity distribution, the total volume
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of porosity present and the deviation found in the result. The type o f porosifier used (30 or 45 
ppi) pre-dominantly controlled the mean pore size.
4.3.1.1 Accuracy of Macroporosity Measurement
Any errors incurred during image analysis were kept to a minimum due to the use of the Optimas
6.1 imaging software. The software analyses the porosity present by placing colour thresholds on 
two phases: grain and porosity. Therefore, if the thresholds for each phase are correct then errors 
with respect to the amount of porosity and the size and shape of the porosity are limited.
However, on one of the samples there appeared scratches (formed during polishing stage) and in 
another sample some gas porosity was present inside some closed porosity. The software finds it 
difficult to “see” the difference between the scratches and actual porosity present, as their colour 
thresholds are similar. Scratches present on one sample could be eliminated from detection by 
the software by softening the image, thus reducing the presence of the scratches, therefore 
improving the accuracy o f the result.
4.3.2 Image Analysis - Microporositv
The macroporosity plays an active role in bone regeneration and has a strong influence on the 
mechanical properties of ceramics. However, the microporosity in its own right is an important 
parameter to focus on, as this is where ingress and migration o f fluids and cells occurs. The 
following results show the microscopic structural features of the I.I. bioceramics, including the 
microporosity distributions o f the samples.
Microstructural SEM analysis was taken from the same samples used in section 4.3.1, so that 
each batch o f samples was analysed against the experimental variables: sintering temperature, 
drying method and the type o f porosifier used. Therefore, a comparison can be made between 
these variables and the amount of microporosity present.
Tables 4.4 (a) and (b) show comparative microporosity distribution data between samples 
sintered at 1150°C and at 1280°C respectively. It was found that the sintering temperature had 
the greatest influence on the microporosity distribution of the I.I. bioceramics.
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61 4 35 Mesh 45 37.3 1.8 1.5
61 4 35 Tissue 45 51.6 1.8 1.6
61 4 35 Mesh 30 25.2 1.4 1.1
61 4 35 Tissue 30 34.4 1.5 1.2
Table 4.4 (a): Microporosity data fo r  I.I. samples sintered at 1150°C






















75 14 11 Mesh 45 11.6 1.1 0.7
75 14 11 Tissue 45 13.6 1.0 0.8
75 14 11 Mesh 30 35.3 1.5 1.3
75 14 11 Tissue 30 10.2 0.6 0.7
Table 4.4 (b): Microporosity data fo r  samples sintered at 1280°C
The volume porosity present in samples sintered at 1150°C and 1280°C was 37.1% ± 15.1% and 
17.7% ± 10.2% respectively (95% confidence level). The large volume microporosity found in 
the 30 ppi fabricated sample, dried on metal mesh and sintered at 1280°C, was due to the 
formation of scratches on the surface of the sample during the polishing stage. Image analysis 
revealed difficulty in reducing the counts o f dark areas on the micrograph and therefore unable to 
distinguish between scratches and actual porosity counts. As a consequence, the deviation in the 
microporosity present at 1280°C was increased, however, the deviation was greater still in those 




Sintering the I.I. samples at 1280°C instead o f at 1150°C reduced the total volume microporosity 
of the bioceramics by 52%. At 1280°C, the samples contain approximately 14% a-TC P, while at 
1150°C the bioceramic contains 4% a-TCP, 61% HA and 35% P-TCP (section 4.2). As 
discussed in sections 3.1 and 4.2, the P-TCP high temperature phase transformation to a-TCP 
occurs at 1180°C. Figures 4.15 (a) and (b) show SEM micrographs from I.I. bioceramics sintered 
at 1150°C and 1280°C respectively. It can be seen that there is an inconsistency in the respective 
microstructures, and therefore the amount of microporosity present in the two samples. An 
increase in sintering temperature results in a denser microstructure due to the formation o f a - 
TCP (section 4.2).
Figure 4.15 (a): Photomicrograph o f  a section o f  61% HA, 35% /3-TCP, 4% a-TCP 1.1. sample
sintered at 1150°C. Scale bar = 10pm
Figure 4.15 (b): Photomicrograph o f  a section o f  75% HA, 14% a-TCP, 11%) /3-TCP I.I. sample
sintered at 1280°C. Scale bar = 10pm
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The P-TCP content in samples sintered at 1150°C produces a granular structure, which offers 
more scope for error in image analysis. This was because it was more difficult to place colour 
thresholds on the grain structure and microporosity. At 1280°C, due to the presence o f calcium 
phosphate hydrate in the base powder 118 (section 4.2), a thermal phase transformation from p- 
TCP to a-TCP occurs. This transformation causes microstructural changes driven by grain 
growth via the elimination of microporosity. As a consequence, samples sintered at 1280°C have 
52% less microporosity than those sintered at 1150°C.
The average microporosity present in all samples was 27.4%. The microporosity was found to be 
independent o f the grade o f porosifier used and drying method, as the amount o f microporosity 
present in the 45 ppi foam samples and the 30 ppi foam samples was 28.6% and 26.3% 
respectively. Conversely, as previously discussed, the microporosity is dependent on sintering 
temperature. The microporosity present in samples sintered at 1150°C and 1280°C was 37.1% 
and 17.1% respectively. This temperature control over the microporosity of the bioceramics is 
shown in figure 4.16.
% M icroporosity ] 5
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Figure 4.16: Microporosity changes as a function o f  sintering temperature in I.I. samples
Table 4.4 (a) also indicates that the deviation in the pore size was larger at 1150°C than at 
1280°C, table 4.4 (b). In addition, the mean pore size was 0.5pm larger at 1150°C than at 
1280°C. Figure 4.17 represents the cumulative pore distributions of the microporosity 
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Figure 4.17: Cumulative micropore distribution fo r  all the samples analysed by image analysis
The greater number o f counts of porosity from 0 -  0.4pm at 1150°C was due to the discrepancies 
in image analysis. The granular microstructure due to the lack o f formation o f a-TCP, where a 
vitreous reaction occurs, offered a difficult surface for image analysis. Colour thresholds used to 
identify the grain and porosity would not capture the complete microporosity distribution (i.e. the 
larger microporosity counts). Therefore, the results for the samples sintered at 1150°C are not as 
accurate when compared to the samples sintered at 1280°C.
4.3.2.1 Accuracy of Microporosity Measurement
The Optimas 6.1 image analysis software was used for measuring microporosity. As for the 
macroporosity analysis, colour thresholds were set on the porosity phase and the grain phase. 
The software can be formatted in this way, to measure the percent porosity present and 
individual pore sizes. In some of the 1150°C fired samples, the pores were less defined than in 
the 1280°C fired samples. This posed some problems as the software manipulation had to be 
employed to soften the image so the software could distinguish between the two phases present 
(grain structure and porosity).
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4.3.3 Strength-Density Relationship o f I.I. Bioceramics
All forty samples were tested in compression until failure. The compressive stress was then 




















(MPa) -  95% 
Confidence 
Level
1 1280 45 Mesh 1.46 ± 0.07 3.34 ± 1.34
2 1280 45 Tissue 1.46 ± 0.10 4.66 ± 1.51
3 1150 45 Mesh 1.33 ± 0.19 5.27 ± 2.82
4 1150 45 Tissue 1.37 ±0.17 4.68 ± 2.84
5 1280 30 Mesh 1.40 ±0.11 1.90 ± 1.19
6 1280 30 Tissue 1.78 ±0.25 9.94 ± 8.05
7 1150 30 Mesh 1.15 ±0.14 2.29 ± 1.87
8 1150 30 Tissue 1.22 ± 0.21 4.18 ± 3.28
Table 4.5: Summary o f  mechanical data fo r  I.I. bioceramics
Figures 4.18 (a) to (e) show the strength-density relationships o f the samples analysed. 
Regression analysis was also performed with R -  values quoted on the figures indicating a good 
correlation in particular in those samples fabricated from 30ppi foams, those samples sintered at 
1280°C and those samples dried on tissue paper. Figures 4.18 (a) and (b) compare the 
mechanical properties of I.I. bioceramics fabricated from different grade porosifiers (45 and 30 
ppi). Figures 4.18 (c) and (d) compare samples fabricated at different sintering temperatures 
(1150°C and 1280°C), and figure 4.18 (e) shows the effects o f the drying regime on the 
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Figure 4.18 (e): Graph indicating strength-density relationship in samples dried on metal mesh
and tissue paper
Figure 4.18 (e) illustrates that drying on tissue has reduced the deviation in the results. A 
polynomial relationship (as described in section 2.4.5.2) was used in order to evaluate the scatter 
in the results. Regression analysis revealed that the R -  value was double that from the samples 
dried on mesh, as the counts o f closed porosity (from poor drying) were eliminated, therefore 
reducing porosity and increasing strength. Figure 4.18 (b) also shows that the deviation in the 
compressive stress for the samples made from 30 ppi foams were lower than for 45 foam 
samples (i.e. high R -  value).
All the samples indicate a strength-density relationship whereby an increase in density results in 
increased strength. Figure 4.19 illustrates the strength-density relationship o f all I.I. bioceramic 
samples. Regression analysis indicates an R-value o f 0.76 over the whole sample range. This 
suggests that a relatively strong correlation is present, however there is also some deviation in 
the results due to the drying medium used. The polynomial relationship used for figure 4.18 (e) 
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Figure 4.19: Graph indicating strength-density relationship in all 1.1, samples
Ceramics inherently have a wide distribution o f errors associated with them, mainly due to the 
nature of internal flaws, their size and distribution, and also due to surface flaws. It has been 
found that varying the experimental parameters has a profound influence on the structure of the 
bioceramics and therefore the mechanical properties. The results in table 4.5 have been 
calculated as 95% confidence levels, indicating that 19 from every 20 samples lie within the 
range quoted, thus qualifying the results statistically.
An improvement to the experimental method that would reduce the systematic error in the results 
would be to use rollered platens. Figure 4.20 is a schematic and exaggerated diagram of the 
situation that occasionally occurred when the surface o f the sample was not totally in contact 
with the platens. This resulted from inaccuracies in the grinding stage of preparing the samples. 






Figure 4.20: Exaggerated schematic o f  shearing effects that occasionally occurred in samples
when prepared samples were not quite parallel
The structural integrity o f the samples remained during testing, however, on subsequent handling 
the samples disintegrated to powder form. It was difficult to measure the modulus o f the samples 
as once they have failed elastically (i.e. the first structural strut) they were deemed out o f the 
elastic region o f the material, however the force absorbed by the sample continued to increase 
until the final remaining material had failed. This is shown graphically below in figure 4.21.
subsequent failures
point o f first failure
Figure 4.21: Typical load-deformation curve fo r  1.1, hioceramic material
Therefore, the modulus, if measured by the failure of the first structural strut, is not a true 
reflection of the actual modulus of the sample. For this reason, the modulus o f the samples has 
not been calculated.
Figure 4.22 represents the strength-macroporosity relationship o f the samples analysed. As with 
the strength-density relationship there is a correlation in the results (R - value o f 0.80) indicating 
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Figure 4.22: Graph indicating the relationship between decreasing porosity, which results in an
increase in strength
Figure 4.23 shows the differences in strength in relation to the experimental parameters varied in 
the research. The 1280°C sintered samples have higher strengths than those sintered at 1150°C, 
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Figure 4.23: Correlation between strength, sintering temperature and the type o f  porosifier used
Sintering temp. (°C) Porosifier size (ppi)
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4.3.4 Drying Effects on Strength o f 1.1. Bioceramics
As was shown in section 4.3.1, the drying method used (either metal mesh or tissue paper) had a 
pronounced effect on macroporosity, and therefore on strength. This is shown in figure 4.24. 
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Figure 4.24: Effect o f  drying on the compressive strength o f  the 1.1, samples
Drying on tissue extracts excess moisture from the samples, and hence there were fewer counts 
o f closed porosity in the samples. As was shown in figure 4.22, a reduction in porosity results in 
an increase in strength.
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4.3.5 Summary of I.I. Bioceramic Results 
Fabrication
An interconnected macroporosity network has been fabricated by the impregnation o f HA/TCP 
slips into reticulated PU foams, and the subsequent burnout o f PU foam on sintering. This 
method gives the negative image of the foam in the form of a macropore network in the 
bioceramic (bow tie shaped pores resulting from the burnout of the PU foam).
Effect of Drying on Macroporositv Network
Drying on tissue extracts a greater volume of moisture from the samples when compared with 
drying on a metal mesh. Samples dried on metal mesh have a greater number o f closed pores that 
disrupt the interconnected porosity, hence increasing porosity and reducing strength.
The larger sized pore channels in 30 ppi samples allow excess moisture to be extracted easier 
than in the 45 ppi samples that have smaller pore channels. It is easier to impregnate the 30 ppi 
foam samples than 45 ppi, as the pore channels are larger. However, there is also a greater 
possibility for the slip to “slump” out of the foam and leave closed pores that are not 
representative o f the ideal structure (i.e. interconnected bow tie shapes pores from foam 
burnout). Poor impregnation in some samples leads to an increase in closed porosity resulting in 
a weaker structure by disrupting the interconnectivity of the porosity in the samples.
The macroporosity in the I.I. bioceramics is dependent on the type of porosifier used and the 
drying mechanism employed. The macroporosity is independent o f the sintering temperature. In 
addition, the size and shape o f the macroporosity was potentially not ideal for bone remodelling 
purposes, due to the fact that the pores were wider at their edges than at their centres.
Effect o f Sintering Temperature and Composition on Microporositv
The microporosity is dependent on the sintering temperature and independent o f porosifier type 
and drying medium. The microporosity network is greater in both size and total volume in those 
samples sintered at 1150°C than 1280°C, and there was evidence to suggest the formation o f a 
vitreous, glassy structure in 1280°C samples as the micropores are well defined and are clearer
118
4: Results
than in 1150°C sintered samples. The thermal transformation at 1180°C from (3-TCP to a-TCP, 
results in a well defined, glassy structure in those samples sintered at 1280°C (75% HA, 14% a - 
TCP, 11% P-TCP) compared to those at 1150°C (61% HA, 35% p-TCP, 4% a-TCP).
Mechanical Properties
There is a correlation between strength and density in the samples, indicating that an increase in 
density results in an increase in strength. There is also a strength-porosity relationship, indicating 
the greater the amount of porosity present, the lower the strength o f the bioceramic. The 1280°C 
sintered bioceramics have greater strengths than those sintered at 1150°C.
Drying has a pronounced effect on mechanical properties. Drying on tissue extracts excess 
moisture and hence reduces porosity and increases strength. There is a large variation in results 
due to the fabrication parameters used, e.g. the testing procedure could be improved and hence 
reduce the uncertainty in the results by using rollered platens on compression testing. This would 
avoid shearing o f samples in some cases where the surfaces o f the bioceramic were not ground 
perfectly flat.
4.3.6 Key Findings
• An interconnected porosity network has been fabricated in HA/TCP bioceramics sintered 
at 1150°C and 1280°C. The size and shape of the porosity however would require further 
investigation for potential bone remodelling applications.
• Fabricated I.I. bioceramics have a compressive strength of 4.50 ± 2.86 MPa over a 40 
sample size range. The samples possessed a volume macroporosity size range of 7 -  
31%, with mean pore sizes ranging from 56 -  152pm.
• The variation in strength was largely due to differences in sintering temperature, drying 
method and the type o f porosifier used, also due to uncertainties in testing procedure.
• The drying method used has been shown to influence the macroporosity distribution and 
hence has implications with respect to properties such as strength.
• The microporosity was dependent on the sintering temperature used.
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Objectives and Aims for Future Research
The following aims and objectives for future research are to be addressed in section 4.4 -  Open 
Porous Scaffold Bioceramics:
• To improve the pore size and shape of the interconnected macroporosity structure, by 
increasing the total volume macroporosity, pore size and the interconnectivity o f the 
porosity.
• To improve reliability of the bioceramics in both fabrication and testing procedure.
• The ultimate aim o f the research is to develop a bioceramic material with an 
interconnected porosity network, in the correct size range for possible bone remodelling, 
combined with suitable mechanical properties for load bearing applications.
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4.4 Open Porous Scaffold (OPS) Bioceramics
The objectives and aims for future research, detailed at the end o f the I.I. results (section 4.3.6), 
are to be addressed in this section. The focus of research and the aim of the OPS fabrication, was 
to produce HA/TCP bioceramics with guaranteed interconnected porosity and a total volume 
porosity, pore size and pore shape in the correct size range for bone remodelling, and in doing 
so, fabricating a material suitable for bone substitute applications. It was also an objective to 
produce OPS bioceramics with a structure resembling the orientated nature o f cancellous bone 
(section 3.8.2.1). Figures 4.25 (a) and (b) demonstrate the OPS bioceramics produced by the 
method described in section 3.8.2.
Figure 4.25 (a): 75%HA, 14%a-TCP, 11%/3-TCP OPS bioceramic -  3 0 ppi
Figure 4.25 (b): 75%HA, 14%a-TCP, 11%/3-TCP OPS bioceramic -  45 ppi
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For the fabrication o f OPS bioceramics, three variables were used in order to ascertain 
differences in the macroporosity distribution and the resultant effect on mechanical properties 
(section 4.4.3). The alterations to the macroporosity distribution include changes to the total 
volume porosity, the mean pore size and standard deviation of the pore size. The three 
experimental variables include the different foam porosifiers used during fabrication (30 and 45 
ppi), the sintering temperature (1150°C and 1280°C) and the shape of porosity due to an 
elongation procedure detailed in section 3.8.2.1. The porosity shape is stated as normal (N), 
longitudinal (L) or transverse (T). The mechanical properties will be correlated to the structural 








Batch 1 30 N 1280
Batch 2 30 L 1150
Batch 3 30 T 1280
Batch 4 30 N 1150
Batch 5 30 L 1280
Batch 6 30 T 1150
Batch 7 45 N 1280
Batch 8 45 L 1150
Batch 9 45 T 1280
Batch 10 45 N 1150
Batch 11 45 L 1280
Batch 12 45 T 1150
Table 4.6: The batches o f  samples fabricatedfrom the OPS procedure
In total, 120 samples were fabricated with 60 samples fabricated from 30 ppi foam and 60 from 
45 ppi porosifier foams. The samples fabricated from the two different porosifier foams were 
subjected to an elongation procedure, as described in section 3.8.2.1, to produce orientated 
structures, labelled L and T on table 4.6. The L and T suffix relates to the formation of
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longitudinal (L) and transverse (T) shaped porosity as opposed to the pores in untreated foams 
that are spherical i.e. N -  normal. Half of these unorientated (N) and orientated samples (L and 
T) were sintered at 1150°C and the other half at 1280°C. Therefore; there were 12 different 
batches of material with 10 samples per batch totalling 120 samples.
4.4.1 Image Analysis -  Macroporositv
The following results show the macroporosity measured in the OPS samples and include 
examples of the micrographs from SEM analysis and the macroporosity distributions from the 
OPS fabrication method.
The SEM micrographs also illustrate the structural differences in the samples due to the 
orientation procedure described in section 3.8.2.1. Sections of the samples from each batch were 
used to evaluate the macroporosity distribution. The entire surface area o f a sample 
representative o f the batch was analysed from four SEM images to assess the macroporosity 
distribution.
Tables 4.7 (a) and (b) show comparative compositions and macroporosity distribution data for 
OPS samples fabricated from 30 ppi foams and 45 ppi foams respectively.
The total volume porosity o f the OPS was found to be within a suitable range for bone ingrowth 
as discussed in section 2.3.2. The elongation procedure has had the effect o f reducing the total 
volume porosity within each batch of samples. However, the total volume porosity remains 
suitably sufficient for bone replacement applications from a porosity distribution stand point i.e. 
volume porosity (%), size and distribution of pores.
It can be stated from comparing the results in tables 4.7 (a) and (b), that the mean pore size is 





























75 14 11 1280 N 93.0 3509.4 328.9 ±60.9
61 4 35 1150 N 87.7 3463.6 263.8 ± 66.8
75 14 11 1280 L 85.3 3725.5 214.0 ±60.7
61 4 35 1150 L 85.7 2414.9 229.7 ± 38.0
75 14 11 1280 T 78.1 3382.7 295.4 ±70.8
61 4 35 1150 T 82.0 3571.4 249.4 ± 59.2
Table 4.7 (a): Composition and macroporosity data fo r  OPS samples fabricated from  30 ppi
foams
Approximate 
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75 14 11 1280 N 84.1 1887.6 242.8 ± 62.6
61 4 35 1150 N 80.2 2334.9 241.8 ±95.7
75 14 11 1280 L 73.6 3701.0 210.0 ±62.5
61 4 35 1150 L 77.4 2382.8 146.2 ±59.1
75 14 11 1280 T 83.0 2927.1 220.6 ± 57.5
61 4 35 1150 T 79.3 3444.2 215.7 ±36.7
Table 4.7 (b): Macroporosity data fo r  OPS samples fabricated from  45 ppi foam s
The macro-structure of the OPS samples is determined by the type of porosifier used (30 or 45 
ppi), not the sintering temperature or elongation procedure used in order to produce orientation 
in the porosity. Figure 4.26 shows the volume porosity of the OPS samples.
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Figure 4.26: Total macroporosity volume (%) o f  OPS samples
One o f the main aims o f this section o f research was to guarantee the interconnectivity o f the 
porosity in OPS samples. Figures 4.27 (a) to (f) show SEM images o f the OPS samples and 
illustrate both the improved pore shape o f the porosity and the degree o f interconnectivity o f the 
samples. The orientation in the elongated samples is also illustrated.
Figure 4.27 (a): OPS 3 0 ppi Nsam ple Figure 4.27 (b): OPS 45 ppi N  sample
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Figure 4.27 (c): OPS 3 0 ppi L sample Figure 4.27 (d): OPS 45ppi L sample
Figure 4.27 (e): OPS 3 0 ppi Tsample Figure 4.27 (f): OPS 45 ppi Tsample
The cumulative pore distribution for the OPS samples, shown in figure 4.28, again clarifies the 
obvious advantages in pore size for possible bone substitute applications o f the OPS samples. It 
demonstrates a wide porosity distribution with pores ranging in size from 180 -  300pm.
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Figure 4.28: Cumulative pore distribution graph fo r  OPS samples
4.4.1.1 Accuracy of Macroporosity Measurement
There were difficulties found with measuring the macroporosity in some OPS samples due to the 
high volume porosity present and the three dimensional structure. The image analysis software 
uses colour contrast to measure porosity, so that the struts o f the samples appear white and the 
pores black. In some cases however, struts would overlap with underlying pores varying the 
amount of porosity that could be measured. In these cases equation 17 was used to evaluate the 
macroporosity present:
Total porosity = theoretical density o f phase produced -  apparent density x 100% (17)
theoretical density o f phase produced
Theoretical density o f HA: 3.16g/cm3 
Theoretical density o f a-TCP: 3.07g/cm3 
Theoretical density o f p-TCP: 2.86g/cm3 [109]
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4.4.2 Image Analysis - Microporositv
As the same base powders were used for the production o f I.I. and OPS bioceramics, it was 
confirmed from OPS microstructural analysis that the sintering temperature had determined the 
amount of microporosity present (as was found in the I.I samples). Therefore, it is only necessary 
to show the distribution o f microporosity with respect to sintering temperature (1150°C and 
1280°C). Microstructural SEM carried out on the same samples used in section 4.4.1. Four SEM 
images of the microporosity distribution from each sample used for analysis, as the 
microporosity distribution within the samples was consistent.
Tables 4.8 (a) and (b) show comparative microporosity distribution data between those samples 
sintered at 1150°C and at 1280°C respectively. It was found that the sintering temperature had 
the greatest influence on the microporosity distribution of the OPS bioceramics.
















HA a-TCP P-TCP Porosifier size (ppi)
61 35 4 30 25.2 1.4 1.1
61 35 4 45 34.4 1.5 1.2
Table 4.8 (a): Microporosity data fo r  OPS samples sintered at 1150°C
















HA a-TCP p-TCP Porosifier size (ppi)
75 14 11 30 10.2 0.6 0.7
75 14 11 45 13.6 0.9 0.8
Table 4.8 (b): Microporosity data fo r  OPS samples sintered at 1280°C
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It was found that it is the sintering temperature that governs porosity at the microstructural level. 
The volume o f microporosity present in samples sintered at 1150°C and 1280°C was 29.8% and 
11.9% respectively. Increasing the sintering temperature to 1280°C from 1150°C reduced the 
total volume o f microporosity o f the OPS bioceramics by 60.1%. Figures 4.29 (a) and (b) show 
SEM images o f the microstructures o f the OPS bioceramics sintered at 1150°C and 1280°C. The 
decrease in the amount of microporosity with increasing temperature is illustrated in figure 4.30.
Figure 4.29 fa): Photomicrograph o f  a 61% HA, 39% TCP OPS sample sintered at 1150°C.
Scale bar = 10pm
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Figure 4.29 (b): Photomicrograph o f  a 75% HA, 25% TCP OPS sample sintered at 1280°C.
Scale bar = 10pm
% M icroporosity
1280  j 1150
Sintering temp. (°C)
Figure 4.30: Microporosity changes as a function o f  sintering temperature in OPS samples
As a consequence of the thermal transformation of grade 118 powder to a-TCP at 1180°C 
(section 4.2), the microporosity o f the OPS samples has been reduced. As discussed in section 
4.3.2, the (5-TCP content in samples sintered at 1150°C produces a granular structure that 
appears less dense than the microstructure obtained when samples are sintered at 1280°C. At 
1280°C, due to microstructural changes driven by grain growth via the elimination of
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microporosity, because o f the formation o f a-TCP, samples have less microporosity than those 
sintered at 1150°C. The pores at 1280°C are clearly defined, figure 4.29 (b), however at 1150°C, 
figure 4.29 (a), the pores appeared in the form of a granular structure and lacked clarity. Figure 





150 ■  1150
■  1280
o cs| vq ^
■4 cn rn
Pore S iz e  (jtni)
Figure 4.31: Cumulative micropore distribution fo r  all OPS samples analysed by image analysis
The cumulative microporosity distribution o f OPS samples are dependent in both pore size and 
size range on sintering temperature. This was found to be due to the thermal transformation of 
non-stoichiometric CaP to a-TCP, resulting in microstructural changes decreasing microporosity 
at higher sintering temperatures.
4.4.2.1 Accuracy of Microporosity Measurement
The granular microstructure due to the lack of formation o f a-TC P at 1150°C, offered a difficult 
surface for image analysis. Colour thresholds used to identify the grain and porosity would not 
capture the complete microporosity distribution (i.e. the larger microporosity counts). The 
software was formatted to measure the percent porosity present and individual pore sizes. On 
some of the 1150°C fired samples, the pores were less defined than in the 1280°C fired samples.
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This posed some problems as the software manipulation had to be employed to soften the image 
so the software could distinguish between the two phases present (grain structure and porosity).
4.4.3 Strength-Density Relationship o f OPS Bioceramics
In total, 120 samples had a breaking stress of 0.32MPa ± 0.01 MPa at 95% confidence levels. 




























30 N 1150 0.43 0 .02 0.34 0.11
30 L 1150 0.37 0 .02 0.28 0.06
30 T 1150 0.38 0.04 0.31 0.05
30 N 1280 0.46 0.04 0.37 0 .10
30 L 1280 0.41 0.04 0.30 0.06
30 T 1280 0.45 0.04 0.40 0.07
45 N 1150 0.33 0.03 0.20 0.04
45 L 1150 0.31 0.02 0.28 0.04
45 T 1150 0.31 0 .02 0.33 0 .10
45 N 1280 0.40 0 .02 0.33 0.05
45 L 1280 0.38 0.03 0.33 0.06
45 T 1280 0.37 0.03 0.35 0.08
Table 4.9: Summary o f  mechanical data fo r  OPS bioceramics
Figure 4.32 shows that those samples sintered at 1280°C have higher densities and strengths than 
those at 1150°C. The strengths reported are low, but there was evidence from 95% C.L. that the 
fabrication procedure was consistent and reliable.
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Comparison of Mechanical Data for OPS Bioceramies 
Sintered at 1280°C and 1150°C
0.45
Strength (MPa) Density (g/cmA3)
Figure 4.32: Strength-density comparison fo r  OPS bioceramics sintered at 1280°C and 1150°C
In producing an open porous structure with porosity in a suitable size range for bone 
remodelling, the mechanical property requirements have been compromised and substantially 
reduced. The OPS samples possess sufficient pore volume, pore size and interconnectivity for 
possible bone ingrowth, they also have shown limitations due to their low strengths. The 
mechanical properties of the OPS bioceramics are currently not sufficient for loading purposes in 
the body.
4.4.4 Surface Flaws Associated with OPS Fabrication
Detailed SEM analysis revealed the presence o f  surface flaws in the struts of the OPS structures 
that could be seen to significantly affect the mechanical properties. Figures 4.33 (a) to (d) 
illustrate these microcracks that on loading collapse and result in low strengths.
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Figure 4.33 fa): Formation o f  microcracks 
on surface o f  OPS -  30ppi N
Figure 4.33 (b): Formation o f  microcracks 
on surface o f  OPS -  45ppi L
Figure 4.33 (c): Formation o f  microcracks Figure 4.33 fd): Formation o f  microcracks
on surface o f  OPS -  45ppi T on surface o f  OPS -  30ppi L
The microcracks appear to form primarily at areas where numerous struts converge. These are 
termed triple point junctions, as usually three struts meet at areas o f high PU foam concentration. 
On heating, the PU foam flows and meets at these triple point junctions, under its own surface 
energy. Further heating (at ~ 500°C) forces the PU foam to form gaseous products that escape 
from the ceramic scaffold structure. This creates structural weaknesses, mainly at triple point 
junctions where there were high concentrations of PU foam, which on further sintering cause 
surface stresses and formation of microcracks. The high stresses cannot be relieved by viscous 
flow of the ceramic and hence microcracks form.
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On loading, these microcracks grow and converge until the crack length increases, lowering the 
stress to cause failure and decreasing the overall strength of the bioceramic. This explains why 
there were no substantial differences in strength between the untreated OPS samples and those 
subjected to orientation procedures. It was hypothesised that those samples with elliptical shaped 
pores (instead o f spherical pores) would have lower strengths due to the higher stress 
concentrations at their tips. However, due to the consistent presence in all OPS bioceramics of 
the aforementioned microcracks, strengths were consistently low throughout the whole range o f 
samples, irrespective of their geometry.
It is these microcracks that must be reduced in size, or even eliminated, in order to improve the 
mechanical properties of the OPS bioceramics. However, this must be achieved without 
compromising the interconnected macroporosity structure successfully fabricated for possible 
bone remodelling purposes.
4.4.5 Summary of OPS Bioceramics Results
Fabrication
An interconnected macroporosity network resembling that of cancellous bone has been 
successfully fabricated. An orientated structure resembling the directional differences (due to 
loading) in cancellous bone has also been fabricated. The benefits o f producing an open porous 
structure with pores in a an appropriate size range for bone remodelling (150 -  300pm) has been 
off-set by the limitations of the material for load bearing capabilities.
Macroporositv Network
The total volume macroporosity in OPS bioceramics was 74-93%. The size and shape o f the 
porosity is more favourable for potential bone ingrowth, with pores that are circular and possess 




Those scaffolds sintered at 1280°C possessed higher strengths than those sintered at 1150°C. It 
was the formation of microcracks formed on sintering that was the dominating factor 
predisposing samples to failure. This also explained why the OPS bioceramics had such 
unpredictable low strengths throughout the sample range. The fabrication procedure was 
consistent and reliable.
4.4.6 Key Findings
• A high volume interconnected macroporosity network (resembling that of cancellous 
bone) was successfully fabricated.
• The process offered consistent and reliable results, however the mechanical properties of 
the OPS bioceramics were not sufficient for load bearing applications.
• The formations of microcracks on sintering at triple point junctions on the interconnected 
struts, were the reason for the consistent low strengths reported.
Objectives and Aims for Future Research
The following aims and objectives for future research are to be addressed in sections 4.5 and 4.6 
-  Spinal Fusion Bioceramics and Sol-Gel Treated Spinal Fusion Bioceramics respectively:
• To improve the structure-property relationship o f the bioceramics without compromising 
the successful fabrication of the interconnected porosity network that is needed for any 
possible bone regeneration.
• To reduce/eliminate the microcracks on the surface o f the OPS in order to improve 
mechanical properties.




4.5 Spinal Fusion (SF) Bioceramics
The objective o f this section of research was to produce a bioceramic for a specific practical 
application i.e. for spinal fusion interbody operations, by improving the structure-property 
relationship of the material. This was achieved by increasing the density o f the OPS bioceramics 
whilst retaining the interconnected macroporosity network successfully fabricated previously for 
the OPS samples (section 4.4). Figure 4.34 (a) and (b) illustrates scanned images of the SF 
structures produced.
Figure £ 34 (all Longitudinal section o f  91% (b):
HA SF sample sintered at 1300°C. Scale 1cm
= 2.5 mm = 2.5mm
4.5.1 Image Analysis - Macroporosity
The method used to fabricating the SF bioceramics consisted o f developing an outer dense shell 
surrounding an internal porosity network -  see figures above and section 3.8.3. The internal 
porosity structure was formed by exactly the same method as for the OPS bioceramics. 
Therefore, the interconnected macroporosity distribution matched that o f the OPS structures 
formed by using the 45 ppi porosifiers.
The following results show the macroporosity measured in the SF samples and includes 
examples of the micrographs from SEM analysis and the macroporosity distribution from the SF 
fabrication method. Sections o f the samples from each batch were used to evaluate the 
macroporosity distribution. The entire surface area o f the macroporosity distribution o f the 
sample representative of the batch was analysed from four SEM images.
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Level M ean 
Pore Size 
(pm)
M axim um 
Pore Size 
(pm)
118 6 22 72 1150 81.1 210.6 ±62.3 2871.5
118 5 39 57 1200 90.2 234.7 ±55.4 2569.1
118 4 40 56 1250 73.4 223.5 ±48.9 2110.5
118 5 45 50 1300 84.5 218.8 ±78.9 2928.6
118 5 46 49 1350 74.8 221.8 ±88.4 3333.5
130 83 10 7 1200 86.1 219.4 ±47.1 2858.7
130 86 10 4 1250 75.9 214.2 ±59.7 2329.6
130 91 6 3 1300 86.4 243.9 ±92.8 2437.7
130 91 5 4 1350 92.2 236.4 ± 74.6 3046.3
Table 4.10: Composition and macroporosity data fo r  SF samples fabricated from  45 ppi foam s
The following SEM micrographs, figures 4.35 (a) - (c), illustrate the macroporosity network of 
the SF bioceramics. As was illustrated in table 4.10, the total volume porosity and mean pore 
size lie within the same size range as for the OPS 45 ppi samples, table 4.7 (b), section 4.4.1.
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Figure 4.35 (a): 91% HA SF  bioceramic Figure 4.35 (b): 46% a-TCP, 49%) J3-TCP SF
sintered at 1300°C bioceramic
Figure 4.35 (c): 72% /3-TCP, 22% a-TCP SF  
bioceramic
As can be seen from figures 4.35 (a) to (c), the internal macroporosity structure is identical to 
that for the OPS bioceramics (exact method) as illustrated in section 4.4.1. Figure 4.36 shows the 
cumulative macropore distribution from image analysis for the SF bioceramics. This is identical 
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Figure 4.36: Cumulative pore distribution fo r  SF bioceramics
The mean pore size range for the OPS samples was 177 -  299pm and for SF samples was 157 -  
292pm, thus the OPS and SF samples offer a suitable structural template for bone substitute 
applications. There were far greater counts o f porosity in an appropriate size range for bone 
growth (150 -  300pm), therefore producing a hierarchial porosity structure resembling the 
structure of cancellous bone.
Figures 4.37 shows an SEM micrograph that is representative of the whole batch, illustrating the 
boundary between the dense outer shell and the internal macroporosity network, indicating that 
the interior macroporosity network was not compromised.
Figure 4.37: 91% HA SF bioceramic
140
4: Results
It is important to note that the fabrication o f an outer dense shell has not compromised the 
interconnectivity of the macroporosity network. There is a definite distinction between the dense 
shell, which offers mechanical support, and the internal interconnected macroporosity network 
that is needed for bone regeneration.
Macro structural SEM analysis also suggested evidence o f similar microcracks formed on 
sintering as found in OPS bioceramics. Figures 4.38 (a) and (b) show the effects o f foam burnout 
and the formation of subsequent stresses as surface microcracks on cooling.
Figure 4.38 (a): Formation o f  microcracks 
on surface o f  91% HA SF  sample
Figure 4.38 (b): Formation o f  microcracks on 
surface o f  46% a-TCP, 49%> J3-TCP SF  sample
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4.5.2 Image Analysis -  Microporositv
As the same base powders were used for the production of I.I., OPS and SF bioceramics, it was 
confirmed that the sintering temperature determined the amount of microporosity present. 
Therefore, it is only necessary to show the distribution of microporosity with respect to sintering 
temperature. Microstructural SEM analysis was taken from the same samples used in section
4.5.1. Four SEM images of the microporosity distribution from each sample were taken for 
analysis, as the microporosity distribution within the samples was consistent.
Table 4.11 shows the composition and comparative microporosity distribution data between the 
SF samples. It was found that the sintering temperature had the greatest influence on the 






















118 6 22 72 1150 31.2 1.4 1.0
118 5 39 57 1200 19.4 1.0 0.8
118 4 40 56 1250 15.0 1.0 0.7
118 5 45 50 1300 11.5 0.8 0.7
118 5 46 49 1350 3.8 0.4 0.2
130 83 10 7 1200 20.2 1.1 0.7
130 86 10 4 1250 13.8 1.0 0.8
130 91 6 3 1300 10.9 0.9 0.8
130 91 5 4 1350 3.4 0.5 0.3
Table 4.11: Composition and microporosity data fo r  SF samples
As discussed in sections 4.2, 4.3.2 and 4.4.2, the p-TCP content in samples sintered at 1150°C 
produces a granular structure that appears less dense than the micro structure sintered at 
temperatures higher than this. At 1180°C, due to microstructural changes driven by grain growth 
via the elimination o f microporosity (because of formation o f a-TCP) samples possess less
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microporosity than those sintered at 1150°C. These microstructural changes, due to sintering 
temperature, are shown in figures 4.43 (a) to (e).
Figure 4.43 fa): SF  bioceramic sintered at 
1150°C
Fisure 4.43 (b): SF  bioceramic sintered at 
1200°C
Fisure 4.43 (c): SF  bioceramic sintered at Fisure 4.43 (d): SF  bioceramic sintered at
1250°C 1300°C




The decrease in the amount o f microporosity with increasing temperature, due to the formation 
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Figure 4.44: Microporosity changes as a function o f  sintering temperature in OPS samples
Figure 4.45 shows the cumulative pore distributions o f the microporosity distribution of the SF 
samples. The cumulative microporosity distribution in 1.1., OPS and SF samples are similar in 
both pore size and size range, and was found to be dependent on sintering temperature. This was 
found to be due to the thermal transformation of non-stoichiometric CaP to a-TCP, resulting in 
microstructural changes decreasing microporosity.
P ore S iz e  (iim )
Fisure 4.45: Cumulative micropore distribution fo r  all SF  samples
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4.5.3 Strength-Density Relationship of SF Bioceramics
In total 100 SF bioceramics were compression tested with rollered platens, and found to have a 
compressive strength o f 2.85MPa ± 0.52MPa, with an apparent density of 0.99g/cm3 ±
3 •0.05g/cm . Table 4.12 is an analysis of the mechanical properties o f all the samples compression 
tested, by quoting 95% confidence intervals for the results. This analysis represents the normal 
distribution for the samples, and states that only 5% of the sample lies outside the range quoted. 
Table 4.13 shows a summary of the mechanical properties of the three phases produced (HA, cx- 
TCP, p-TCP) from the base powders.
Bulk Density (g/cm3) (95% 
Confidence Level)




HA a-TCP HA a-TCP
1200 0.96 ± 0.06 0.92 ± 0.04 2.89 ±0.16 2.54 ± 0.63
1250 1.00 ±0.05 1.00 ±0.04 2.96 ± 0.33 2.63 ± 0.53
1300 1.06 ±0.04 1.04 ±0.05 3.81 ±0.80 2.68 ± 0.54
1350 1.08 ±0.07 1.06 ±0.04 4.33 ± 0.98 3.29 ±0.93
Table 4.12: Mechanical data fo r  HA and a-TCP SF bioceramics sintered at 1200°C, 1250°C,
1300°C and 1350°C
Phase Bulk Density (g/cm3) (95% 
Confidence Level)
Compressive Strength 
(MPa) (95% Confidence 
Level)
HA 1.03 ±0.06 3.50 ±0.57
a-TCP 0.99 ± 0.05 2.73 ± 0.60
P-TCP 0.94 ± 0.05 2.31 ±0.39
Table 4.13: Summary o f  mechanical data fo r  SF  bioceramics
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Figure 4.46 graphically illustrates the compressive strength o f each batch of bioceramics 
produced by the SF method.
1200 1250 1300 1350 1200 1250 1300 1350 1150
HA (°C) alphaTCP (°C) | 13 TCP !
(°C)
Fisure 4.46: Mechanical properties o f  each batch o f  SF  bioceramic
Figures 4.47 (a) and (b) represent the strength-density and strength-porosity relationships 
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Fisure 4.47 (b): Strength-porosity relationship fo r  OPS and SF  samples
Figure 4.47 (a) illustrates that the SF bioceramics correlate with strength-density relationships as 
for OPS samples. Regression analysis on the data gave an R-value of 0.939 indicating a good 
correlation of the results. Figure 4.47 (b) indicates that the SF method has not compromised the 
interconnected macroporosity network formed from the OPS process, while increasing the 
strength o f the SF bioceramics.
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Figure 4.48 shows the effect o f a phenomenon termed stress shielding. Note that the integrity o f 
the internal interconnected porosity structure remains consistent and interconnected, even after 
failure. It has also been found that failure occurs in the outer dense shell o f the SF bioceramics. 
This is an important phenomenon that would have implications for possible future practical 
applications, as the interior porosity network needed for bone regeneration was protected and 
retained its structural integrity on failure.
Fisure 4.48: Range o f  failed SF  samples after compression testing -  left to right: HA 1200°C,
HA 1300°C, HA 1350°C
4.5.4 Summary o f SF Bioceramics Results 
Fabrication
The SF method developed, which produces a dense outer shell surrounding a cylindrical OPS 
interior, does not compromise the interconnected macroporosity network needed for possible 
bone regeneration. The SF samples had a distinct boundary between the dense outer shell and the 
interior porosity network. On stressing, the outer dense shell “protects” the interior 
macroporosity network by resisting the stress on compression. This was important as the 
interconnected macroporosity network was retained and remained structurally intact. This 





The total volume macroporosity of SF samples was identical to those fabricated by the OPS 
bioceramics prepared with 45 ppi porosifiers, which was 73-92%. Similar macropore sizes were 
also evident, ranging from 50 -  1000pm, with a mean pore size range from 157 -  292pm.
Mechanical Properties
SF bioceramics had improved mechanical properties in comparison to OPS bioceramics due to 
an increase in the density of the samples without compromising the interconnected porosity 
network. Compressive strengths were reported as 2.85MPa ± 0.52MPa with apparent densities of 
0.99g/cm3 ± 0.05g/cm3.
The SF bioceramics show a direct strength-density correlation with the OPS samples previously 
fabricated, so that an increase in density results in increased strength (figure 4.78). The process 
offers consistency and reliability in both the fabrication procedure and the testing method. Due to 
the use of rollered platens much of the systematic error found with the compression testing of the
I.I. bioceramics was eliminated. Surface microcracks on the struts, formed on sintering, remain 
present and it is these together with the microstructure o f the dense shell (i.e. microporosity and 
grain growth evolution) that control strength.
4.5.5 Key Findings
• SF bioceramics for specific, clinical applications have been successfully fabricated (i.e. 
for spinal fusion interbody operations).
• The SF bioceramics had an identical, internal, interconnected macroporosity network to 
the OPS bioceramics previously fabricated. This porosity was in the correct size for 
potential bone regeneration within the bioceramic.
• The strength o f the SF bioceramics was improved, compared to the OPS bioceramics 
with the same porosity (i.e. the porosity network was not compromised during 
fabrication). However, further improvements to the structure o f the samples need to be 
addressed e.g. surface microcracks.
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Objectives for Future Research
The following aims and objectives for future research are to be addressed in sections 4.6 and 4.7 
-  Sol-Gel treated SF Bioceramics and Calcium Phosphate Granular Material respectively:
• To improve the structure-property relationship o f the bioceramics by addressing the issue 
of surface microcracks created on sintering, and hence ultimately to improve the 
mechanical properties o f the bioceramics. This needs to be achieved without 
compromising the interconnected macroporosity network.
• To fabricate further bioceramics for clinical applications, such as a granular form o f the 
materials produced, for use in impaction grafting.
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4.6 Sol-Gel Treated SF Bioceramics
The objective o f this research was to address the issue o f surface microcracks that are the cause 
o f structural weakness. By reducing, or eliminating these microcracks, the critical crack lengths 
that magnify stress on loading are reduced and hence strength increased.
4.6.1 Image Analysis - Macroporositv
The method used in the fabrication of the sol-gel treated SF bioceramics consisted o f fabricating 
SF bioceramics (as in section 4.5), and thermally treating with a sol-gel solution to reduce or 
eliminate surface microcracks that cause structural weakness on testing. The internal porosity 
structure was formed by exactly the same method as for the OPS bioceramics. Therefore, the 
interconnected macroporosity distribution is identical to the OPS structures formed by using the 
45 ppi porosifiers.
Figures 4.49 (a) to (c) show images o f the SF bioceramics treated with sol-gel solution. HA, a- 
TCP and p-TCP samples were treated with sodium methoxide solution (detailed in section 3.8.5) 
and sintered at 500°C and 1100°C.
Fisure 4.49 (a): 91% HA SF  bioceramics treated 
with sol-gel. Left to right: untreated, sintered at 
500°C, sintered at 1100°C
Fisure 4.49 (b): 46% a-TCP SF  bioceramics 
treated with sol-gel. Left to right: untreated, 
sintered at 500°C, sintered at 1100°C
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Fisure 4.49 (c): 72% P-TCP SF  bioceramics treated with sol-gel.
Left to right: untreated, sintered at 500°C, sintered at 1100°C
The following results show the composition and macroporosity measured in the SF samples and 
includes examples o f the micrographs from SEM analysis and the macroporosity distribution 
from the SF fabrication method. Sections o f the samples from each batch were used to evaluate 
the macroporosity distribution. The entire surface area o f the macroporosity distribution o f the 
sample representative o f the batch was analysed from four SEM images. Table 4.14 shows the 




o f Soda Sol- 
Gel (°C)












500 91 6 3 89.4 228.8 ± 77.2 2675.5
500 5 46 49 90.2 211.1 ±88.6 2435.9
500 6 22 72 93.8 220.4 ± 47.5 2198.2
1100 91 6 3 81.2 213.9 ±54.7 2726.4
1100 5 46 49 75.6 243.3 ± 71 .6 3105.3
1100 6 22 72 82.6 234.4 ± 90.3 2967.7
Table 4.14: Composition and macroporosity data fo r  SF  samples fabricated from  45 ppi foam s
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During fabrication, the low viscosity sol-gel solution flows throughout the macroporosity and 
does not compromise the interconnectivity of the porosity network. Figure 4.50 shows an SEM 
micrograph, indicative o f the batch o f sol-gel treated SF bioceramics, demonstrating the 
macroporosity structure o f the samples after soda sol-gel treatment. As was illustrated in table 
4.14, the total volume porosity and mean pore size lie within the same size range as for the OPS 
and SF samples.
Fisure 4.50: 46% a-TCP treated with sol- 
gel at 500°C
Figure 4.51 shows the cumulative macropore distribution from the SF bioceramics treated with 
sol-gel solution. Macropores were similar in size range to those found in OPS and SF untreated 
bioceramics (50-1000pm). The porosity distribution is identical to that for OPS and SF 
bioceramics fabricated from the 45 ppi foam porosifiers. Therefore, the treatment by sol-gel 
solution to increase strength by reducing or eliminating surface microcracks, has not 
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Fisure 4.51: Cumulative Pore Distribution fo r  SF  samples Treated with Soda sol-gel
Figure 4.52 (a) and (b) demonstrate the improvement in microstructure due to the sol-gel 
treatment. The figures illustrate structural changes around triple point junctions where surface 
microcracks would usually be present. In OPS and SF bioceramics, it was these areas that pre­
dominantly indicated PU foam burnout and subsequent microcrack formation on further 
sintering, and hence reduced strength. However, figures 4.52 (a) and (b) illustrate the reduction 
in size and in some instances the total elimination o f the microcracks previously identified as a 
structural weakness on loading.
Figure 4.52 (a): Microstructure o f  a HA Fisure 4.52 (b): Microstructure o f  a f-T C P
treated SF sample at 500°C treated SF  sample at 1100°C
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Fisure 4.53 (a): Microstructure o f  HA sol- 
gel treated and sintered at 500°C
4.6.2 Image Analysis - Microporositv
Microstructural SEM analysis revealed a change in surface structure when compared to SEM 
micrographs from OPS and SF bioceramics (sections 4.4.2 and 4.5.2 respectively). The structural 
differences were most notable in TCP, and in particular the high microporosity p-TCP 
bioceramics. Figures 4.53 (a) and (b) show the microstructural changes caused by the sol-gel 
treatment.
Sodium phosphate 
on HA surface Underlying 
HA surface
Fisure 4.53 (b): Microstructure o f  p-TCP  
sol-gel treated and sintered at 1100°C
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The sodium phosphate crystals sit on the surface o f the HA sample as a second phase, figure 4.53 
(a). Analysis o f the crystals by EDX during SEM analysis revealed their composition as sodium 
phosphate. The P-TCP image, figure 4.53 (b), shows that the surface structure has been altered 
due to the treatment, and therefore the soda sol-gel has been incorporated into the structure. The 
1100°C sintered samples had 24.9% less microporosity than those sintered at 500°C, as table 
4.15 illustrates. The treatment of sol-gel solutions on the surface of the sintered bioceramics, has 
produced a polycrystalline surface layer that was more prominent on the high microporosity TCP 
and in particular the p-TCP structures. A less profound effect was observed for a-TCP samples 
due to the denser, more crystalline, microstructure.
M icroporosity (% )




Table 4.15: Microporosity changes due to sol-gel treatment
Figure 4.54 shows the cumulative micropore distribution for the sol-gel treated SF bioceramics. 
The majority o f the microporosity was less than 3 pm in size, however some minor incidences of 















Fisure 4.54: Microporosity distribution fo r  sol-gel treated SF bioceramics
4.6.3 Strength-Density Relationship for Sol-Gel Treated SF Bioceramics
In total. 60 SF sol-gel treated bioceramics were compression tested (with rollered platens), and 
found to have a compressive strength o f 5.94MPa ± 1.06MPa, the samples were analysed as a 
normal distribution. Apparent densities o f 1.51g/cm3 ± 0.22g/cm3 were found. Table 4.16 shows 
the mechanical properties of all batches o f samples analysed, and the strength increases made 













500°C HA 1.71 ±0.31 6.01 ± 1.54 71.7
a-TCP 1.28 ± 0.11 4.72 ± 0.83 72.9
p-TCP 1.14 ± 0.15 4.46 ± 1.09 75.6
1100°C HA 1.76 ±0.25 7.50 ± 0 .78 114.3
a-TCP 1.55 ±0 .30 6.28 ± 1.15 130.0
p-TCP 1.59 ±0 .22 6.69 ± 0.99 163.4
Table 4.16: Mechanical properties and strength increases fo r  SF  bioceramics treated with sol-
gel against those untreated
&  s> v* 05 *> *?> #  b &
Pore S iz e  (jim)
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The average strength increases for the treated SF bioceramics was 105% greater than those SF 
bioceramics previously fabricated (section 4.5). However, the greatest strength increases 
occurred in those coatings sintered at 1100°C, and in particular the p-TCP bioceramics. Figure 
4.55 shows the mechanical properties data as a comparison between untreated SF bioceramics 







Untreated Treated with So 1-Gel
Fisure 4.55: Comparison o f  mechanical property data fo r  untreated and treated SF  bioceramics
Strength increases in samples produced by the sol-gel method have been made without 
compromising the interconnected macroporosity network, as shown in figure 4.56, which shows 
the strength-porosity relationship of the bioceramics produced. Figure 4.57 shows the strength- 
density relationship o f the bioceramics and demonstrates that the process was consistent with 
previously fabricated bioceramics. Regression analysis established that the samples possessed an 
R-value of 0.967, indicating an excellent correlation between strength and density for the OPS, 
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Figure 4.57: Strength-density relationship o fS F  treated bioceramics
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4.6.4 Summary o f SF Sol-Gel treated Bioceramics 
Fabrication
The sol-gel treatment successfully increased the strength of the SF bioceramics without 
compromising the interconnected macroporosity network. The soda sol-gel solution changed the 
colour o f the surface o f the SF bioceramics on sintering. On failure, the deep interiors o f the 
samples retain the colour of their original phases (e.g. HA -  blue, TCP -  white). Hence, it can be 
hence stated that the soda sol-gel only affects the surface of the structure, and therefore primarily 
addresses the surface microcracks previously identified as sources of weakness.
Structure-Property Relationship
The structure-property relationship of the bioceramics has been improved by reducing in size, 
and in some instances eliminating completely, the surface microcracks previously identified as 
the cause for structural weakness. Microstructural analysis revealed the formation o f a 
polycrystalline phase on the TCP samples. The solution was able to adhere to the surface o f these 
high microporosity samples with more success than for HA samples (crystalline surface) and 
hence reduce or eliminate surface microcracks and increase strength.
Mechanical Properties
Those SF treated bioceramics sintered at 1100°C had an average compressive strength of 
6.82MPa, those sintered at 500°C had compressive strength o f 5.06MPa. The average 
compressive strength o f all the samples analysed by 95% confidence levels, was 5.94MPa ± 
1.06MPa, with a bulk density of 1.51g/cm3 ± 0.22g/cm3.
The average strength increase in comparison to untreated SF bioceramics was 105%, with the 




• The sol-gel solution treatment has increased the strength o f the SF bioceramics without 
compromising the interconnected macroporosity network required for possible bone 
regeneration.
• The strength increases were possible due to improvements made in the structure-property 
relationship. Low viscosity sol-gel solutions flow into the microcracks previously 
identified as structural weak points for failure. As a result, the microcracks are reduced in 
size or even eliminated.
• Microstructural analysis revealed structural changes to the SF bioceramics, revealing a 
polycrystalline phase on the surface of the SF bioceramics (especially on high 
microporosity P-TCP samples).
Objectives for Future Research
The following aims and objectives for future research are to be addressed in sections 4.7 and 4.8
-  Calcium Phosphate Granular Material and Wicking Properties respectively:
• To fabricate further CaP bioceramics from the methods developed for practical and
clinical applications e.g. granular material for possible use in impaction grafting.
• To evaluate the wicking properties o f the CaP phases produced (HA, a-TCP and p-TCP),




4.7 CaP G ranular Material
CaP granules (varying in size from 2-8mm) were fabricated by using the 1.1, method and die- 
plunger compression tested up to 500N and 1000N respectively as detailed in sections 3.8.4 and 
3.12.3. A commercially available product, manufactured by Stryker Orthopaedics termed 
BoneSave®, was also tested by the same compression test, and the results compared.
4.7.1 Image Analysis of Granular Material
Figures 4.58 (a) to (d) show images o f the granular material fabricated. Figure 4.58 (a) illustrates 
the commercially available product BoneSave®. Figures 4.58 (b) to (d) show the 75% HA, 14% 
a-TCP and 11% P-TCP granular material fabricated from the 1.1, method (sintered at 1300°C), 
with sizes ranging from 2-4mm, 3-5mm and 4-8mm respectively.
Fisure 4.58 (a): Granular BoneSave®  
material -  2-4mm in size
Fisure 4.58 (b): Granular material from  1.1, 
method -  2-4mm in size
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Fisure 4.58 (c): Granular material from  1.1. Fisure 4.58 (d): Granular material from  1.1,
method -  3-5mm in size method -  4-8mm in size
The granular material fabricated has identical porosity to the block material formed from the 1.1, 
method described in section 4.3. The macroporosity is generated due to the burnout o f the 
polymer PU foam that leaves the negative image o f the foam as the interconnected porosity 
network. The macroporosity in BoneSave® granules is generated due to the burnout o f the 
isolated porosifier, and is not interconnected.
4.7.2 Die-Plunger Compression Tests
The following results were used for comparative purposes only between the HA/TCP granules 
fabricated and the BoneSave® granules. The compressive moduli calculated were not the true 
materials properties of the granules. This was due to the fact that the granules on loading would 
topple and re-order themselves. Table 4.17 represents the relative moduli o f the materials tested 
by die-plunger compression testing. This also explains the sudden drops in stress on the stress- 
strain curves in figures 4.59 (a) to (d).
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Bone Substitute Material 
Tested
Relative Modulus up to 500N 
o f Loading (GPa)
Relative Modulus from 500 -  
1000N of Loading (GPa)
BoneSave® 29.5 45.1
HA/TCP 2 -  4mm 49.6 66.5
HA/TCP 3 -  5mm 40.3 66.4
HA/TCP 4 -  8mm 5.9 35
Table 4.17: Mechanical data (for comparison purposes only) fo r  granular material tested
The low relative modulus reported from the 4-8mm sized granules was due to the large degree o f 
toppling, crushing and re-ordering o f the granules on loading. Figure 4.59 (d) shows the constant 
re-ordering of these larger sized granules by the constant drops in stress on the stress-strain 
curve. These affects were less pronounced for the smaller sized granules in particular the 2-4mm 
sized granules, that provide a more consistent and predictable mechanical response relative to the 
larger diameter granules.
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Figure 4.59 (a): Stress-strain curve fo r  BoneSave ® material -  2-4mm in size
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Figure 4.59(b): Stress-strain curve fo r  2-4mm sized HA/TCP granular material
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Figure 4.59 (c): Stress-strain curve fo r  3-5mm sized HA/TCP granular material
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Figure 4.59 (d): Stress-strain curve fo r  4-8mm sized HA/TCP granular material
The stress-strain curves shown above were for comparison purposes only between each batch 
and the values given for relative moduli in table 4.17, and do not reflect the true material 
properties of the materials. It can be seen from the graphs that the 2-4mm and 3-5mm HA/TCP 
granules have improved mechanical integrity when compared to BoneSave®, and suggests that 
these materials would possibly have advantages over BoneSave® if used for impaction grafting. 
The fabricated granules from the 1.1, method have the added advantage over BoneSave® that 
they have interconnecting as opposed to isolated porosity.
4.7.3 Summary o f CaP Granular Material Results
Fabrication
HA/TCP granules ranging in size from 2-8mm, have been successfully fabricated with 
interconnected porosity, and superior mechanical properties compared to a commercially 
available product termed BoneSave®, which does not have interconnected porosity. The base 
powders (118 and 130) used in 1.1. HA/TCP granular fabrication, were the same base powders as 




The material properties analysed were not the true material properties due to the toppling effect 
of the granules on loading. Therefore, the results were only for comparison within the batch of 
material tested. I.I. HA/TCP 2-4mm and 3-5mm size granules, demonstrated improved 
mechanical resistance to loading when compared to BoneSave®. The results indicate that, for 
this testing procedure, the I.I. HA/TCP granules offer an improved material for possible use in 
impaction grafting. This has been concluded on the basis of the combination of improved 
mechanical resistance and the presence of interconnected porosity.
4.7.4 Key Findings
• HA/TCP granules with an interconnected porosity network and varying in size from 2- 
8mm have been successfully fabricated.
• The fabricated granules offer improved mechanical resistance when compared to a 
commercially available product - BoneSave®. This combined with the improved 





The following results have been obtained from simple wicking experiments, in order to evaluate 
the potential of the HA, a-TC P and (3-TCP SF bioceramics to wick up fluids. The samples have 
identical macroporosity, but due to the nature o f the microstructure o f the phases (i.e. different 
sintering temperatures) they have varying amounts o f microporosity; HA has the least, then a -  
TCP and p-TCP have the greatest amount o f microporosity. A methylene blue indicator solution 
was used as the wicking fluid. A saturation test and mass gain test was performed.
4.8.1 Saturation Results
It was immediately noticeable upon immersion the three phases in the indicator solution that the 
TCP samples began to wick up the solution. HA did not wick up at the same rate as the TCP 
samples. Figures 4.60 (a) to (e) show images o f the bioceramics before, during and after 
saturation. The samples were removed after 60 minutes immersion. Figure 4.60 (a) shows HA, 
a-TCP and P-TCP from left to right, in the remainder o f the images the order o f samples from 
left to right is a-TCP,P-TCP and HA.
Figure 4.60 (a): Samples Figure 4.60 (b): Samples Figure 4.60 (c): Samples
prior to saturation after lm in  saturation after lOmin saturation
Figure 4.60 (d): Samples Figure 4.60 (e): Samples
after 40min saturation after 60min saturation
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Table 4.18 shows the time taken for the samples to be fully saturated along with the respective 
sintering temperatures and microporosities.
Bioceramic Phase Time for Saturation 
(minutes)
% Microporosity Sintering Temperature
(°C)
HA 50 9.5 1300
a-TCP 20 17.5 1300
P-TCP 2 32.0 1150
Table 4.18: Saturation times as a function o f  microporosity
The HA (low microporosity) SF bioceramic wicks up 25 times slower than the P-TCP (high 
microporosity) SF bioceramic. Figure 4.61 shows a plot o f saturation time versus microporosity 
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Figure 4.61: Comparison o f  saturation times against microporosity fo r  phases produced
4.8.2 Mass Gain Results
Separate HA, a-TCP and p-TCP SF bioceramics were immersed in indicator solution in a petri 
dish and left for 24 hours in order to evaluate the mass gain o f the samples. Figure 4.62 
illustrates the bioceramics before and after immersion for 24 hours.
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Figure 4.62: HA, a-TCP and J3-TCP SF bioceramics before and after immersion in indicator
solution fo r  24 hours
Table 4.19 below represents the mass gain results as a function o f microporosity in the phases. 













HA 1.45 2.02 39.3 9.5 1300
a-TCP 1.33 2.02 51.9 17.5 1300
p-TCP 1.06 1.92 81.1 31.0 1150
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Figure 4.63: Comparison o f  mass gain versus microporosity fo r  phases produced
As all the samples have the same macroporosity; both the saturation and mass gain experiments 
demonstrate that the wicking properties of the bioceramics are a function o f the microporosity.
4.8.3 Summary of Wicking Experiment Results
In summary, the main findings from the wicking experiments were as follows:
• The HA bioceramics wick up to 25 times slower (i.e. to be fully saturated) compared to 
P-TCP bioceramics.
• After 24 hours immersion in indicator solution the HA, a-TCP and p-TCP bioceramics 
increased in mass by 39%, 52% and 81% respectively.
• The results suggest there is a correlation between the microporosity o f the bioceramics 
and their wicking properties.
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Chapter 5 General Discussion and Conclusions
At this point it is useful to return to the main aims and objectives of the research that will be 
addressed in this section:
1) To produce CaP bioceramics based on hydroxyapatite (HA), a-tricalcium phosphate (a- 
TCP) and p-tricalcium phosphate (p-TCP) with a guaranteed interconnected network of 
macropores in the appropriate size range (i.e. 150 - 300pm) for bone formation and re­
vascularisation.
2) To improve the structure-property relationship (i.e. with the ultimate aim of improving 
mechanical properties) of the fabricated bioceramics without compromising the 
interconnected macroporous network vital for bone ingrowth.
3) To develop bioceramics for specific clinical applications including for example spinal 
fusion interbody operations, maxillofacial procedures, chondylar defects and granular 
material as a bone graft substitute.
5.1 Analysis of the Interconnected Macroporosity Network
There is a need to develop an interconnected macroporosity network in bone substitute materials 
resembling that o f cancellous bone to act as a scaffold to aid bone formation, ingrowth and re­
vascularisation in a diseased or damaged site. The importance of fabricating an interconnected 
porosity network is a key issue addressed by numerous authors [45, 47, 49, 50, 63]. As seen in 
table 2.2 (p.33), few fabrication methods successfully produce CaP bioceramics with a 
guaranteed interconnected macroporosity combined with sufficient mechanical properties for use 
in load-bearing applications. Therefore, the first objective o f the research was to fabricate such a 
porosity network in the CaP bioceramics.
5.1.1 Comparing the Macroporositv Network of the Bioceramics Produced
Switching the focus of research from producing dense Impact-Impregnated (I.I.) bioceramics 
with a low volume interconnected network of porosity, to producing Open Porous Scaffold 
(OPS) bioceramics with a high volume interconnected network o f porosity, has proved 
successful from the point of view of developing a porosity structure with the potential for bone 
remodelling. It must not be overlooked that the internal porosity network in Spinal Fusion (SF)
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bioceramics is identical to that in the OPS bioceramics. Figure 5.1 compares the porosity 
distributions o f I.I. bioceramics with the OPS bioceramics (identical structure to internal SF 
bioceramics). Table 5.1 indicates how changing the fabrication procedure has produced CaP 
bioceramics with an improved porosity size distribution that is acceptable for bone ingrowth.
Cumulative Pore Distributions for Impact-Impregnated 
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Figure 5.1: Comparison ofporosity distributions fo r  Impact-Impregnated samples and OPS
Pore range (pm) Total % porosity of Impact- 
Impregnated Samples





Table 5.1: Comparison o f  changes in porosity in dense (I.I) and porous (OPS) samples
It is generally accepted (and has been discussed in chapter 2.3) that a pore size range o f 150- 
300pm is appropriate for vascularised growth within a bioactive ceramic [61, 65, 73]. Figure 5.2 
indicates the differences in the porosity size range between the I.I. dense bioceramics and the 
high volume porosity OPS bioceramics.
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Graph Comparing the Effects of Changing Fabrication 
Procedure to produce Improved Pore Distribution
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Figure 5.2: Improved pore size range in OPS compared with Impact-Impregnated samples
The objective o f producing the I.I. bioceramics was to impregnate and substantially fill the 
spaces o f the polyurethane (PU) foam with the ceramic slip, then to burn out the reticulated PU 
foam to leave an interconnected porosity network resembling the structure of the foam. Hence 
the majority of the porosity lies in the 0-150pm size range, as this is the size range o f the PU 
struts burnt out on sintering. Figure 5.3 illustrates this structure.
Figure 5.3: Structure o f  I.I. bioceramics indicating the bow-tie shaped pores not ideal in shape
fo r  potential bone remodelling
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By producing the OPS and SF bioceramics from the same foam template (and therefore same 
porosity distribution), that is by impregnating and coating the slip on to the struts o f the foam 
resembling the positive porosity image o f the foam, the majority o f the porosity is in the 
appropriate size range (150-300pm) and shape for bone formation and ingrowth. Figure 5.4 
illustrates an example of the OPS and SF structures produced.
Figure 5.4: Structure o f  OPS bioceramic indicating the high volume porosity structure and good
pore size and shape
Figures 5.1 and 5.2 clearly indicate the structural advantages as far as bone remodelling is 
concerned with switching the focus o f research to produce OPS and SF bioceramics, in that a 
porosity distribution in the appropriate size range for bone ingrowth has been produced. Figures 
5.5, 5.6 and 5.7 are expanded sections o f figure 5.1. From these it can be seen that OPS and SF 
bioceramics have a much more appropriate pore size distribution than I.I. samples in terms of 
potential for bone remodelling.
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Cumulative Pore Distributions for Impact- 
Impregnated Samples and Open Porous Scaffolds 
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Figure 5.5: Cumulative pore distribution for size range 0-150pm
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Figure 5.6: Cumulative pore distribution fo r  size range 150-450pm
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Cumulative Pore Distributions for Impact- 
Impregnated Samples and Open Porous Scaffolds 
for the Pore Size range 450 - 1150pm
^120 
1 100 




I Im pact-Im pregnated  
Sam ples
I O pen Porous Scaffo ld s
j J l J I l j l l l l l
tP & <V> V  op nnP
Pore size, A rea E quivalent d iam eter (fim)
Figure 5.7: Cumulative pore distribution fo r  size range 450-1150pm
This is not to say that the I.I. bioceramics do not have a role to play as a possible bone substitute 
materials. These dense bioceramics have similar porosity distributions to those found in cortical 
bone, where one function of the porosity is to distribute nutrients (through cylindrical Haversian 
systems) to facilitate bone ingrowth. Figure 5.8 illustrates the difference in macroporosity 
produced in the samples from the different fabrication procedures. This reiterates the point that 
fabricating OPS and SF bioceramics (SF bioceramics identical in porosity structure to OPS) 
results in a bone substitute material with greater volume porosity and an improved pore size 
distribution to encourage bone growth.
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T issue Mesh TissueMesh
Figure 5.8: Comparison o f  macroporosity in I.I. and OPS samples
For the I.I. bioceramics, it is the drying mechanism that is the main influence on macroporosity. 
Drying on tissue rather than on metal mesh extracts all excess moisture from the samples and 
reduces the possibility o f closed porosity occuring. Typical macroporosity in I.I. bioceramics 
ranges from 7-31% compared with 72-93% for OPS and SF bioceramics.
To summarise, the switch to producing OPS and SF bioceramics has resulted in the fabrication 
of samples with an interconnected macroporosity network in the appropriate size range for bone 
formation and ingrowth. The first objective of the research was therefore achieved.
5.2 Structure-Property Relationships of Bioceramics Produced
The following section will focus on the second objective o f addressing the structure-property 
relationship o f the bioceramics and how to improve the relationship in order to improve the 
mechanical properties without compromising the interconnected macroporosity network. The 
same approach o f addressing the structure-property relationship is used to assess the sol-gel 
treated SF bioceramics. In addition, x-ray diffraction (XRD) analysis and scanning electron 
microscopy (SEM) were used to examine microstructural changes resulting from the treatment 
employed.
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5.2.1 Comparing the Structure-Property Relationships of I.I.. OPS and SF Bioceramics
The mechanical properties o f CaP ceramics, as with all engineering ceramics, are highly 
dependent on the processing route as a consequence o f the effects of processing on the 
microstructure o f the final product. The sintering temperature, the type of porosifier used, the 
drying route taken and the resultant macropore distribution will all affect the microstructure and 
hence the mechanical properties of the samples produced. Table 5.2 summarises the mechanical 














1.50 ±0 .60 0.35 ± 0.05 1.01 ±0.05 1.51 ±0.22
Volume 
Porosity (%)
7 - 3 1 7 5 - 9 5 7 0 - 9 2 7 2 - 9 4
Sample Size 40 120 100 60
Table 5.2: Summary o f  mechanical data from  fabricated samples
It can be seen from table 5.2 that by shifting focus to OPS and SF methods that the porosity 
requirements of the bioceramics and the reproducibility and hence consistency has been 
improved, however strength has decreased. The large variations found in the I.I. samples were 
primarily due to the drying effects and the dependence on sintering temperature. The level of 
porosity is similar in OPS and SF bioceramics as the same PU template was used as was 
discussed in section 5.1.1. There is evidence o f a strength-density and strength-porosity 
relationship as illustrated by figures 5.9 and 5.10 respectively.
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Figure 5.10: Graph illustrating strength-porosity relationship o f  OPS and SF bioceramics
produced
The increase in density in SF bioceramics was due to the fabrication o f a dense shell surrounding 
an OPS cylindrical specimen, which has increased strength without compromising the 
interconnected porosity network. On loading, the dense outer shell acts as a stress-shield and 
supports the interior open porosity. This is an important criterion on stressing as the 
interconnected macroporosity network necessary for bone i ngrowth was retained even on failure. 
Figure 5.11 indicates this important phenomenon.
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Figure 5.11: Stress-shielding phenomenon in fa iled  HA SF bioceramics whereby interior 
porosity network is retained as the outer dense shell supports stress
It is the outer dense shell that provides the majority o f the support for stress on loading. It was 
established by SEM analysis that grain growth and microporosity were temperature dependent. 
This temperature dependency is shown in figures 5.12 through to figure 5.14, whereby an 
increase in temperature results in a reduction in microporosity from 31.2% at 1150°C to 3.6% at 
1350°C (see table 4.11, p.141).
Figure 5.12: Microstructure o fS F  bioceramics at 1150°C indicating high microporosity
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Figure 5.13: Microstructure o fS F  bioceramics at 1250°C indicating a reduction in 
microporosity with increase in sintering temperature
Figure 5.14: Microstructure o f  SF bioceramics at 1350°C indicating low microporosity
The switch to fabricating OPS as opposed to I.I. bioceramics has successfully resulted in samples 
with a high volume interconnected macroporosity network with pores in the appropriate size 
range for bone ingrowth. However, as table 5.2 indicates the strength properties o f the OPS 
samples have dramatically lowered even though the process has become more reproducible. The 
formation of microcracks on sintering at areas o f high concentration o f PU foam, termed triple 
point junctions, created structural weaknesses that were the cause o f such unpredictable and 
variable low strengths. Figure 5.15 shows an example o f these microcracks that are 
commonplace through out the structure. In OPS (and SF bioceramics) it is the presence o f these 
small flaws that severely limit the mechanical properties o f the bioceramic. Hence there is a need 
to improve the structure-property relationship still further.
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Figure 5.15: Microcrack formation on sintering creating structural weaknesses lowering
mechanical properties
Under loading, the microcracks formed grow until they collapse and cause brittle failure. The 
success o f producing an interconnected macroporosity network for bone ingrowth has affected 
the structure-property relationship and resulted in a structurally weak material and hence low 
mechanical properties.
The strength properties achieved in the OPS and SF bioceramics were insufficient to meet the 
demands for clinical application. Therefore, research switched focus to address the surface 
microcracks that are the cause o f structural weakness, and hence to improve the structural 
properties o f the OPS and SF bioceramics with the aim of increasing mechanical properties 
without compromising the interconnected macroporosity network.
5.2.2 Structure-Property Improvements to SF Bioceramics due to Sol-Gel Treatment
The second objective to be fulfilled by the research was to improve the structure-property 
relationship without compromising the interconnected macroporosity network essential for bone 
ingrowth.
It has already been described how microcrack formation on sintering in OPS an SF bioceramics 
is responsible for the consistent low strengths found on stressing in these high volume porosity
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samples. These are partially responsible for failure in SF bioceramics due to the stress shielding 
by the outer dense shell.
The sol-gel method involves treating the SF bioceramics with a low viscosity solution that flows 
into the micropores and surface microcracks o f the specimen and on sintering forms a 
polycrystalline structure that reduces or even eliminates the structural weaknesses previously 
identified. Figures 5.16 and 5.17 show the strength-density and strength-porosity relationships of 
the sol-gel treated samples compared to the previously fabricated samples.
R = 0.967
■ O pen Porous 
Scaffolds
▲ Spinal Fusion
•  SF Sol-Gel
0.5 21.5
Density (g/cmA3)
Figure 5.16: Graph showing strength-density relationship o f  OPS, SF and sol-gel treated SF
bioceramics
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Figure 5.17: Graph showing strength-porosity relationship o f  OPS, SF  and sol-gel treated SF
bioceramics
It is important to note that the sol-gel treated SF bioceramics have increased strengths without 
compromising the interconnected macroporosity network (figure 5.17). Table 5.2 emphasizes 
this point. As with producing the SF bioceramics, there is a strength-density correlation that is a 
coinciding theme throughout the research.
Figure 5.18 shows a strength-density graph o f all the untreated and treated SF bioceramics, and 
figure 5.19 summarises the strength differences between the two fabrication procedures and 
samples treated with sol-gel at 500°C and 1100°C.
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Figure 5.18: Strength-density data fo r  all SF  bioceramics
500°C 1100°C
Untreated Treated with Sol-Gel
Fisure 5.19: Summary o f  all SF  bioceramics results
Figure 5.19 indicates not only that treating the SF bioceramics with a sodium methoxide sol-gel 
solution has increased strength, but also that those samples treated and sintered at 1100°C have 
higher strengths than those sintered at 500°C. However, this graph also shows that the high 
microporosity TCP samples are the most sensitive to the sol-gel treatment as they show the 
greatest relative increase in strength. This is particularly true for the high microporosity p-TCP 
bioceramics. This suggests that the sol-gel solution has reacted and changed the surface structure
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of the TCP bioceramics more than the HA bioceramics due to the larger microporosity present. 
Hence, the ability o f the oxide formed to bond to the surface and therefore reduce or eliminate 
the microcracks previously identified as weak points, has increased the strength of the 
bioceramics.
SEM and XRD analysis confirmed the structural and chemical changes that accompanied the 
increase in strength. It must be noted that the sol-gel treatment has not compromised the 
interconnected macroporosity network; this is confirmed from figure 5.17.
Figures 5.20 and 5.21 show the structural differences before and after the treatment with soda 
sol-gel. Both SEM images are taken from areas one would expect to find microcracks i.e. at 
triple point junctions. Figure 5.20 demonstrates this phenomenon clearly. Conversely, figure 
5.21 shows a similar area as for figure 5.20 where microcracks would be expected. As a result o f 
the sol-gel treatment not only have the microcracks been reduced but also eliminated.
Figure 5.20: Microcrack formation on Figure 5.21: Elimination o f  microcracks
sintering in SF untreated bioceramic and change in surface structure due to sol-
gel treatment
Another example of the effect o f this treatment is shown in figures 5.22 and 5.23. Figure 5.22 
shows the microcracks common in untreated bioceramic scaffolds and figure 5.23 a similar area 
where microcracks would be expected. However, the sol-gel treatment has eliminated these 
structural weaknesses and altered the surface structure of the SF bioceramics.
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Figure 5.23: Elimination o f  microcracks 
and formation o f  amorphous phase on 
surface o f  bioceramic
At higher magnifications it is possible to distinguish the difference in surface structure between 
untreated and treated SF bioceramics. This is indicated in figures 5.24 (before treatment with sol- 
gel) and figure 5.25 (after sol-gel treatment).
Figure 5.22: Presence o f  microcracks at 
triple point junctions in SF  bioceramics
Figure 5.25: Formation o f  
polycrystalline structure at surface o f  
a-TCP SF  bioceramic
Figure 5.24: Vitreous, glassy surface o f  
46% a-TCP SF  bioceramic
These structural differences were most notable in the TCP samples and in particular p-TCP 
bioceramics due to the larger microporosity compared to HA bioceramics. As a result the greater 
strength increases were found in the p-TCP bioceramics e.g. sol-gel treated P-TCP bioceramics 
at 1100°C have strength increases o f 160% without compromising the interconnected 
macroporosity network.
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Figure 5.26 indicates the XRD analysis o f the untreated and treated SF bioceramics.




Figure 5.26: Comparison ofX RD  data fo r  SF  samples untreated and SF  samples treated with
sol-gel
It can be noted that the greatest evidence o f for structural and chemical differences is in the TCP 
phases and it is these that also demonstrate the greatest strength increases as a result o f the sol- 
gel treatment. The large amount of microporosity in these phases, (shown by SEM micrographs) 
and thus superior ability of sol-gel to bond to surface o f TCP bioceramics, has altered the 
chemical structure o f the phase. This structural and chemical alteration is shown in figure 5.27 at 
31.5° - 33.5° where the apatitic structural group in TCP samples has been altered due to the 
reaction with the soda sol-gel. Conversely, the HA XRD traces do not indicate a change in the 
apatitic group and therefore the chemical and structural changes are not as marked as for the 
TCP samples. The strength increases in HA bioceramics are not as great as for the TCP and in 
particular the high microporosity p-TCP bioceramics.
The structural and hence mechanical property improvements due to the treatment o f soda sol-gel, 
via the elimination o f microcracks and the altering o f the chemical structure, has improved the
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mechanical properties of the SF bioceramics without compromising the interconnected 
macroporosity network needed for bone ingrowth. This was a main objective of the research as 
the initial fabricated bioceramics with an improved porosity structure were structurally weak.
Table 5.3 illustrates the structural and mechanical properties of the sol-gel treated SF 
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1 0 0 -2 3 0 2 - 1 2 1.11 5 .0 -7 .0 1.6 -3 .3 0.05 4.9 -  7.0
Youngs Modulus 
(GPa)
7 - 3 0 0 .0 5 -0 .1 0 .2 -3 .1 - - - -
Volume porosity 
(%)
5 - 1 0 4 0 -9 5 1 0 -4 0 4 0 - 6 0 7 2 -9 0 > 95 7 2 - 9 4
Interconnected or 
isolated porosity?
Int. Int. Int. Isol. Int. Int. Int.
Pore size range 
(pm)
1 0 -2 0 0 1 0 -1 0 0 0
**
1 0 0 -4 0 0 100 - 
400
15 - 120 50 - 500 50 -1000  +
Reference Rho et. al. 
[15]
Rho et. al. 
[15]










* The content of bone varies due to its location in the body. 
** Porosity size range in bone can be greater than this.
Table 5.3: Comparison o f  structural and mechanical properties o f  some current bone 
replacement materials with the sol-gel treated bioceramics fabricated in current research
It can be seen from table 5.3 that the open porous SF treated bioceramics have similar structures 
from the point o f view of volume porosity, interconnected porosity and pore size range to other 
materials produced in the field i.e. by Sepulveda [121] and Binner [110]. However the sol-gel 
treated SF samples have improved mechanical resistance compared to these materials. When 
compared to a commercially available product, Endobon®, the material produced from the 
current research has improved structural characteristics (i.e. volume porosity and pore size 
range) and also improved compressive strength. The sol-gel treated SF bioceramics has similar 
mechanical properties to materials developed by Liu [123], however the materials produced by 
the current research has improved structural characteristics compared to this material i.e. 
interconnected porosity, high volume porosity, pore size range. It can also be seen from table 5.3
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how the materials produced by the current research closely approximate the structural and 
mechanical properties o f cancellous bone.
The materials produced from the current research offer a significant advancement in the field as 
a superior range o f materials has been produced with appropriate structural characteristics for 
bone ingrowth that also exhibit a diversity o f applications.
5.3 Microporosity Evaluation and Wicking Properties of SF Bioceramics
The microporosity present in the bioceramics produced has two important roles. Firstly, there is 
potential for the microporous materials to be used as drug carriers so that diseased or damaged 
bone can be treated in-vivo by the release o f bone morphogenetic proteins through the 
microporous structure. Secondly, the amount of microporosity present is an indication to how 
well the bioceramics wick up fluid, an important element when considering the potential 
biocompatibility of a material.
5.3.1 Microporositv Dependence on Sintering Temperature
The microporosity distribution of all samples analysed is shown in figure 5.27. Although the 
pores <2 pm are more numerous, the pores >2  pm provide a greater contribution to the volume 
fraction of microporosity.
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C um ulative Pore D istribution  for Sam ples  
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Figure 5.27: Cumulative micropore distribution o f  all the samples analysed
The microporosity was found to be dependent on sintering temperature and independent o f the 
type o f porosifier used or drying mechanism. The microporosity changes seen above 1180°C 
correspond to an increase in grain growth, particularly in the calcium deficient grade 118 HA 
powders. Figures 5.28, 5.29 and 5.30 illustrate the differences in microstructure at 1150°C, 
1250°C and 1350°C in SF bioceramics, indicating the reduction in microporosity with increased 
sintering temperature.
Figure 5.28: Microporous structure o f  1150°C sintered SF  bioceramic
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Figure 5.29: Microporous structure of1250°C  sintered SF  bioceramic
Figure 5.30: Microporous structure of1350°C  sintered SF  bioceramic
The predominant phase in 1150°C sintered samples with grade 118 powders is [3-TCP. Above 
1180°C a vitreous reaction occurs that forms a hard, glassy a-TCP phase. A further increase in 
sintering temperature (figure 5.30) reduces the microporosity still further due to coalescence of 
grains. The micrographs demonstrate how sensitive the base powders are to sintering 
temperature and the importance of absolute control over the temperature ramp rate and overall 
temperature inside the sintering oven for phase control.
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Figure 5.31 indicates the dependency o f microporosity by sintering temperature and the 
independence from the porosifier used. The 1280°C fired bioceramics have 52% less 
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Figure 5.31: Graph showing how the experimental parameters affect the microporosity in the
samples
The presence of a-TC P in the 1280°C fired samples, which introduces a volume increase on 
formation and hence a smaller grain size, is a possible explanation for the difference in 
microporosity, as the number of sites for micropores to nucleate is smaller. Another argument is 
the possibility of forming a vitreous, glassy phase resulting from mass flow and the coalescence 
o f grains at high temperatures.
The microporosity in the 1280°C fired samples is more clearly defined. However, in the 1150°C 
fired samples, where there is no transformation to a-TCP, the grains appear to cluster together in 
clumps (i.e. no vitreous formation and hence no coalescence o f grains) leaving the microporosity 
to be less defined and randomly distributed in pockets surrounded by clustered grains. This adds 
weight to the argument that at high temperatures the coalescence o f grains is predominantly the 
driving force for the reduction in microporosity with increasing temperature.
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5.3.2 Wicking Experiments and Relationship to Microporosity
Wicking experiments were performed to evaluate how the microporosity affects the wicking 
properties o f the three phases (HA, a-TCP and P-TCP). For example, as an indication to the 
relative solubility of the three phases, it is reported in the literature that HA is 20 times less 
soluble than P-TCP [50].
It was found from the wicking experiments that P-TCP samples were fully saturated after two 
minutes o f immersion in a methylene blue indicator solution. HA samples were fully saturated 
after 50 minutes of immersion. Therefore, HA which has 52% less microporosity than P-TCP 
wicks up 25 times slower. This coincides with the solubility results reported in-vivo in the 
literature [42]. Figure 5.32, 5.33 and 5.34 show images o f the samples prior to immersion, during 
immersion and after immersion respectively.
Figure 5.32: SF bioceramics prior to Figure 5.33: SF  bioceramics during
immersion immersion
Figure 5.34: SF  bioceramics after immersion
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In a separate experiment, samples were left immersed for 24 hours to ensure full saturation of the 
samples by the indicator solution. After 24 hours HA, a-TCP and p-TCP bioceramics increased 
in mass by 39%, 52% and 81% respectively. This confirms the relationship between 
microporosity and wicking properties i.e. an increase in microporosity correlates with an 
increase in wicking properties.
5.4 Fabricated Bioceramics for Practical and Clinical Applications
It is necessary not only to produce bioceramics purely for laboratory research, but also to transfer 
that research and technology into the manufacture of bioceramics for clinical applications. This 
was another objectives of this research laid out in section 2 .8 , whereby research concentrated 
upon four practical areas. These being, the development and compression testing of synthetic 
CaP granules (from the I.I. method) for impaction grafting in revision hip operations, block 
material for potential use in maxillofacial surgery (jaw reconstruction), cylindrical graft material 
for spinal fusion interbody operations and also a synthetic alternative for non-load bearing 
chondylar defects in the knee joint.
The need to produce these practical synthetic graft materials also illustrates the diversity of the 
process, and that not only the size and shape o f the samples can be tailored (as well as porosity 
distributions), but the chemical composition can also be altered for specific biological and 
mechanical requirements.
5.4.1 CaP Granules for Impaction Grafting
As the supply of allograft material is limited and allograft is also of poor quality, there is a need 
to develop an alternative material for impaction grafting in revision hip operations. The two 
grades o f powders used in the present study (118 and 130 -  both supplied by Stryker 
Orthopaedics) are also used as base powders in a commercially available synthetic granular 
alternative to allograft for use in impaction grafting developed by Stryker Orthopaedics and 
named BoneSave®. BoneSave® has been proven to be biocompatible with bone and has 
excellent wicking properties. However it does not have interconnected macroporosity. CaP 
granules fabricated via the I.I. method were produced in similar size ranges to BoneSave® and 
both materials were then compression tested using a die-plunger and their mechanical properties
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compared. Figure 5.35 illustrates an example o f the stress-strain curves o f the fabricated CaP 
granules from the I.I. method and the BoneSave® granules. Table 5.4 shows the respective 
modulus of each size range against that for BoneSave®. The study was carried out in order to 
evaluate the relative mechanical response under compression loading of the material fabricated 
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Figure 5.35: Die-plunger compression test fo r  CaP granules fabricated from  I.I. method and
BoneSave®
Bone Substitute Modulus up to 500N (GPa) Modulus from 500 -  1000N 
(GPa)
BoneSave® 29.5 45.1
2 -  4mm sized CaP granules 49.6 66.5
3 -  5mm sized CaP granules 40.3 66.4
Table 5.4: The respective moduli fo r  the two different granules tested
The granules produced using the I.I. method had a higher compressive modulus relative to 
BoneSave®. This is particularly true for the 2-4mm sized granules. Larger sized granules tend to 
shear at the edges as they topple and re-order themselves on loading hence have a lower 
compressive modulus. It must be noted that the moduli reported are not the true material moduli 
due to the toppling effect of the granules on testing. The results are purely relative within the 
batch tested.
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The research has successfully fabricated granules that are similar in size to current/commercial 
alternatives for impaction grafting, but with higher compressive moduli. The fabricated granules 
have the added advantage over BoneSave® of having interconnected porosity.
5.4.2 Block Graft Material for Maxillofacial Operations
Maxillofacial operations or jaw  reconstruction surgery, offer a vast area of application for 
synthetic bone graft materials. With the difficulty in shaping allograft material, due to its 
relatively high mechanical properties and the extra surgical site required for autograft 
procedures, there is a need to develop a bone substitute that can be specifically tailored for 
individual requirements in order to fabricate blocks, wedges and space fillers at the time of 
surgery. Figures 5.36 and 5.37 show I.I. bioceramics that have interconnected macroporosity and 
that have been ground down very simply and quickly to produce different shapes that could be 
used as space fillers in maxillofacial operations.
Figure 5.36: A wedge o f  J3-TCP I.I. bioceramic Figure 5.37: Further examples o f  the varying shapes
ground down fo r  potential use in maxillofacial that can be produced from  the I.I. procedure. HA
operations. Scale: lcm  = 2mm bioceramics are shown in this figure. Scale: I cm =
lcm
The above images once again illustrate the diversity o f the process in producing a broad range of 
sizes and shapes for specific operations. In addition, chemical compositions can also be tailored 
by using the two different base powders -  118 and 130.
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5.4.3 Spinal Fusion Interbody Graft Material
In certain surgical procedures in the spine, cylindrical spinal fusion graft material is required to 
assist bone ingrowth between vertebrae in the spinal column e.g. for broken spinal discs that 
have been ruptured into the spinal column. At present hollow metal (usually titanium) cylindrical 
cages 8 -12mm in diameter and 12-20mm in length are filled with allograft material in order to 
aid bone growth between the two vertebrae. There are perceived advantages in developing an 
alternative in the form o f the bioceramic components similar to those developed in the current 
research programme. Figures 5.38 to 5.40 illustrate the type o f material fabricated and the type 
o f structure that could be used in this type o f surgery.
Figure 5.38: Example o f  HA SF bioceramic 
produced by current method cut 
longitudinally
  1mm
Figure 5.39: SF  bioceramic image 
taken from  above
Figure 5.40: Examples o f  HA, a-TCP and J3-TCP SF  
bioceramics
The samples have an internal interconnected macroporosity network resembling cancellous bone 
with a l-3mm thick outer dense shell to promote structural integrity. Results from the present 
research showed that untreated SF bioceramics (no sol-gel treatment) had an average 
compressive stress of 3MPa, with those SF bioceramics treated with soda sol-gel having
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compressive stresses averaging 6MPa. This was achieved by improving the structure-property 
relationship o f the bioceramics without compromising the interconnected macroporosity 
network.
5.4.4 Chondvlar Defects
These non-load bearing samples are required for filling in defects in knee joints whereby 
diseased cartilage and bone (e.g. due to severe degenerative arthritis) has been worn away to 
leave defects. These space fillers ideally should have interconnected porosity in the correct size 
range for bone formation and ingrowth (i.e. 150 - 300pm). Examples o f porous scaffolds 
fabricated in this research are shown in figures 5.41 and 5.42 below.
Figure 5.41: Porous scaffold bioceramic Figure 5.42: Porous scaffold bioceramic
produced from  30 ppi porosifier and produced from  45 pp i porosifier and
sintered at 1150°C sintered at 1150°C
The samples shown above are cylindrical versions of the OPS bioceramics or conversely, SF 
bioceramics without the dense outer shell. The dense outer shell is not incorporated, as these 
samples are required for non-load bearing applications, although SF bioceramics could also be 
used.
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The range of samples described here highlights the diversity o f the process developed in this 
research. Size and shape can be tailored as well as the chemical composition and interconnected 
porosity distributions. Producing bioceramics with the correct interconnected pore size range for 
bone ingrowth, combined with appropriate mechanical properties, suggests that the bioceramics 
have the potential to be successful bone substitute materials.
5.5 Conclusions
The main aims and objectives of the research have been successfully achieved. These were to 
fabricate HA/TCP bioceramic scaffolds o f varying geometries, with open, interconnected pores 
in the appropriate size range for potential bone formation, that also have sufficient mechanical 
strength to withstand load-bearing activities in-vivo.
This study confirmed the potential o f the fabricated bioceramics for use as bone substitute 
materials. The research was driven by both the need to supplement the materials structure- 
property relationship, and also by clinical needs. However, the research has been directed 
towards structural improvements, resulting in improved mechanical properties.
The initial aim of this research was to produce HA/TCP bioceramics with an interconnected 
porosity in the correct size range for possible bone formation and ingrowth. This was achieved 
by the development of Impact-Impregnated (I.I.) bioceramics. However, the size of the porosity 
along with the low total volume porosity, was not ideal for bone remodelling.
In developing novel techniques to producing Open Porous Scaffold (OPS) bioceramics, a high 
volume interconnected porosity network was successfully fabricated, resembling that of 
cancellous bone. This offered an improved pore size, shape and porosity structure, when 
compared to the I.I. bioceramics. The formation o f microcracks on sintering, on the 
interconnected struts, combined with low densities, lowered the stress to cause failure, and 
therefore lowered the mechanical properties o f the OPS bioceramics. These properties were not 
adequate for possible load-bearing applications.
However, the techniques developed in producing OPS bioceramics were used to retain the same 
porosity network for Spinal Fusion (SF) bioceramics. These samples were produced for a 
specific clinical application with improvements made to the mechanical properties, by the
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fabrication of a dense outer shell protecting the interior porosity network and increasing density. 
This was achieved without compromising the structure o f the interior porosity network.
Further treatment o f these SF bioceramics by the use o f sol-gel solutions, resulted in further 
improvements to the microstructure, for example, by addressing the issue o f surface microcracks. 
The interconnected macroporosity network was not compromised by this method. Hence, the SF 
bioceramics treated with sol-gel solution had increased mechanical properties due to 
improvements made in the structure-property relationship. Therefore, the potential for these 
bioceramics to be used in load-bearing applications is enhanced.
In addition to manufacturing HA/TCP bioceramics with varying geometries and adequate load- 
bearing capabilities and porosity requirements, materials for other clinical applications have also 
been produced. These include granular material for use as an alternative to a commercially 
available product BoneSave®, developed by Stryker Orthopaedics. In a comparison between 
BoneSave® and the granular material developed in this research, the developed granular material 
had improved mechanical resistance to loading. Cylindrical OPS samples have been produced 
for possible use in non-weight bearing chondylar repair. In addition, I.I. bioceramics in the form 
of wedges for potential use in maxillofacial applications have also been developed. This 
illustrates the diversity o f applications possible with the materials developed, and the range of 
sample geometries that can be fabricated.
To conclude, the materials developed in the current research programme offer structural and 
mechanical advantages over other bioceramic materials. The fabrication procedure guaranteed an 
interconnected macroporosity network within the HA/TCP scaffold and high volume porosity, 
with pores in the appropriate size range for bone ingrowth. This was combined with adequate 
mechanical properties for possible load-bearing applications. Superior ranges of materials 
suitable for a diversity of applications have therefore successfully been developed.
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5.5.1 Future Work
The results from the current programme indicate the need for further research in the following 
areas:
• Biological/Dissolution Studies
• Further Improvements to the Structure-Property Relationship
• Composition and Orientation
Biological/Dissolution Studies
• Due to the nature o f the microporous structure o f the materials produced (in particular
high microporosity p-TCP bioceramics), there is a possibility o f using the materials as a
base for drug carriers (such as bone morphogenetic proteins), to enable diseased or 
infected bone to be treated via a drug release mechanism through the micropores. This 
shows promise especially in the P-TCP bioceramics due to their large surface areas at the 
microstructural level and excellent wicking properties.
• A simulated body fluid study is required in order to assess the potential of the fabricated 
bioceramics to participate in ionic interactions to form CaP deposits on its surface. The 
commercially available product BoneSave® is produced from the same powders used in 
this study, and hence it would be assumed that the bioceramics fabricated in this research 
would behave in a similar manner both in-vitro and in-vivo.
• A study of the effect on the dissolution on the strength properties o f the materials
produced would also be required. Materials could be removed from a simulated body 
fluid after set periods e.g. one day, four days, one week, one month etc, and mechanically 
tested.
• In addition to simulated body fluid tests and in-vivo experiments on the HA/TCP 
bioceramics produced, it would be necessary to run a comparison study between the SF 
bioceramics and those SF bioceramics treated with sol-gel solution with improved 
mechanical properties. Any strength improvements due to surface or microstructural 
changes would ultimately affect the potential biological response of the bioceramics. This 
would be required to be researched both in-vitro and in-vivo.
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Further Improvements to the Structure-Property Relationship
• In order to improve the mechanical properties without compromising the hierarchial 
porosity size range, many different processes such as compression treatment by plasma 
spraying, flame glazing or ion exchange whereby smaller ions are exchanged in the 
atomic lattice inducing compressive stresses by solid solution hardening (e.g. Zr) may be 
researched to reduce the potential of crack growth on loading.
• To evaluate crack lengths that determines failure (i.e. Griffith flaws) in the bioceramics 
produced, and to perform a study to investigate the strength improvements due to 
changes in size o f the Griffith flaws.
• Low thermal coefficient expansion coatings, that on cooling place the surface o f a 
material under compression, and hence improve the mechanical properties by stunting 
crack growth, is also an area of future research.
Composition and Orientation
• A compositional change to the apatite structure in CaP bioceramics induces not only 
structural and mechanical changes, but also affects the dissolution and biocompatibility 
o f the materials. The introduction of materials that exhibit such effects as piezoelectricity 
and ferroelectricity could be of use in the body as polarised materials aid bone growth at 
an accelerated rate [162].
• To continue the research started in the current programme on altering the orientation of 
the porosity within the OPS bioceramics. Sol-gel treatments (as used in the SF research) 
could be employed to evaluate how elliptical shaped pores affect the strength o f the 
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In tro d u ctio n
Joint rep lacem ent p rocedures such  a s  revision impaction grafting 
a re  stretching allograft bone stocks to their limits [1], The need for 
synthetic alternatives that offer a  structural and biological matrix for 
graft incorporation is param ount for future bone replacem ent and 
reconstruction surgery [2],
Hydroxyapatite/tricalcium phosphate  (HA/TCP) synthetic bone graft 
alternatives have been shown to be  biocompatible with bone [3], The 
p resen ce  of an interconnected porosity network has  a strong 
influence on the osteoinductive potential of th e se  synthetic bone 
graft m aterials [4],
Early work by the authors focused  on an impact-impregnation (I I.) 
technique to produce a d en se  bioceram ic [5], The current study 
describes the production of open porous scaffold (OPS) calcium 
p hosphate  ceram ics that p o s se ss  an interconnected open porous 
network in the required size  range for osteoid growth and 
revascularisation.
Materials and Methods
Two g rad es  of calcium phosphate  powder were blended together to 
form a HA/TCP ceram ic slip which w as then ball milled for 24hrs with 
zirconia milling media. This slip w as used  to im pregnate 
polyurethane (PU) foam via a m echanical plunging procedure. The 
im pregnated foam w as held abo v e  the slip bath in order for the slip 
to flow and coat the struts of the foam. The sam ples produced were 
then dried on tissue  paper and treated  with high velocity com pressed  
air to avoid the formation of any  c losed cells. The im pregnated 
blocks w ere dried a t 120°C for 15hrs.
The PU foam s were graded a s  30 and 45 ppi (pores per inch). The 
slip viscosity ranged from 6000 -  8000 cps (m easured  with a 
Brookfield Viscometer, spindle no. 5 and a t 10rpm).
Sam ples w ere sintered slowly up to 500°C to ensu re  PU burnout w as 
com plete. Sintering continued up to 1280°C to ensure  densification.
Final sintered dim ensions w ere 40x25x10mm. Image analysis w as 
perform ed using optical m icroscopy and scanning electron 
microscopy (SEM) analysis. M echanical testing w as performed by 3 
point bending using an 1122 Instron machine. Figure 1 shows a 
typical exam ple of the HA/TCP bioceram ic scaffold produced.
Figure 2: Porosity distribution o f OPS compared to 
dense bioceramics previously produced
Figure 3 rep resen ts  the  strength-porosity relationship betw een the O PS 
and im pact-im pregnated bioceram ics. Figure 4 illustrates the strength- 
density correlation in the calcium phosphate  bioceram ics produced.
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Figure 3. Strength-Porosity relationship Figure 4: Strength-Density relationship 
for OPS and I I. bioceramics for OPS and I I bioceramics
O ne hundred and twenty sam ples p o sse sse d  a breaking s tress , with a 
95% confidence level, of 0.30M Pa±0.01M Pa. The low strengths 
reported w ere due to the formation of blow-out holes at triple point 
junctions on the  interconnected struts. Figure 5 illustrates this 
phenom enon which is typical in all bioceram ic scaffolds produced. A 
small applied s tre ss  may be magnified many tim es a t the tip of a  crack 
reducing the strength of the overall bioceramic.
a
Figure 1: Interconnected porosity of HA/TCP 
bioceramic scaffold produced by current method
Results
Typical macroporosity in the bioceram ic scaffolds varied from 40- 
70% with over 79% of porosity lying in the size range 150-450pm in 
a rea  equivalent diameter. The fabrication procedure guaranteed  
interconnected porosity. Figure 2 rep resen ts  the porosity distribution 
of the open porous scaffolds (O PS) com pared to those reported 
earlier by the im pact-impregnation technique i.e. d en se  bioceram ics 
[5].
The average  pore size acknow ledged for facilitating osteogenesis  
(i.e. > 300pm ) has  been met by the p resen t fabrication technique.
U N IV E R S IT Y  OF
BATH Q p
> b i c
c e n tre  fo r
o rth o p a e d ic
io m e c h a n ic s
Figure 5: Formation of blow-out holes resulting 
in poor strengths due to critical crack formation
C o n c lu s io n s
HA/TCP bioceram ics with interconnected porosity in the size range 
appropriate for bone ingrowth have been  successfully produced. The 
fabrication procedure has  proved to be reliable and consistent. Future 
work will focus on eliminating m icrocracks in o rder to optimise
m echanical properties.
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Introduction
Joint replacement procedures such as revision impaction grafting and spinal fusion interbody operations are stretching allograft 
bone stocks to their limits [1]. The need for synthetic alternatives that offer a structural and biological matrix for graft 
incorporation are paramount for future bone regeneration procedures [2],
Synthetic bone graft alternatives that offer biocompatibility to the host bone (i.e. a biological response) such as 
hydroxyapatite/tricalcium phosphate (HA/TCP), in addition to possessing an interconnected porosity network have been shown 
to have a strong influence on the osteoinductive potential of these materials [3, 4, 5],
The current method allows the production of calcium phosphate ceramic components (CPC) that possess an interconnected open 
porous network in the required size range for osteoid growth and revascularisation.
Materials and Methods
The method can be described as the reticulated foam technique, whereby two grades of calcium phosphate powder are blended 
together to form a HA/TCP ceramic slip. The slip is then ball milled for 24hrs with zirconia milling media. This slip is used to 
impregnate polyurethane (PU) foam via a mechanical plunging procedure. The impregnated foam is then held above the slip bath 
in order for the slip to flow and coat the struts of the foam. The impregnated foam is then dried on tissue paper and treated with 
high velocity compressed air to avoid the formation o f any closed cells.
Samples are dried at 120°C for 15hrs. The PU foams are graded as 30 and 45ppi (pores per inch). The slip viscosity ranges from 
6000 -  8000 cps (measured with a Brookfield Viscometer, spindle no. 5 and at lOrpm).
Samples are sintered slowly until 600°C to ensure PU burnout is complete. Sintering continues up to 1280°C to ensure 
densification. Image analysis was performed using optical microscopy, digital photography and SEM analysis. Mechanical 
testing was performed by 3 point bending using an 1122 Instron.
Results
Figure 1 shows the macroporosity generated by the process (scale bar is 1mm). Macroporosity in the samples varies from 40 -  
70%. Typical pore sizes far exceed 300pm (the pore size acknowledged as that needed for osteogenesis) -  see figure 2. Approx. 
79% of all pores were between 150 -  450pm in area equivalent diameter.
Typical strut thicknesses ranging from 100 -  500pm were also reported, as was a strut thickness-pore size-mechanical strength 
relationship.
Cumulative Pore Distribution fo r all Normal sam ples - 30 
and 45 ppi
Pore sire . Equivalent d iam eter (pm)
Fig. 1: Macroporosity of 45ppi HA/TCP sample Fig. 2: Pore distribution of samples
One hundred and twenty samples possessed a breaking stress with a 95% confidence level o f 0.30MPa±0.01 MPa (error margin of 
just 3%). The low strengths reported are due to the formation o f blow-out holes at triple point junctions on the interconnected 
struts.
Conclusions
Major requirements for replacement bone materials have been met including a wide range o f interconnected porosity from 50 -  
1000pm. Bioactivity combined with an excellent porosity size range suggests excellent possibility o f osteogenesis. In addition 
this fabrication procedure offers consistency and reliability. Future work will look at improving strength o f these open porous 
calcium phosphate based ceramics.
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influence on the osteoinductive potential of these synthetic bone f f r
graft materials [2]. Figures 4 and  5. Porosity distribution o f  O PS compared to
dense bioceramics previously produced
Early work by the authors focused on an Impact-impregnation (I I.)
technique to produce a dense bioceramic [3], The current study Figure 6 represents the strength-porosity relationship between the  OPS
describes the production of open porous scaffold (OPS) calcium and Impact-Impregnated bioceramics. Figure 7 illustrates the strength-
phosphate ceramics that possess an interconnected open porous density correlation in the calcium phosphate bioceramics produced
network in the required size range for bone ingrowth.
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M aterials and  M ethods
Two grades of calcium phosphate powder were blended together to 
form a HA/TCP ceramic slip which was then ball milled for 24hrs. 
This slip was used to impregnate polyurethane (PU) foam via a 
mechanical plunging procedure. The impregnated foam was held 
above the slip bath in order for the slip to flow and coat the struts of 
the foam. The samples produced were then dried on tissue paper 
and treated with high velocity compressed air to avoid the formation 
of any closed cells. Figure 1 illustrates this procedure. The 
impregnated blocks were dried at 120 C for 15hrs 
DIP DRIP
I V  d r y
Figure 6 , Strength-Porosity relationship for Figure 7 Strength-Density relationship for
O PS a nd  11 bioceramics O PS and I I bioceramics
One hundred and twenty samples possessed a breaking stress, with a 
95% confidence level, of 0.30M Pa:0 01MPa. The low strengths 
reported were due to the formation of microcracks at triple point 
junctions on the interconnected struts due to thermal shrinkage 
Figures 8 and 9 illustrate this phenomenon which is typical in all the 
bioceramic scaffolds produced. A small applied stress may be 
magnified many times at the tip of a  crack reducing the strength of the 
overall bioceramic. It is the presence of these small flaws that severely 
limit the strength of the bioceramic.
Slip Ixtih
Figure I: Scheirtatic o f fabrication procedure Jar OPS
The PU foams were graded as  30 and 45 ppi (pores per inch). The 
slip viscosity ranged from 6000 -  8000 cps (measured with a 
Brookfield Viscometer, spindle no. 5 and at 10rpm)
Samples were sintered slowly up to 600 C to ensure PU burnout was 
complete. Sintering continued up to 1280 C to ensure densification. 
Final sintered dimensions were 40x25x10mm. Image analysis was 
performed using optical microscopy and scanning electron 
microscopy (SEM). Mechanical testing was performed by 3 point 
bending using an 1122 Instron machine. Figures 2 and 3 show 
typical examples of the HA/TCP bioceramic scaffolds produced.
Figures 8  and  9 Formation o f microcracks resulting in poor 
strengths due to critical crack formation
C onclusions
HA/TCP bioceramics with interconnected porosity in the size range 
appropriate for bone ingrowth have been successfully produced. The 
fabrication procedure has proved to be reliable and consistent Future 
work will focus on eliminating microcracks in order to optimise 
mechanical properties
(Jraph Indenting Strength vs Densit> Relations 
for lmp»ct-lmjre0iation and Open llimus 
ScafTd*
Graph Showing Correlation Between 
Porosity and .Strength for Impact- 
impregnation and Open Porous .Samples
•/« M aero porosity
A c k n o w i i ' J c i  i ' t ' Mt s
Figures 2 and 3: Interconnected porosity o f HA/TCP bioceramic 
scaffolds produced by current method  
R esults and D iscussion
The average pore size acknowledged for facilitating osteogenesis 
(i.e. > 300pm) has been met by the present fabrication technique.
Typical macroporosity in the bioceramic scaffolds varied from 40- 
70% with over 79% of porosity lying in the size range 150-450pm in 
area equivalent diameter. The fabrication procedure guaranteed 
interconnected porosity. Figures 4 and 5 represent the porosity 
distributions of the open porous scaffolds (OPS) compared to those 
reported earlier by the Impact-impregnation technique i.e. dense 
bioceramics [3].
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Introduction R esu lts  and  D iscussion
Synthetic calcium phosphate (CaP) bioceramics have been used 
successfully a s  bone substitute materials for over thirty years. The 
majority of CaP bioceramics are based on hydroxyapatite (HA) and 
tricalcium phosphate (TCP) [1]. Factors such as  porosity, 
biocompatibility and structural integrity are of critical importance in 
the development of bioactive calcium phosphates [2].
This study involves fabricating CaP ceramics that combine both a 
porosity network appropriate for bone regeneration and mechanical 
properties that give structural integrity to the bioceramics. Open 
porous scaffolds (OPS) were produced with orientated porosity in 
order to replicate the structure found in trabecular bone It was 
hypothesised that different shaped pores would result in a range of 
strengths, a s  elliptical shaped pores would decrease  the stress to 
cause failure and hence be weaker than CaP OPS with spherical 
pores. Figure 1 shows typical exam ples of the HA/TCP bioceramic 
scaffolds produced, l-f V- £' A V
One hundred and twenty OPS sam ples with an interconnected 
macroporosity network were produced. Figure 3 shows the broad 
distribution of pore sizes in the sam ples analysed; it can be seen that 
the majority of pores fall in the 150-300pm size range appropriate for 
bone ingrowth and overall shows a hierarchal pore structure with a size 
range from 50-1000pm. A volume porosity of 40-70% was reported 
Figure 4 gives a summary of the mechanical properties for the OPS 
produced. The results are given as  95% confidence levels and indicate 
consistent low strength and a low apparent density Those samples 
sintered at 1280 C possess slightly greater strengths than those 
sintered at 1150 C due to the allotropic transformation to a-TCP a t high 
temperatures. The consistently low strengths reported indicate a 
different failure mechanism than that originally hypothesised i.e due to 
the elongation of PU foam _________________________________________
Figure 3 Macropore distribution o f CaP O PS Figure 4 Mechanical data summary for CaP OPS  
It was hypothesised in the initial stages of this work, that the elliptical 
shaped pores would create higher stress concentration factors at their 
tips than the spherical pores of the untreated foams, hence decreasing 
their resistance to mechanical stress However. SEM studies revealed 
the low strengths reported were due to the formation of microcracks 
during thermal shrinkage on cooling. Figure 5 shows examples of the 
thermal shrinkage due to sintering and the resulting weakness in the 
scaffold structure thus created On stressing, these microcracks 
severely limit the strength of the bioceramic. Therefore, the 
mechanical properties of the OPS were not controlled by the different 
shaped pore structures as hypothesised, but by the microcracks 
formed due to thermal shrinkage. This explains the consistently low 
strengths m easured______________________________________________
Figure I CaP O PS from left to right (a) 3ON 1280 C, (b) 4SL 1150 C. (c) 3OT 1280 C 
M aterials and M ethods
Two different calcium phosphate powders (118 and 130) were 
blended to form thixotropic ceramic slips. The 118 CaP powder is 
non-crystalline and undergoes phase transformations to (J- and a- 
TCP on sintering. Powder 130 is highly crystalline and on sintering 
forms HA. The process used to fabricate the OPS is shown in figure 
2. The CaP thixotropic slips were used to coat the cells of the 
reticulated polyurethane (PU) foams. This was achieved with the aid 
of a mechanical plunging device designed specifically to allow the 
slip to penetrate throughout the open porous structure of the foam 
The foams were then held above the slip bath for the slip to seep out 
of the foam. Careful turning allows complete wetting of the struts of 
the foam. The final stage was to spray the samples with high velocity 
compressed air in order to avoid the formation of closed cells and to 
dry the scaffold structure. In this way the pore interconnectivity of the 
dried scaffolds is guaranteed. The work detailed is covered under 
British Patent Application no. 0318901.6 
d ip  d r ip■ ■
Figure 5 Formation o f  microcracks lowering the strength o f  the CaP O PS bioceramic 
C onclusions
OPS have pores typically in the size range 150 300pm and 40
70% porosity by volume. The majority of pores were in the 
appropriate size range for bone ingrowth. The mechanical properties 
of the sam ples produced were found to be low Elongating the pore 
structure in transverse and longitudinal directions did not affect the 
total porosity of the bioceramics or their mechanical properties 
Further work will focus on the elimination of the microcracks present 
in order to optimise the properties of the materials produced. 
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Slip bath
Figure 2: Fabrication procedure for CaP O PS  
In order to achieve the orientated structure observed in cancellous 
bone, a  technique was developed to elongate the cells of PU 
reticulated foam prior to fabrication. Sheets of foam were stretched 
and thermally transformed to produce elliptical shaped pores. This 
produced PU scaffolds with pore structures classed as normal i.e. 
untreated foam (N), longitudinal (L) or transverse (T) a s  described in 
figure 1. The PU foams were graded a s  30 or 45 ppi (pore per inch). 
The untreated foams possessed spherical pores ranging in size from 
850-1500pm.
Further drying at 110 C for 24hrs and subsequent sintering at 
1150 C or 1280 C (depending on the phase required) produces the 
CaP OPS bioceramic. Image analysis was performed using optical 
microscopy and scanning electron microscopy (SEM). Mechanical 
testing was performed by 3 point bending using an 1122 Instron 
machine.
] C'umul a t i P b r e  Distribution for CaP OPS I
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Introduction
Calcium phosphate (CaP) ceramics, such as hydroxyapatite/tricalcium phosphate (HA/TCP), possessing an interconnected 
porosity network in the appropriate size range for promoting bone ingrowth offer the possibility o f a structural/biological 
matrix for replacing diseased or damaged bone. The bioceramic must possess mechanical integrity to avoid failure whilst 
offering a bioactive surface for bone ingrowth.
The objective o f the current study was to produce a HA/TCP bioceramic that imitated the orientated trabecular structure found 
in cancellous bone. The structure-property relationship o f these bioceramics was then analysed. It was hypothesised that the 
mechanical properties would be linked to the shape o f the pore structure due to the orientation o f the open porous scaffolds 
(OPS). The current research was compared to previous work that produced HA/TCP dense bioceramics with an interconnected 
porosity network.
M aterials  and M ethods
In order to achieve the elongated structure resembling cancellous bone, a technique was developed to elongate the cells of 
polyurethane (PU) reticulated foam. PU foams provided the substrate for the production of HA/TCP bioceramics and were 
graded as 30 or 45ppi (pores per inch). The PU foams possessed spherical pores ranging in size from 850- 1500pm. These were 
stretched and thermally transformed in order to produce elliptical shaped pores. Following this procedure, 120 foam samples 
were cut to dimensions of 40mm x 25mm x 10mm in both longitudinal and transverse directions. This produced HA/TCP 
scaffolds with pore structures classed as normal i.e. untreated foam (N), longitudinal (L) or transverse (T).
A thixotropic ceramic slurry was produced in order to achieve optimum coating o f the PU foam walls. Foam samples were 
impregnated with the aid of a mechanical plunging device that compressed the foam sample in order to draw the slurry into the 
foam and coat its structure. The samples produced were then dried on tissue paper and treated with high velocity compressed 
air to ensure the interconnectivity o f the porosity network. Drying of the final samples occurred at 120°C for 15hrs followed by 
sintering up to 1280°C. Scanning electron microscopy and image analysis was used to assess the porosity distribution and 3- 
point bending was used to evaluate the mechanical properties.
Results and Discussion
OPS bioceramics possessed an interconnected macroporosity network o f 30-60% with bending strengths of 0 .16-0.56MPa. 
Typical pore sizes o f OPS were in the size range 200-600pm. The fabrication o f CaP OPS produced a wide range of  
macroporosity in the correct size range for ossification processes to occur. The dense bioceramics previously manufactured had 
an interconnected macroporosity network of 7-31%, pore size range o f 50-200gm and compressive strengths of 1-21 MPa. 
Figure 1 illustrates the difference in macroporosity produced from the elongation fabrication procedure.
□  1150°C  
■  1280°C
Graph Showing how M acroporosity varies with 
changes in Porosifier and Sintering Tem perature
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Fieure 1: Variations between the normal (N), longitudinal (L) and transverse (T) shaped pore bioceramic
It was hypothesised that the shape o f the pore structure would influence the mechanical properties of the HA/TCP OPS produced. 
However, the low strengths reported were due to the formation o f microcracks during thermal shrinkage on cooling. On stressing, 
these microcracks severely limit the strength of the bioceramic. Therefore, the mechanical properties o f the OPS were not 
controlled by the different shaped pore structures as hypothesised, but by the microcracks formed due to thermal shrinkage. 
C onclusions
The HA/TCP bioceramics produced possess an interconnected porosity network between 100-1000pm+ in size and 30-60% by 
volume. Elongating the pore structure did not effect the total porosity o f the bioceramics. Strengths were low due to microcrack 
formation on sintering. Further work will address the elimination of these microcracks that magnify stress and cause failure. 
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Abstract
Calcium phosphate (CaP) ceramics possessing an interconnecting porosity network in the 
appropriate size range for vascularisation offer the possibility of providing a structural matrix for 
replacement of diseased or damaged bone. Such bioceramics must possess sufficient mechanical 
strength to avoid failure whilst offering a bioactive surface for bone regeneration. The objective 
of the current study was to produce a hydroxyapatite/tricalcium phosphate (HA/TCP) bioceramic 
that imitated the orientated trabecular structure found in cancellous bone. The structure-property 
relationship of these bioceramics was then analysed. It was hypothesised that the mechanical 
properties would be linked to the shape of the pore structure due to the orientation of the open 
porous scaffolds (OPS) produced. OPS bioceramics possessed an interconnected macroporosity 
network of 40-70% by volume with bending strengths of 0.30MPa ± 0.01 MPa and apparent 
densities of 0.35g/cm ± 0.05g/cm3. Typically, pore sizes in the range o f 150-300pm were 
produced. The fabrication of CaP OPS resulted in a wide range of macroporosity in the correct 
size range for osseointegration to occur. Elongating the pore structure did not affect the total 
porosity of the bioceramics. Strengths were low due to microcrack formation on sintering and not 
due to the shape of the pores present in the scaffold as initially hypothesised.
Introduction
Synthetic CaP bioceramics have been used successfully as bone substitute materials for over 
thirty years [1]. The majority of CaP bioceramics are based on hydroxyapatite (HA) and 
tricalcium phosphate (TCP) [2, 3]. The chemical composition o f synthetic HA resembles that o f 
the mineral component found in natural bone. Synthetic HA is generally mechanically stronger 
than synthetic TCP, however it does not possess the bioactivity of its counterpart. TCP may be 
formed due to phase transitions on sintering of synthetic HA, provided the Ca:P ratio is non- 
stoichiometric i.e. does not equal 10:6. Vacancies present in the structure allow Ca2+ and PO4 3' 
ions to form apatite precipitations within the ceramic substrate. This stimulates bone growth and 
enhances the integration of the implant material with natural bone [4].
Factors such as porosity, biocompatibility and structural integrity are o f critical importance in the 
development of bioactive calcium phosphates [5, 6]. The macroporosity o f such bioceramics 
plays an important role in osteoconduction. Osteoconductive bioceramics provide a scaffold for 
the ingrowth of bone and are affected by the total pore volume of the material [7].
This study involves fabricating CaP ceramics that encapsulate both a porosity network 
appropriate for bone regeneration and mechanical properties that resemble those o f natural bone.
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Open porous scaffolds (OPS) were produced with specifically orientated porosity (spherical, 
longitudinal and transverse) in order to replicate the structural anisotropy found in trabecular 
bone. It was hypothesised that the different shaped pores would result in a range of strengths, as 
elliptical shaped pores would decrease the critical crack size for failure and hence be weaker than 
CaP scaffolds with spherical pores.
Materials and Methods
A ceramic slurry was prepared using two forms o f hydroxyapatite Grades 118 and 130 powders, 
supplied by Stryker Howmedica Osteonics. Grade 130 is a stable, crystalline phase o f HA that 
does not thermally transform to other apatitic structures. Grade 118 is less crystalline than Grade 
130 and is calcium deficient, allowing the transformation at high temperatures to p- and a-TCP. 
Blending the powders in different proportions allows the fabrication o f any composition of 
HA/TCP bioceramic. The powders were incorporated into distilled water with other constituents - 
binders, plasticisers and surfactants - in order to avoid agglomeration and to ensure that the slip 
was thixotropic. Once formed the slip was ball milled with zirconia milling media for 24hrs at 
20rpm.
Polyurethane (PU) foams were used as a structural template for the manufacture o f CaP OPS 
bioceramics. Figure 1 shows the PU foam structure and illustrates the open interconnected 
porosity o f the foam in the as-received condition. The PU foams were graded as 30 or 45 ppi 
(pore per inch). The untreated foams possessed spherical pores ranging in size from 850- 1500pm. 
In order to achieve the elongated structure resembling cancellous bone, a technique was 
developed to elongate the cells o f PU reticulated foam. Sheets of foam were stretched and 
thermally transformed to produce elliptical shaped pores. Following this procedure, 120 foam 
samples were cut from the sheets to dimensions o f 40mm x 25mm x 10mm in both longitudinal 
and transverse directions. This produced PU scaffolds with pore structures classed as normal i.e. 
untreated foam (N), longitudinal
Figure 1: The structure o f  a 4 5ppi PU foam  used fo r  impregnation o f  slip. Note the open, 
interconnected porosity o f  the foam  that resembles cancellous bone.
The thixotropic slurry was incorporated into the PU foam samples with the aid o f a mechanical 
plunging device that ensured the slip coated the walls o f the foam; the thixotropic nature o f the 
slip assists this process. The sample was held above the slip bath to allow the slip to flow and coat 
the struts o f the foam. The samples were simultaneously dried on tissue paper and treated with 
high velocity compressed air to ensure the interconnectivity o f the porosity network. Drying of 
the final samples was carried out at 120°C for 15 hours followed by sintering at either 1150°C or 
1280°C in order to produce HA/TCP bioceramics with both a -  and p-TCP phases, such as 80:20 
HA/TCP. Scanning electron microscopy and image analysis were used to assess the porosity 





One hundred and twenty OPS samples with an interconnected macroporosity network were 
produced. Figure 2 shows the broad distribution o f pore sizes in the samples analysed; it can be 
seen that the majority o f pores fall in the 150-300pm size range appropriate for bone ingrowth. 
Figure 3 gives a summary o f the mechanical properties for the OPS produced. The results are 
given at 95% confidence levels and indicate consistent low strength and a low apparent density. 
Those samples sintered at 1280°C possess slightly greater strengths than those sintered at 1150°C 
due to the allotropic transformation to a-TCP at high temperatures. The consistently low 
strengths reported indicate a different failure mechanism than that originally hypothesised i.e. due 
to the elongation of PU foam.
C um ulative Pore Distribution for CaP O PS
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Figure 2: Macropore distribution of CaP OPS
CaP Open Porous 
Scaffolds
Bending Strength (MPa) 0.30 ±0.01
Apparent Density (g/cm ) 0.35 ± 0.05
Porosity (%) 4 0 - 7 0
Sample size 120
Samples sintered at 1280°C 
(MPa)
0.35 ± 0.05
Samples sintered at 1150°C 
(MPa)
0.28 ± 0.02
Figure 3: Mechanical data summary for CaP OPS
Figure 4 shows scanning electron micrographs (SEM) of the CaP OPS samples produced using 
foams with the different orientations and pore sizes (30 or 45ppi) -  normal (a), longitudinal (b) 
and transverse (c). It was hypothesised in the initial stages o f this work, that the elliptical shaped 
pores would create higher stress concentration factors at their tips than the spherical pores o f the 
untreated foams, hence decreasing their resistance to mechanical stress.
(a) (b) (c)
Figure 4: CaP OPS from left to right: (a) 30N 1280°C, (b) 45L 1280°C, (c) 30T 1280°C.
Flowever, SEM studies revealed the low strengths reported were due to the formation of 
microcracks during thermal shrinkage on cooling. Figure 5 shows examples o f the thermal 
shrinkage due to sintering and the resulting weakness in the scaffold structure thus created. On 
stressing, these microcracks severely limit the strength of the bioceramic. Therefore, the 
mechanical properties of the OPS were not controlled by the different shaped pore structures as
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hypothesised, but by the microcracks formed due to thermal shrinkage. This explains the 
consistently low strengths measured.
Figure 5: Formation o f  microcracks lowering the strength o f  the bioceramic 
Conclusions
A technique has been successfully developed for the production o f CaP open porous scaffold 
(OPS) bioceramics with completely interconnected porosity. The samples produced have a 
superior network o f interconnected porosity compared to previously produced forms of porous 
bioceramics. OPS have pores typically in the size range 150 -  300pm and 40 -  70% porosity by 
volume. The majority of pores were in the appropriate size range for bone ingrowth. The 
mechanical properties o f the samples produced were found to be low. SEM revealed the cause to 
be microcrack formation on sintering. Elongating the pore structure in transverse and longitudinal 
directions did not affect the total porosity of the bioceramics or their mechanical properties. 
Further work will focus on the elimination o f the microcracks in order to optimise the properties 
of the materials produced.
Acknowledgments
The authors wish to thank the University o f Bath and Stryker Howmedica Osteonics for their 
financial support and the Centre o f Electron Optics at the University o f Bath for use of their 
facilities.
References
[1] M. Jarcho: Clinical Orthopaedics and Related Research. Vol. 157 (1981), p.259.
[2] A. Ravaglioli, A. Krajewski: Materials Science Forum. Vol. 250 (1997), p.221.
[3] R. Z. LeGeros: Clinical Orthopaedics and Related Research. Vol. 395 (2002), p.81.
[4] A. Royer, J. C. Vigiue, M. Heughebaert, J. C. Heughebaert: Journal o f Mat. Sci.: Mat. in
Med. Vol. 4 (1993), p.76.
[5] D. M. Liu: Materials Science Forum. Vol. 250 (1997), p. 183.
[6] O. Richart, M. Descamps, A. Liebetrau: Bioceramics 14: Key Engineering Materials. No. 
218-2 (2002), p. 9.
[7] J. Wang, W. Chen, Y. Li, S. Fan, J. Weng, X. Zhang: Biomaterials. Vol. 19 (1998), p. 
1387.
227
